Sabra Health Care REIT (SBRA) 10-K28 Feb 142013 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Feb. 24, 2014	Jun. 30, 2013
Entity Information [Line Items]	'	'	'
Entity Registrant Name	'Sabra Health Care REIT, Inc.	'	'
Entity Central Index Key	'0001492298	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Entity Common Stock, Shares Outstanding	'	38,932,617	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$953.40

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Assets	'	'
Real estate investments, net of accumulated depreciation of $151,078 and $129,479 as of December 31, 2013 and December 31, 2012, respectively	$915,418	$827,135
Loans receivable, net	185,293	12,017
Cash and cash equivalents	4,308	17,101
Restricted cash	5,352	4,589
Deferred tax assets	24,212	24,212
Assets held for sale, net	0	2,215
Prepaid expenses, deferred financing costs and other assets	63,252	29,613
Total assets	1,197,835	916,882
Liabilities and stockholdersâ€™ equity	'	'
Mortgage notes payable	141,328	152,322
Secured revolving credit facility	135,500	92,500
Senior unsecured notes payable	414,402	330,666
Accounts payable and accrued liabilities	22,229	11,694
Tax liability	24,212	24,212
Total liabilities	737,671	611,394
Commitments and contingencies (Note 15)	'	'
Stockholdersâ€™ equity	'	'
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 and zero shares issued and outstanding as of December 31, 2013 and 2012, respectively	58	0
Common stock, $.01 par value; 125,000,000 shares authorized, 38,788,745 and 37,099,209 shares issued and outstanding as of December 31, 2013 and 2012, respectively	388	371
Additional paid-in capital	534,639	353,861
Cumulative distributions in excess of net income	-74,921	-48,744
Total stockholders' equity	460,164	305,488
Total liabilities and stockholdersâ€™ equity	$1,197,835	$916,882

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2012
Assets	'	'	'
Accumulated depreciation	$151,078	'	$129,479
Stockholdersâ€™ equity	'	'	'
Preferred stock, par value	$0.01	'	$0.01
Preferred stock, shares authorized	10,000,000	'	10,000,000
Preferred stock, shares issued	5,750,000	5,800,000	0
Preferred stock, shares outstanding	0	'	0
Common stock, par value	$0.01	'	$0.01
Common stock, shares authorized	125,000,000	'	125,000,000
Common stock, shares issued	38,788,745	'	37,099,202
Common stock, shares outstanding	38,788,745	'	37,099,202

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock	Preferred Stock	Preferred Stock	Preferred Stock	Common Stock	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital	Additional Paid-in Capital	Cumulated Distributions in Excess of Net Income
In Thousands, except Share data	Total	Common Stock	Preferred Stock	Preferred Stock	Preferred Stock	Common Stock	Common Stock	Additional Paid-in Capital	Common Stock	Preferred Stock	Cumulated Distributions in Excess of Net Income
Balance at Dec. 31, 2010	$177,533	'	'	$0	'	$251	'	$177,275	'	'	$7
Common stock, shares outstanding	'	'	'	'	'	36,891,712	'	'	'	'	'
Net income	12,842	'	'	'	'	'	'	'	'	'	12,842
Amortization of stock based compensation	4,600	'	'	'	'	'	'	4,600	'	'	'
Stock issuance, shares	'	'	'	'	'	'	11,830,640	'	'	'	'
Stock issuance	'	163,238	'	'	'	'	118	'	163,120	'	'
Common dividends	-31,640	'	'	'	'	'	'	'	'	'	-31,640
Preferred stock, shares outstanding	'	'	'	0	'	'	'	'	'	'	'
Balance at Dec. 31, 2011	326,573	'	'	0	'	369	'	344,995	'	'	-18,791
Common stock, shares outstanding	37,099,202	'	'	'	'	37,099,209	'	'	'	'	'
Net income	19,513	'	'	'	'	'	'	'	'	'	19,513
Amortization of stock based compensation	8,817	'	'	'	'	'	'	8,817	'	'	'
Stock issuance, shares	'	'	'	'	'	'	207,497	'	'	'	'
Stock issuance	'	51	'	'	'	'	2	'	49	'	'
Common dividends	-49,466	'	'	'	'	'	'	'	'	'	-49,466
Preferred stock, shares outstanding	0	'	'	0	'	'	'	'	'	'	'
Balance at Dec. 31, 2012	305,488	'	'	0	'	371	'	353,861	'	'	-48,744
Common stock, shares outstanding	38,788,745	'	'	'	'	38,788,745	'	'	'	'	'
Net income	33,715	'	'	'	'	'	'	'	'	'	33,715
Amortization of stock based compensation	8,707	'	'	'	'	'	'	8,707	'	'	'
Stock issuance, shares	'	'	'	'	5,750,000	'	1,689,536	'	'	'	'
Stock issuance	'	33,896	138,250	'	58	'	17	'	33,879	138,192	'
Preferred dividends	'	'	'	'	'	'	'	'	'	'	-7,966
Common dividends	-51,926	'	'	'	'	'	'	'	'	'	-51,926
Preferred stock, shares outstanding	0	'	'	5,750,000	'	'	'	'	'	'	'
Balance at Dec. 31, 2013	$460,164	'	'	$58	'	$388	'	$534,639	'	'	($74,921)

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues:	'	'	'
Rental income	$128,988	$101,742	$80,678
Interest income	5,792	1,428	3,547
Total revenues	134,780	103,170	84,225
Expenses:	'	'	'
Depreciation and amortization	33,281	30,263	26,591
Interest	40,460	34,335	30,319
General and administrative	16,423	16,104	14,473
Impairment	0	2,481	0
Total expenses	90,164	83,183	71,383
Other income (expense):	'	'	'
Loss on extinguishment of debt	-10,101	-2,670	0
Other income	-800	2,196	0
Total other income (expense)	-10,901	-474	0
Net income	33,715	19,513	12,842
Preferred stock dividends	7,966	0	0
Net income attributable to common stockholders	$25,749	$19,513	$12,842
Net income per common share, basic	$0.69	$0.53	$0.43
Net income per common share, diluted	$0.68	$0.52	$0.43
Weighted-average number of common shares outstanding, basic	37,514,637	37,061,111	30,109,417
Weighted-average number of common shares outstanding, diluted	38,071,926	37,321,517	30,171,225

Consolidated_Statement_of_Stoc1

Consolidated Statement of Stockholders' Equity (Parenthetical) (USD $)	0 Months Ended								12 Months Ended
	Oct. 23, 2013	Jul. 31, 2013	1-May-13	Jan. 07, 2013	Oct. 29, 2012	Aug. 01, 2012	Apr. 24, 2012	Feb. 29, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Common dividends	$0.34	$0.34	$0.34	$0.34	$0.33	$0.33	$0.33	$0.33	$1.36	$1.32	$0.96

Consolidated_Statement_of_Cash

Consolidated Statement of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income	$33,715	$19,513	$12,842
Adjustments to reconcile net income to net cash provided by operating activities:	'	'	'
Depreciation and amortization	33,281	30,263	26,591
Non-cash interest income adjustments	79	24	0
Amortization of deferred financing costs	3,280	2,685	1,998
Stock-based compensation expense	7,819	8,279	4,600
Amortization of premium	-671	-347	-15
Non-cash loss on extinguishment of debt	859	628	0
Straight-line rental income adjustments	-14,709	-4,893	-2,092
Impairment	0	2,481	0
Change in fair value of contingent consideration	200	0	0
Changes in operating assets and liabilities:	'	'	'
Prepaid expenses and other assets	-3,459	-82	-1,035
Accounts payable and accrued liabilities	5,430	1,321	5,695
Restricted cash	-3,725	-3,620	-3,879
Net cash provided by operating activities	62,099	56,252	44,705
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	-125,955	-205,424	-204,500
Origination of loans receivable	-165,960	-22,180	0
Preferred equity investments	-7,038	0	0
Acquisition of note receivable	'	'	-5,348
Additions to real estate	-764	-1,046	-86
Repayment of note receivable	0	10,000	5,348
Proceeds from sale of real estate	2,208	0	0
Net cash (used in) provided by investing activities	-297,509	-218,650	-204,586
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	200,000	106,000	0
Principal payments on senior unsecured notes	-113,750	0	0
Proceeds from secured revolving credit facility	143,500	135,000	0
Payments on secured revolving credit facility	-100,500	-42,500	0
Proceeds from mortgage notes payable	0	56,651	0
Principal payments on mortgage notes payable	-10,994	-62,226	-3,027
Payments of deferred financing costs	-8,954	-6,800	-677
Payment of contingent consideration	-1,300	0	0
Issuance of preferred stock	138,249	0	0
Issuance of common stock	34,517	53	163,242
Dividends paid	-58,151	-48,929	-31,640
Net cash provided by financing activities	222,617	137,249	127,898
Net (decrease) increase in cash and cash equivalents	-12,793	-25,149	-31,983
Cash and cash equivalents, beginning of period	17,101	42,250	74,233
Cash and cash equivalents, end of period	4,308	17,101	42,250
Supplemental disclosure of cash flow information:	'	'	'
Interest paid	$38,541	$32,613	$28,557

BUSINESS

BUSINESS	12 Months Ended
BUSINESS	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Business	'
	BUSINESS
	Overview
	Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”) and commenced operations on November 15, 2010. Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner, or by subsidiaries of the Operating Partnership. As of December 31, 2013, Sabra’s portfolio included 121 properties held for investment (consisting of (i) 96 skilled nursing/post-acute facilities, (ii) 23 senior housing facilities, and (iii) two acute care hospitals), 10 debt investments (consisting of (i) four mortgage loans, (ii) three construction loans, (iii) one mezzanine loan, and (iv) two pre-development loans) and two preferred equity investments.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation and Basis of Presentation
	The accompanying consolidated financial statements include the accounts of Sabra and its wholly owned subsidiaries as of December 31, 2013 and 2012 and for the years ended December 31, 2013, 2012 and 2011. All material intercompany transactions and balances have been eliminated in consolidation. The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
	GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
	The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. At December 31, 2013, the Company did not have any consolidated VIEs.
	As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2013, none of the Company's investments in loans are accounted for as real estate joint ventures.
	As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies.

	Use of Estimates
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
	Reclassifications
	Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. As a result, certain reclassifications were made to the consolidated statements of income, consolidated statements of cash flows and footnote disclosures for all periods presented.
	Real Estate Investments and Rental Revenue Recognition
	Real Estate Acquisition Valuation
	The Company accounts for the acquisition of income-producing real estate or real estate that will be used for the production of income as a business combination. All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition-date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2013, 2012 and 2011, the Company acquired two, 23, and 11 real estate properties, respectively, and expensed $1.5 million, $1.7 million and $3.2 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income.
	Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
	Depreciation and Amortization
	Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the lesser of the lease term, the expected useful life of the asset on a straight-line basis and the remaining lease term of any ground leases. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years.
	Impairment of Real Estate Investments
	The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. The Company recorded a $2.5 million impairment loss during the year ended December 31, 2012 related to the asset held for sale. The Company did not record any impairment losses on its real estate investments during the years ended December 31, 2013 or 2011.
	Rental Revenue Recognition
	The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. If the lease provides for tenant improvements, the Company determines whether the tenant improvements, for accounting purposes, are owned by the tenant or by the Company. When the Company is the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the physical use of the leased asset until the tenant improvements are substantially completed. When the tenant is the owner of the tenant improvements, any tenant improvement allowance that is funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term.
	The Company makes estimates of the collectibility of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. As of December 31, 2013 and 2012, there was no allowance for doubtful accounts recorded against the Company's tenant receivables.
	Assets Held for Sale and Discontinued Operations
	The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as “assets held for sale” for all periods presented in the accompanying consolidated financial statements. Mortgage notes payable and other liabilities related to real estate held for sale are classified as “liabilities related to assets held for sale” for all periods presented in the accompanying consolidated financial statements. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2012, the Company determined that one property with an aggregate book value of $2.2 million met the held for sale criteria. The asset held for sale was sold on February 1, 2013 for $2.2 million. As of December 31, 2013, the Company did not have any assets held for sale.
	Discontinued operations is a component of an entity that has either been disposed of or is deemed to be held for sale and, (i) the operations and cash flows of the component have been or will be eliminated from ongoing operations as a result of the disposal transaction, and (ii) the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction. Under the agreement with the Company's tenant pertaining to the Company’s asset held for sale as of December 31, 2012, revenues and cash flows associated with the asset held for sale would not be eliminated as a result of the ultimate disposal of the asset. Accordingly, the operations of the asset held for sale as of December 31, 2012 were not classified as discontinued operations.
	Loans Receivable and Interest Income
	Loans Receivable
	The Company’s loans receivable are recorded at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a real estate loan receivable is the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan.
	The Company reviews on a quarterly basis credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The Company’s loans receivable are evaluated for impairment at each balance sheet date. The Company considers a loan to be impaired when, based upon current information and events, it believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the Company’s expectation that it will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the present value of payments expected to be received, observable market prices, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or amounts expected to be received in satisfaction of a loan are lower than the carrying value of that loan. As of December 31, 2013, all of the Company’s loans were performing and none were considered to be impaired.
	Interest Income
	Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest. As of December 31, 2013, no loan investments have been placed on nonaccrual status.
	Cash and Cash Equivalents
	The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value.
	The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2013. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits all funds.
	Restricted Cash
	Restricted cash primarily consists of amounts held by mortgage lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts to the tenants and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheet. As of December 31, 2013 and 2012, restricted cash totaled $5.4 million and $4.6 million, respectively, and restricted cash obligations totaled $3.5 million and $2.3 million, respectively.
	Stock-Based Compensation
	Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors are recognized in the statements of income based on their estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance based vesting conditions is recognized based on the Company's estimate of the ultimate value of such award after considering the Company's expectations of future performance.
	Deferred Financing Costs
	Deferred financing costs representing fees paid to third parties to obtain financing are amortized over the terms of the respective financing agreements using the interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close. As of December 31, 2013 and 2012, the Company’s deferred financing costs were included in prepaid expenses, deferred financing costs and other assets on the accompanying consolidated balance sheets and totaled $15.4 million and $12.4 million, respectively, net of amortization.
	Income Taxes
	The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT.
	The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when a company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
	Fair Value Measurements
	Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired real estate loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:

	•	Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

	•	Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

	•	Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.
	When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach.
	Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument.
	The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market).
	The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities.
	Per Share Data
	Basic earnings per common share is computed by dividing net income applicable to common shares by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities. See Note 12, “Earnings Per Common Share” to the Consolidated Financial Statements.
	Industry Segments
	The Company has one reportable segment consisting of investments in healthcare-related real estate properties.
	Beds, Units and Other Measures
	The number of beds, units and other measures used to describe the Company’s real estate investments included in the Notes to Consolidated Financial Statements are presented on an unaudited basis.

ACQUISITIONS_OF_REAL_ESTATE

ACQUISITIONS OF REAL ESTATE

12 Months Ended

Dec. 31, 2013

Business Combinations [Abstract]

Acquisition of Real Estate

RECENT REAL ESTATE ACQUISITIONS

During the year ended December 31, 2013, the Company acquired one senior housing facility and one acute care hospital for total consideration of $122.8 million. The consideration was allocated as follows (in thousands):

Intangibles

Land

Building and Improvements

Tenant Origination and Absorption Costs

Tenant Relationship

Total Consideration

5,563

114,666

2,196

349

122,774

The tenant origination and absorption costs intangibles and tenant relationship intangibles acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 18 years and 28 years, respectively.

For the year ended December 31, 2013, the Company recognized $2.9 million and $1.0 million of total revenues and net income attributable to common stockholders, respectively, from these properties.

Forest Park - Frisco Contingent Consideration

On October 22, 2013, the Company purchased Forest Park Medical Center - Frisco, a 54-bed acute care hospital located in Frisco, Texas. The total purchase price was $119.8 million, of which approximately $10.5 million is being held in escrow. This amount will be held in escrow for up to 20 months and the amount ultimately released from escrow is contingent on the tenant achieving certain performance hurdles. The seller will be paid a fee of $0.5 million per annum during the escrow period. As of October 22, 2013, the amount the Company expected to release from escrow was valued at $7.3 million and is treated as contingent consideration. As of December 31, 2013, based on the performance of the facility the contingent consideration liability is estimated at $7.5 million and is included in accounts payable and accrued liabilities in the accompanying consolidated balance sheets. As of December 31, 2013, the $10.5 million held in escrow is included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. During the year ended December 31, 2013, the Company recorded an adjustment to the contingent consideration liability of $0.2 million and included this amount in other expense on the accompanying consolidated statements of income.

REAL_ESTATE_INVESTMENTS

REAL ESTATE INVESTMENTS	12 Months Ended
	Dec. 31, 2013
Real Estate Investments, Net [Abstract]	'
Real Estate Investments	'
	REAL ESTATE PROPERTIES HELD FOR INVESTMENT
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of *December 31, 2013*


	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	737,188	$	(132,068	)	$	605,120

	Senior Housing		23		1,518			153,247		(13,337		)	139,910

	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287


			121		12,468			1,066,242		(150,925		)	915,317

	Corporate Level							254		(153		)	101

								$	1,066,496	$	(151,078	)	$	915,418

	As of *December 31, 2012*


	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	746,510	$	(116,426	)	$	630,084

	Senior Housing		22		1,486			148,210		(9,949		)	138,261

	Acute Care Hospital		1		70			61,640		(3,001		)	58,639

			119		12,382			956,360		(129,376		)	826,984

	Corporate Level							254		(103		)	151

								$	956,614	$	(129,479	)	$	827,135



		December 31, 2013			December 31, 2012
	Building and improvements	$	879,926		$	782,221

	Furniture and equipment	50,567			43,810

	Land improvements	4,392			4,535

	Land	131,611			126,048

		1,066,496			956,614

	Accumulated depreciation	(151,078		)	(129,479		)
		$	915,418		$	827,135

	Stoney River Marshfield Earn Out
	On December 18, 2012, the Company acquired a 60-bed assisted living facility, located in Marshfield, Wisconsin ("Stoney River Marshfield"), for $8.2 million through a triple-net sale-leaseback transaction with First Phoenix Group, LLC ("First Phoenix"). At the time of purchase, the facility was not completely stabilized and as such the Company and First Phoenix agreed to an earn out arrangement whereby the Company would pay First Phoenix additional consideration in the future contingent on the performance of the facility. The Company estimated the contingent consideration liability at $1.3 million at the time of purchase. Based on performance of the facility, the Company paid First Phoenix $1.9 million of additional consideration during the year ended December 31, 2013 and recorded additional expense of $0.6 million, which is included in other income (expense) on the accompanying consolidated statements of income.
	Operating Leases
	As of December 31, 2013, all of the Company’s real estate properties were leased under triple-net operating leases with expirations ranging from seven to 21 years. As of December 31, 2013, the leases had a weighted-average remaining term of 11 years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities in the accompanying consolidated balance sheets and totaled $1.6 million and $1.1 million as of December 31, 2013 and 2012, respectively. As of December 31, 2013, 81 of the Company’s 121 real estate properties held for investment were leased to subsidiaries of Genesis.
	The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. Because formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenants’ ability to pay their rent obligations to the Company) is the tenants’ lease coverage ratios. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent coverage at the facility level and consolidated EBITDAR to total fixed charge coverage at the parent guarantor level when such a guarantee exists (currently the Genesis lease portfolio). The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to determine trends and the operational and financial impact of the environment in the industry (including the impact of government reimbursement) and the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenants’ ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company.
	As of December 31, 2013, the future minimum rental income from the Company’s properties under non-cancelable operating leases was as follows (in thousands):


2014	$	126,182

2015	129,218

2016	132,263

2017	135,543

2018	138,909

Thereafter	894,424


	$	1,556,539

TENANT_ORIGINATION_AND_ABSORPT

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP	12 Months Ended
	Dec. 31, 2013
TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP [Abstract]	'
Tenant Origination and Absorption Costs and Tenant Relationship	'
	TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP ASSETS
	As of December 31, 2013 and 2012, the Company’s tenant origination and absorption costs and tenant relationship assets were as follows (in thousands):


		Tenant Origination and Absorption Costs						Tenant Relationship
		December 31,
		2013			2012			2013			2012
	Cost	$	8,884		$	6,688		$	1,900		$	1,551

	Accumulated amortization	(837		)	(344		)	(106		)	(38		)

	Net amount	$	8,047		$	6,344		$	1,794		$	1,513

	Decreases in net income as a result of amortization of the Company’s tenant origination and absorption costs and tenant relationship assets for the years ended December 31, 2013 and 2012 are as follows (in thousands):


		Tenant Origination and Absorption Costs						Tenant Relationship
		For the Year Ended December 31,
		2013			2012			2013			2012

	Amortization	$	(493	)	$	(269	)	$	(68	)	$	(31	)
	The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2013 will be amortized for the years ending December 31 as follows (dollars in thousands):


		Tenant Origination and Absorption Costs			Tenant Relationship


	2014	$	591		$	79

	2015	591			79

	2016	591			79

	2017	591			79

	2018	591			79

	Thereafter	5,092			1,399


		$	8,047		$	1,794


	Weighted-Average Remaining Amortization Period	14.8 years			23.3 years

REAL_ESTATE_LOANS_RECEIVABLE

REAL ESTATE LOANS RECEIVABLE	12 Months Ended
	Dec. 31, 2013
REAL ESTATE LOANS RECEIVABLE [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	LOANS RECEIVABLE AND OTHER INVESTMENTS
	As of December 31, 2013, the Company’s loans receivable consisted of the following (dollars in thousands):


	Loan Type	Number of Loans	Facility Type	Principal Balance as of December 31, 2013		Book Value as of December 31, 2013		Weighted Average Contractual Interest Rate		Weighted Average Annualized Effective Interest Rate		Maturity Date
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	148,925	$	149,450	8.2	%	8.1	%	10/31/16 - 1/31/18

	Construction	3	Acute Care Hospital / Memory Care	13,945		14,283		7.7	%	7.6	%	9/30/16 - 10/31/18

	Mezzanine	1	Skilled Nursing	12,350		12,410		12	%	11.5	%	12/27/14

	Pre-development	2	Senior Housing	1,338		1,366		9	%	8.4	%	8/16/15 - 9/13/16

		10		$	176,558	$	177,509	8.4	%	8.3	%


	Recent Loan Originations
	On November 7, 2013, the Company originated a $14.7 million mortgage loan with an affiliate of the First Phoenix Group (the “Weston Loan”) secured by a 50-unit assisted living facility with a 35-bed skilled nursing rehabilitation unit built in 2013 and located in Weston, Wisconsin (the “Weston Facility”), of which $14.4 million was funded at closing and remains outstanding as of December 31, 2013. The Weston Facility is operated by the First Phoenix Group under the Stoney River brand. The Company has an option to acquire the Weston Facility from the borrower (“Sabra Purchase Option”) and the borrower has the option to require the Company to purchase the Weston Facility (“Borrower's Put Option”). Both the Sabra Purchase Option and the Borrower's Put Option become exercisable upon stabilization of the facility through May 6, 2015. The Weston Loan bears interest at a rate of 9.0% per annum and matures upon the earlier to occur of (i) the exercise of the Sabra Purchase Option, (ii) the exercise of the Borrower's Put Option, (iii) in the event the Sabra Purchase Option and the Borrower's Put Option are not exercised, six months after the facility is stabilized, or (iv) November 7, 2016. The purchase price under the Sabra Purchase Option and Borrower's Put Option is formula-based and is expected to approximate market value at the time of exercise. Should the Company acquire the ownership of the facility, the Company expects to enter into a long-term triple net lease with the First Phoenix Group, which is dependent on the performance of the Weston Facility.
	On October 31, 2013, the Company made two construction mortgage loan commitments with affiliates of New Dawn Holding Company (“New Dawn”) totaling $17.1 million for the construction of two memory care facilities in Virginia (collectively, the “New Dawn Virginia Loans”), of which $2.0 million was funded at closing. The two memory care facilities, located in Henrico, Virginia, and Williamsburg, Virginia, will each have 48 units and will be operated by New Dawn. The Company has an option to acquire the facility securing each of the New Dawn Virginia Loans upon stabilization of that facility. Each of the New Dawn Virginia Loans bears interest at a rate of 10.0% per annum and matures upon the earlier to occur of (i) Sabra exercising its purchase option on the facility securing that New Dawn Virginia Loan or (ii) October 31, 2018. The purchase price under the Company's purchase option agreement is formula-based and is expected to approximate market value at the time of exercise. If the Company were to exercise its option to purchase these facilities, the Company expects to enter into a long-term triple net lease with New Dawn. As of December 31, 2013, the Company had funded $2.1 million under the New Dawn Virginia Loans.
	On October 22, 2013, the Company entered into a $110.0 million mortgage loan secured by Forest Park Medical Center - Dallas, an 84-bed acute care hospital located in Dallas, Texas (the “Forest Park - Dallas Mortgage Loan”). This acute care hospital contains 22 operating rooms and 84 patient rooms. The Forest Park - Dallas Mortgage Loan has a three-year term, bears interest at a fixed rate of 8.0% per annum and cannot be prepaid until the final six months of the loan term. The Forest Park - Dallas Mortgage Loan is secured by the Forest Park Medical Center - Dallas facility. In addition, the Company has an option at any time during the term of the loan to purchase the facility securing the Forest Park - Dallas Mortgage Loan for up to $168.0 million. The borrowers under the Forest Park - Dallas Mortgage Loan have the right, if Forest Park Medical Center - Dallas is able to achieve certain EBITDAR coverage levels, to require the Company to purchase the facility for up to $168.0 million. As of December 31, 2013, this option was not exercisable as the facility had not achieved those certain EBITDAR coverage levels. If either option on the facility were exercised, the Company would expect to assume the existing long-term triple net lease on the facility.
	On September 30, 2013, the Company entered into an agreement to provide up to $66.8 million of construction financing to FPMC Fort Worth Realty Partners, LP (“Forest Park - Fort Worth”) for the construction of a 54-bed acute care hospital with 12 operating rooms, a medical office building and associated parking structure located in Fort Worth, Texas (the “Forest Park - Fort Worth Construction Mortgage Loan”). Also on September 30, 2013, the Company funded $0.5 million of this loan with available cash. Construction of the facility is expected to be completed by mid-2014. The Forest Park - Fort Worth Construction Mortgage Loan has a three-year term and bears interest at a fixed rate of 7.25% per annum, with an option to extend the term for a fourth year with a fixed rate increasing to 8% per annum. The Forest Park - Fort Worth Construction Mortgage Loan will be secured by the facility when built and is partially guaranteed by two founding members of the Forest Park Medical Center system. In addition, the Company has an option to purchase the acute care hospital and associated parking structure starting 12 months after the facility receives a certificate of occupancy through and until the maturity date of the loan, subject to certain limited rights of the borrower. The purchase price under the purchase option agreement will be calculated by dividing the contractual rent due under the existing lease for the facility over the twelve months following closing by the greater of (i) 8.75% and (ii) the sum of (x) the then current 10-year Treasury rate and (y) 525 basis points. If the purchase option on the facility were exercised, the Company would expect to assume the existing long-term triple net lease on the facility. As of December 31, 2013, the Company had funded $11.9 million under the Forest Park - Fort Worth Construction Loan.
	On June 28, 2013, the Company originated a $12.4 million mezzanine loan (the "Chai Mezzanine Loan") with an affiliate of Chai Facilities Acquisition Company, LLC, the indirect owner of twelve skilled nursing facilities having 1,689 licensed beds in seven states (the "Chai Portfolio"). The Chai Mezzanine Loan has an 18-month term with an option to extend the maturity an additional six months and bears interest at a fixed rate of 12.0% per annum. The Chai Mezzanine Loan is secured by the borrower's equity interests in the entities that own the Chai Portfolio. In addition, the Company has an option to purchase up to $50.0 million of properties within the Chai Portfolio. The option, which commenced three months after the origination date and ends on the maturity date of the Chai Mezzanine Loan, can be exercised on any facility within the portfolio as long as the EBITDAR margin for such facility has reached 15% for at least one month. The purchase price for each facility will be determined by taking the annualized EBITDAR of the facility for the trailing three months prior to option exercise, divided by an EBITDAR coverage ratio of 1.50 and further divided by 9.5%. Should the Company exercise its option to purchase any properties in the Chai Portfolio, the Company would expect to enter into a new 15 year master lease with two five-year renewal options with annual rent increases equal to the greater of the change in the Consumer Price Index and 3.0%.
	On January 31, 2013, the Company entered into a $12.8 million mortgage loan agreement with New Dawn secured by a first trust deed on a 48-unit memory care facility located in Sun City West, Arizona ("Sun City West Mortgage Loan"). The Sun City West Mortgage Loan has a five-year term, bears interest at a fixed rate of 9.0% per annum and cannot be prepaid during the first 3 years of the loan term. In addition, beginning April 2014, the Company has an option to purchase the facility securing the Sun City West Mortgage Loan for a price equal to the greater of (a) the annualized EBITDAR of the facility for the trailing three months prior to option exercise, divided by an EBITDAR coverage ratio of 1.30 and further divided by an implied lease rate of 8.25% (subject to adjustment up to 9.00%), and (b) $15.0 million. In the event the Company exercises the purchase option, the Company would expect to enter into a long-term lease with affiliates of New Dawn. The facility was built in 2012 and is operated by affiliates of New Dawn.
	Other Investments
	On March 5, 2013, the Company entered into an agreement to provide up to $7.2 million of preferred equity funding to an affiliate of Meridian Realty Advisors, L.P. (“Meridian”) for the construction of a 141-bed skilled nursing facility and a 52-unit memory care facility in Austin, Texas (collectively, the “Bee Cave Preferred Equity Investments”), of which $4.3 million was funded on March 5, 2013. In addition, the Company received an option to purchase the skilled nursing facility on or after the earlier to occur of the facility achieving and maintaining 90% occupancy for three consecutive months, or 36 months after receiving the certificate of occupancy for the facility. The Company also received an option to purchase the memory care facility that is not expected to be exercised as it is subordinate to a purchase option given to the manager of the memory care facility. In the event the Company were to exercise the purchase option on the skilled nursing facility, the Company would expect to lease the facility to Meridian under a long-term, triple net lease. The Company's preferred equity investment with respect to the skilled nursing facility provides for an annual 15% preferred rate of return, which accrues on a quarterly compounding basis with payment of the preferred return deferred until the earlier of the closing under the purchase option, or 18 months after receiving a certificate of occupancy for the facility. The Company's preferred equity investment with respect to the memory care facility provides for an annual 15% preferred rate of return, which accrues on a quarterly compounding basis with payment of the preferred return deferred until the earlier of the closing under the purchase option (whether by the manager of the facility or by the Company), or 30 months after receiving a certificate of occupancy for the facility. In the event the applicable purchase option is not exercised, the Company has the right to require Meridian to redeem the Company's investment, including the accrued preferred returns associated with such investment, within 180 days. As of December 31, 2013, the Company had funded $6.9 million under the Bee Cave Preferred Equity Investments.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Debt	'
	DEBT

	Mortgage Indebtedness. The Company’s mortgage notes payable consist of the following (dollars in thousands):


	Interest Rate Type	Book Value as of		Book Value as of		Weighted Average		Maturity
		31-Dec-13		December 31, 2012		Interest Rate at		Date
						31-Dec-13
	Fixed Rate	$	54,688	$	94,373	2.62	%	August 2015 - June 2047

	Variable Rate(1)	86,640		57,949		5	%	Aug-15

		$	141,328	$	152,322	4.08	%


	(1) Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.0% (subject to a 1.0% floor).
	5.5% Notes due 2021. On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), completed an underwritten offering of $350.0 million aggregate principal amount of 5.5% senior unsecured notes (the “2021 Notes”). The 2021 Notes were sold at par, resulting in gross proceeds of $350.0 million and net proceeds of approximately $341.4 million after deducting underwriting discounts and other offering expenses. The 2021 Notes accrue interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year. The net proceeds from the sale of the 2021 Notes were used to (i) fund a tender offer for the 2018 Notes, (ii) fund the redemption price for 2018 Notes that were not retired in the Tender Offer, (iii) acquire the Nye Portfolio (see Note 16, “Subsequent Events,” for additional information) and (iv) repay $4.5 million outstanding under Sabra’s amended and restated revolving credit facility.
	The 2021 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after February 1, 2017, at the redemption prices set forth in the 2021 Notes Indenture, plus accrued and unpaid interest to the applicable redemption date. In addition, prior to February 1, 2017, the Issuers may redeem all or a portion of the 2021 Notes at a redemption price equal to 100% of the principal amount of the 2021 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to February 1, 2017, the Issuers may redeem up to 35% of the principal amount of the 2021 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.5% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2021 Notes are not redeemed, the 2021 Notes mature on February 1, 2021.
	5.375% Notes Due 2023. On May 23, 2013, the Issuers completed an underwritten public offering of $200.0 million aggregate principal amount of 5.375% senior unsecured notes (the “2023 Notes”). The 2023 Notes were sold at par, resulting in gross proceeds of $200.0 million and net proceeds of approximately $194.6 million after deducting underwriting discounts and other offering expenses. The 2023 Notes accrue interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year.
	The 2023 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after June 1, 2018, at the redemption prices set forth in the indenture governing the 2023 Notes (the “2023 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to June 1, 2018, the Issuers may redeem all or a portion of the 2023 Notes at a redemption price equal to 100% of the principal amount of the 2023 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to June 1, 2016, the Issuers may redeem up to 35% of the principal amount of the 2023 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.375% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2023 Notes are not redeemed, the 2023 Notes mature on June 1, 2023.
	8.125% Notes due 2018. On October 27, 2010, the Issuers issued $225.0 million aggregate principal amount of 8.125% senior unsecured notes (the “2018 Notes”), resulting in gross proceeds of $225.0 million and net proceeds of approximately $219.9 million after deducting underwriting discounts and other offering expenses. The 2018 Notes accrue interest at a rate of 8.125% per annum payable semiannually on May 1 and November 1 of each year.
	On July 26, 2012, the Issuers issued an additional $100.0 million aggregate principal amount of 2018 Notes, which were treated as a single class with then-outstanding 2018 Notes. The notes were issued at 106.0% providing net proceeds of $103.0 million after underwriting costs and other offering expenses and a yield-to-maturity of 6.92%. The Company used a portion of the proceeds from this offering to repay the borrowings outstanding under the Prior Revolving Credit Facility (defined below). Pursuant to exchange offers completed on March 14, 2011 and on November 14, 2012, respectively, the Issuers exchanged $225.0 million and $100.0 million aggregate principal amount of 2018 Notes that were issued in October 2010 and July 2012 for substantially identical 2018 Notes registered under the Securities Act of 1933, as amended.
	On June 24, 2013, pursuant to the terms of the indenture governing the 2018 Notes (the “2018 Notes Indenture”), the Issuers redeemed $113.8 million in aggregate principal amount of the outstanding 2018 Notes, representing 35% of the aggregate principal amount of the 2018 Notes outstanding. The 2018 Notes were redeemed at a redemption price of 108.125% of the principal amount redeemed, plus accrued and unpaid interest up to the redemption date. The redemption resulted in a $9.8 million loss on extinguishment of debt, including $9.3 million in payments made to noteholders for early redemption and $0.5 million of write-offs associated with unamortized deferred financing costs and issuance premium.
	On January 8, 2014, the Company commenced a cash tender offer with respect to any and all of the outstanding $211.3 million of the 2018 Notes. Pursuant to the tender offer, we retired $210.9 million of the 2018 Notes at a premium of 109.837%, plus accrued and unpaid interest, on January 23, 2014. Pursuant to the terms of the 2018 Notes Indenture, the remaining $0.4 million of the 2018 Notes were called and were retired on February 11, 2014 at a redemption price of 109.485% plus accrued and unpaid interest. The tender offer and redemption will result in approximately $21.6 million of tender offer and redemption related costs and write-offs for the three months ending March 31, 2014, including $20.8 million in payments made to noteholders for early redemption and $0.8 million of write-offs associated with unamortized deferred financing and premium costs.
	The obligations under the 2018 Notes, 2021 Notes and 2023 Notes (collectively, the “Senior Notes”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future material subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances. See Note 13, “Summarized Consolidating Information” for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.
	The indentures governing the Senior Notes (the “Senior Notes Indentures”) contain restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra’s restricted subsidiaries to pay dividends or other amounts to Sabra. Such limitations on distributions also include a limitation on the extent of allowable cumulative distributions made not to exceed the greater of (a) the sum of (x) 95% of cumulative Adjusted Funds from Operations and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status.The Senior Notes Indentures also provide for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Indenture for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Senior Notes may become due and payable immediately. The Company was in compliance with all applicable financial covenants under the Senior Notes Indentures related to the Senior Notes outstanding as of December 31, 2013.
	Revolving Credit Facility. On November 3, 2010, the Operating Partnership and certain subsidiaries of the Operating Partnership (together with the Operating Partnership, the “Borrowers”) entered into a secured revolving credit facility with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement). On February 10, 2012, the Borrowers amended the secured revolving credit facility (as amended, the “Prior Revolving Credit Facility”) to increase the borrowing capacity from $100.0 million to $200.0 million (up to $20.0 million of which may be utilized for letters of credit) and to include an accordion feature that allowed the Borrowers to increase borrowing availability under the Prior Revolving Credit Facility by up to an additional $150.0 million, subject to certain terms and conditions. On September 20, 2012, the Borrowers utilized the accordion feature to increase the borrowing capacity to $230.0 million.
	On July 29, 2013, the Operating Partnership entered into an amended and restated secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility provides for a borrowing capacity of $375.0 million and includes an accordion feature that allows the Operating Partnership to increase the borrowing availability by up to $225.0 million, subject to terms and conditions. While the Prior Revolving Credit Facility was secured by mortgages on certain of the Company's real estate assets, the Revolving Credit Facility is secured by pledges of equity by the Company's wholly-owned subsidiaries that own certain of the Company's real estate assets. This feature provides the Company with increased flexibility to increase the available borrowings under the Revolving Credit Facility. Borrowing availability under the Revolving Credit Facility is subject to a borrowing base calculation based on, among other factors, the mortgageability cash flow (as such term is defined in the Revolving Credit Facility). The Revolving Credit Facility has a maturity date of July 29, 2016, and includes a one year extension option. As of December 31, 2013, there was $135.5 million outstanding under the Revolving Credit Facility and $135.1 million available for borrowing. Subsequent to December 31, 2013, the Company used a portion of the net proceeds from the offering of the 2021 Notes to repay $4.5 million of the borrowings outstanding under the Revolving Credit Facility.
	Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership's option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (referred to as the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the Revolving Credit Facility, and will range from 2.50% to 3.50% per annum for LIBOR based borrowings and 1.50% to 2.50% per annum for borrowings at the Base Rate. As of December 31, 2013, the interest rate on the Revolving Credit Facility was 3.17%. In addition, the Operating Partnership is required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Revolving Credit Facility. During the year ended December 31, 2013, the Company incurred $1.7 million in interest expense on amounts outstanding under the Revolving Credit Facility and $1.2 million of unused facility fees.
	The obligations of the Operating Partnership under the Revolving Credit Facility are guaranteed by Sabra and certain subsidiaries of Sabra.
	The Revolving Credit Facility contains customary covenants that include restrictions or limitations on the ability to make acquisitions and other investments, make distributions, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. Such limitations on distributions also include a limitation on the extent of allowable distributions made during a trailing four-quarter period not to exceed the greater of (a) the sum of (x) Adjusted Funds from Operations for the trailing four-quarter periods and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status. The Revolving Credit Facility also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of December 31, 2013, the Company was in compliance with all applicable financial covenants under the Revolving Credit Facility.
	Interest Expense. During the years ended December 31, 2013, 2012 and 2011, the Company incurred interest expense of $40.5 million, $34.3 million and $30.3 million, respectively. Included in interest expense for the years ended December 31, 2013, 2012 and 2011, was $3.3 million, $2.7 million and $2.0 million, respectively, of deferred financing costs amortization. As of December 31, 2013 and 2012, the Company had $4.7 million and $5.4 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying consolidated balance sheets.
	Extinguishment of Debt. During the year ended December 31, 2013, the Company recognized $10.1 million of debt extinguishment loss due to the redemption premium and write-offs of unamortized deferred financing costs and issuance premium associated with the redemption of $113.8 million in aggregate principal amount of the outstanding 2018 Notes and write-offs of unamortized deferred financing costs associated with the Revolving Credit Facility. During the year ended December 31, 2012, the Company recognized $2.7 million of debt extinguishment loss due to the write-offs of unamortized deferred financing costs and prepayment penalty fees associated with mortgage debt refinancing.
	The following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2013 (in thousands):


		Mortgage		Senior Notes (1)		Secured Revolving			Total
		Indebtedness				Credit Facility (2)
	2014	$	3,739	$	—	$	—		$	3,739

	2015	86,075		—		—			86,075

	2016	1,647		—		135,500			137,147

	2017	1,688		—		—			1,688

	2018	1,730		211,250		—			212,980

	Thereafter	46,449		200,000		—			246,449

		$	141,328	$	411,250	$	135,500		$	688,078


	(1) Outstanding principal balance for Senior Notes does not include premium of $3.2 million as of December 31, 2013.
	(2) Subject to a one-year extension option.

FAIR_VALUE_DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures	'
	FAIR VALUE DISCLOSURES
	The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.
	Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows:
	Loans receivable: These instruments are presented in the accompanying consolidated balance sheets at their amortized cost and not at fair value. The fair value of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, the underlying collateral value and other credit enhancements.
	Preferred equity investments: These instruments are presented in the accompanying consolidated balance sheets at their cost and not at fair value. The fair value of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investment, the underlying collateral value and other credit enhancements.
	Senior Notes: The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades.
	Mortgage indebtedness: The fair values of the Company’s mortgage notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements.
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2013 and December 31, 2012 whose carrying amounts do not approximate their fair value (in thousands):



		December 31, 2013								December 31, 2012
		Face		Carrying			Fair			Face		Carrying		Fair
		Value (1)		Amount (2)			Value			Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	176,558	$	177,509		$	176,985		$	11,965	$	12,017	$	12,826

	Preferred equity investments	7,695		7,784			7,950			—		—		—

	Financial liabilities:
	Senior Notes	411,250		414,402			421,122			325,000		330,666		345,313

	Mortgage indebtedness	141,328		141,328			130,622			152,322		152,322		152,559


	(1) Face value represents amounts contractually due under the terms of the respective agreements.
	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).
	The Company determined the fair value of financial instruments as of December 31, 2013 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):


				Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets			Significant Other Observable Inputs			Significant Unobservable Inputs
		Total		(Level 1)			(Level 2)			(Level 3)
	Financial assets:
	Loans receivable	$	176,985	$	—		$	—		$	176,985

	Preferred equity investments	7,950		—			—			7,950

	Financial liabilities:
	Senior Notes	421,122		—			421,122			—

	Mortgage indebtedness	130,622		—			—			130,622

	Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.
	During the year ended December 31, 2013, the Company recorded the following amounts measured at fair value (in thousands):


				Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs			Significant Unobservable Inputs
		Total		(Level 1)		(Level 2)			(Level 3)
	Recurring Basis:
	Contingent consideration	$	7,500	—		—			7,500

	The Company’s contingent consideration liability is the result of a $10.5 million purchase price holdback for the Forest Park Medical Center - Frisco facility (the “Holdback Fee”), the release of which is contingent on the tenant achieving certain performance hurdles. In order to determine the fair value of the the Company’s contingent consideration liability, the Company developed probability-weighted scenarios of the potential future performance of the tenant and the resulting payout of the Holdback Fee from these scenarios. As of December 31, 2013, the contingent consideration liability was valued at $7.5 million.
	The following reconciliation provides the details of activity during the year ended December 31, 2013 for financial instruments recorded at fair value using Level 3 inputs:


	Balance as of December 31, 2012	$	1,300

	New contingent liability	7,300

	Increase in contingent liability	800

Settlement of contingent liability	(1,900		)
Balance as of December 31, 2013	$	7,500

The increase in contingent liability was included as other expense on the accompanying consolidated statements of income for the year ended December 31, 2013.

EQUITY

12 Months Ended

Dec. 31, 2013

Equity [Abstract]

Equity

EQUITY

Preferred Stock

On March 21, 2013, the Company completed an underwritten public offering of 5.8 million shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the “Series A Preferred Stock”) at a price of $25.00 per share, pursuant to an effective registration statement. The Company received net proceeds of $138.3 million from the offering, after deducting underwriting discounts and other offering expenses.

The holders of the Company’s Series A Preferred Stock rank senior to the Company’s common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. Holders of shares of the Series A Preferred Stock will generally have no voting rights. However, if dividends on the Series A Preferred Stock are in arrears for six or more quarterly periods, whether or not consecutive, holders of shares of the Series A Preferred Stock will be entitled to vote for the election of two additional directors to serve on the Company’s board of directors until all accrued dividends for past dividend periods with respect to the Series A Preferred Stock have been paid or declared and a sum sufficient for the payment thereof set apart for payment. The holders of Series A Preferred Stock also have voting rights with respect to the Company in certain other circumstances. At December 31, 2013, there were no dividends in arrears.

Generally, the Company is not permitted to redeem the Series A Preferred Stock prior to March 21, 2018, except in limited circumstances to preserve its status as a REIT and pursuant to the special optional redemption provision described below. On or after March 21, 2018, the Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends on such Series A Preferred Stock up to, but not including, the redemption date. In addition, upon the occurrence of a specified change of control (as described in the Articles Supplementary governing the Series A Preferred Stock), the Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends to, but not including, the date of redemption. If the Company exercises any of its redemption rights relating to the Series A Preferred Stock, the holders of Series A Preferred Stock will not have the conversion right described below. The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund.

Upon the occurrence of a specified change of control, each holder of Series A Preferred Stock will have the right (unless, prior to the change of control conversion date specified in the Articles Supplementary governing the Series A Preferred Stock, the Company has provided or provides notice of its election to redeem the Series A Preferred Stock) to convert some or all of the shares of Series A Preferred Stock held by such holder into a number of shares of the Company’s common stock per share of Series A Preferred Stock to be converted equal to the lesser of:

•

the quotient obtained by dividing (i) the sum of the $25.00 liquidation preference plus the amount of any accrued and unpaid dividends to, but not including, the change of control conversion date (unless the change of control conversion date is after a record date for a Series A Preferred Stock dividend payment and prior to the corresponding Series A Preferred Stock dividend payment date, in which case no additional amount for any accrued and unpaid dividend that will be paid on such dividend payment date will be included in this sum) by (ii) the common stock price (as defined in the Articles Supplementary); and

•

1.7864 (the share cap), subject to certain adjustments;

subject, in each case, to provisions for the receipt of alternative consideration as described in the Articles Supplementary governing the Series A Preferred Stock.

Upon issuance of the Series A Preferred Stock, the Company classified the par value as preferred equity on its condensed consolidated balance sheets with the balance of the liquidation preference, net of any issuance costs, recorded as an increase in paid-in capital.

Common Stock

At-The-Market Common Stock Offering Program (“ATM Program”)

On March 18, 2013, the Company entered into a sales agreement (each, a “Sales Agreement”) with each of Barclays Capital Inc., Cantor Fitzgerald & Co., Credit Agricole Securities (USA) Inc., RBC Capital Markets, LLC, RBS Securities Inc. and Wells Fargo Securities, LLC (individually, a “Sales Agent” and together, the “Sales Agents”) to sell shares of its common stock having aggregate gross proceeds of up to $100.0 million (the “ATM Shares”) from time to time through the Sales Agents.

Pursuant to the terms of the Sales Agreements, the ATM Shares may be sold by any method permitted by law deemed to be an “at-the-market” offering, including, without limitation, sales made directly on the NASDAQ Global Select Market, on any other existing trading market for the Company's common stock or to or through a market maker. In addition, with the Company's prior consent, the Sales Agents may also sell the ATM Shares in privately negotiated transactions. The Company will pay each Sales Agent a commission of up to 2% of the gross proceeds from the sales of ATM Shares sold pursuant to the applicable Sales Agreement.

During the three months and year ended December 31, 2013, the Company sold 1.4 million ATM Shares, at an average price of $27.01 per share, generating gross proceeds of approximately $38.3 million, before $0.7 million of commissions. In addition, as of December 31, 2013, the Company had $61.7 million available under the ATM Program.

Other Common Stock Issuances

The following is a summary of the Company’s other common stock issuances during the years ended December 31, 2013 and 2012:

Year Ended December 31,

2013

2012

Exercise of stock options

33,935

41,640

Vesting of common stock units

239,088

165,857

Dividends on Common Stock

The following table lists the cash dividends on common stock paid and declared by the Company during the years ended December 31, 2013 and 2012:

Declaration Date

Record Date

Amount Per Share

Dividend Payable Date

29-Feb-12

15-Mar-12

0.33

30-Mar-12

24-Apr-12

15-May-12

0.33

31-May-12

1-Aug-12

15-Aug-12

0.33

31-Aug-12

29-Oct-12

15-Nov-12

0.33

30-Nov-12

7-Jan-13

15-Feb-13

0.34

28-Feb-13

1-May-13

15-May-13

0.34

31-May-13

31-Jul-13

15-Aug-13

0.34

30-Aug-13

23-Oct-13

15-Nov-13

0.34

29-Nov-13

Distributions with respect to the Company’s common stock can be characterized for federal income tax purposes as taxable ordinary dividends, capital gain dividends, nondividend distributions (return of capital) or a combination thereof. Following is the characterization of the Company’s cash dividends on common stock per share during the years ended December 31, 2013, 2012 and 2011:

Year Ended December 31,

2013

2012

2011

Ordinary dividends

0.4672

0.7992

0.7833

Nondividend distributions

0.8928

0.5208

0.1767

1.36

1.32

0.96

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2013
STOCK-BASED COMPENSATION [Abstract]	'
Stock-based Compensation	'
	STOCK-BASED COMPENSATION
	All stock-based awards are subject to the terms of the 2009 Performance Incentive Plan, which was assumed by the Company in connection with the Separation and REIT Conversion Merger and amended and restated in June 2013. The 2009 Performance Incentive Plan provides for the granting of stock-based compensation, including stock options, time-based stock units, funds from operations-based stock units ("FFO Units"), relative total stockholder return-based stock units ("TSR Units") and performance based restricted stock units to officers, employees and directors in connection with their employment with or services provided to the Company.
	Stock Options
	A summary of the option activity is presented in the following table (dollars in thousands, except per share amounts):


			Range of Per Share Exercise Price		Shares Under Options			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
	Outstanding as of December 31, 2012		$14.37 - $21.83		362,770			$	18.97	2.7	$	1,011

	Granted		—		—			—

	Exercised		$14.37 - $21.83		(298,484	)		19.35

	Forfeited		—		—			—



	Outstanding as of December 31, 2013		$17.17 - $17.31		64,286			$	17.22	2.9	$	574



	Exercisable as of December 31, 2013		$17.17 - $17.31		42,857			$	17.24	2.7	$	381

	The total intrinsic value of stock options exercised was $1.8 million, $0.2 million and $0.2 million during the years ended December 31, 2013, 2012 and 2011, respectively. The Company received $0.5 million for the stock options exercised during each of the years ended December 31, 2012 and 2011. The exercise price for the stock options exercised during the year ended December 31, 2013 was paid through the withholding of shares. The total fair value of stock options that vested during the years ended December 31, 2013, 2012 and 2011 was $0.3 million, $0.6 million and $0.7 million, respectively.
	Restricted Stock Units and Performance-Based Restricted Stock Units
	Under the 2009 Performance Incentive Plan, restricted stock units and performance-based restricted stock units generally have a contractual life or vest over a three- to five-year period. The vesting of certain restricted stock units may accelerate, as defined in the grant, upon retirement, a change in control and other events. When vested, each performance-based restricted stock unit is convertible into one share of common stock. The restricted stock units are valued on the grant date based on the market price of the Company's common stock on that date. Generally, the Company recognizes the fair value of the awards over the applicable vesting period as compensation expense. In addition, since the shares to be issued may vary based on the performance of the Company, the Company must make assumptions regarding the projected performance criteria and the shares that will ultimately be issued. The amount of FFO Units that will ultimately vest is dependent on the amount by which the Company's funds from operation ("FFO") differs from a target FFO amount for a period specified in each grant and will range from 0% to 250% of the FFO Units initially granted. Similarly, the amount of TSR Units that will ultimately vest is dependent on the amount by which the total shareholder return ("TSR") of the Company's common stock differs from a predefined peer group for a period specified in each grant and will range from 0% to 150% of the TSR Units initially granted. Upon any payment of restricted stock units, the participant is required to pay the related tax withholding obligation. The 2009 Performance Incentive Plan provides that unless otherwise elected in advance by the participant, the Company will reduce the number of shares to be delivered to pay the related statutory tax withholding obligation. The value of the shares withheld is dependent on the closing price of the Company's common stock on the date the relevant transaction occurs.
	The following table summarizes additional information concerning restricted stock units at December 31, 2013:


			Restricted Stock Units			Weighted Average Grant Date Fair Value Per Unit
	Unvested as of December 31, 2012		690,107			$	17.54

	Granted		456,921			18.52

	Vested		(513,750	)		20.83

	Dividends reinvested		30,936			16.8


	Unvested as of December 31, 2013		664,214			$	16.48


	As of December 31, 2013, the weighted average remaining vesting period of restricted stock units was 2.2 years. The weighted average fair value per share at the date of grant for restricted stock units for the years ended December 31, 2013, 2012 and 2011 was $18.52, $18.34 and $16.74, respectively. The total fair value of units vested during the years ended December 31, 2013, 2012 and 2011 was $10.7 million, $2.1 million and $1.3 million, respectively.
	The fair value of the TSR Units are estimated on the date of grant using a Monte Carlo valuation model that uses the assumptions noted in the table below. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility was based on historical volatility for the most recent 3-year period ending on the grant date for the Company and the selected peer companies, and calculated on a daily basis. The following are the key assumptions used in this valuation:


		2013			2012			2011
	Risk Free Interest Rate	0.37% - 0.67%			0.38 % - 0.40%			1.18	%

	Expected Stock Price Volatility	33.36% - 36.11%			36.41% - 48.05%			49.2	%

	Expected Service Period	3.0 years			3.0 years			2.7 years

	Expected Dividend Yield (assuming full reinvestment)	—	%		—	%		—	%
	During the years ended December 31, 2013, 2012 and 2011, the Company recognized $7.8 million, $8.3 million and $4.6 million, respectively, of stock-based compensation expense. As of December 31, 2013, there was $7.3 million of total unrecognized stock-based compensation expense related to unvested awards, which is expected to be recognized over a weighted average period of 2.4 years.
	Employee Benefit Plan
	The Company maintains a 401(k) plan that allows for eligible participants to defer compensation, subject to certain limitations imposed by the Internal Revenue Code of 1986, as amended (the “Code”). The Company provides a discretionary matching contribution of up to 3% of each participant's eligible compensation. During the years ended December 31, 2013, 2012 and 2011, the Company's matching contributions were approximately $44,000, $25,000 and $27,000, respectively.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011 and, therefore, the Company did not incur any income tax expense during the years ended December 31, 2013, 2012 and 2011. Taxable income generated during the period preceding this election is subject to federal and state income taxes.
	The Company is subject to corporate income tax on built-in gains (the excess of fair market value over tax basis on properties held by Sabra as of the date Sabra elected to be taxed as a REIT, or January 1, 2011) on taxable dispositions of properties acquired in the REIT Conversion Merger during the first ten years following the election to be taxed as a REIT. As of January 1, 2011, the built-in-gains tax associated with the Company’s properties totaled approximately $145.8 million assuming a 40% corporate tax rate. This built-in gains tax is generally not payable on dispositions of property to the extent the proceeds from such dispositions are reinvested in qualifying like-kind replacement property as defined under various provisions of the Code. The Company does not expect to dispose of any properties held by Sabra at the Separation Date if such a disposition would result in the imposition of a material tax liability. Gains from asset dispositions occurring more than 10 years after the acquisition will not be subject to this corporate-level tax. As a result, the Company has not recorded a deferred tax liability associated with this corporate-level tax.
	The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands):





	Balance at December 31, 2011	$	25,540


	Additions (reductions) based on prior years’ tax positions	(1,328		)
	Additions (reductions) based on 2012 tax positions	—


	Balance at December 31, 2012	$	24,212


	Additions (reductions) based on prior years’ tax positions	—

	Additions (reductions) based on 2013 tax positions	—


	Balance at December 31, 2013	$	24,212


	The Company does not anticipate that the balance in unrecognized tax benefits will change materially in fiscal year 2014. During the period from the Separation Date through December 31, 2013, neither the Company nor its subsidiaries were assessed interest or penalties by any major tax jurisdictions. There would be no effect on the Company’s tax rate if the unrecognized tax benefits were to result in additional taxes owed due to the availability of net operating loss (“NOL”) carryforwards. The NOL carryforwards are recorded as deferred tax assets and have expiration dates from 2019 through 2027. With certain exceptions, the Company is no longer subject to U.S. federal, state or local income tax examinations for years before 2009. For the years before 2009, these jurisdictions can, however, adjust NOL carryforwards from earlier years.

EARNINGS_PER_COMMON_SHARE

EARNINGS PER COMMON SHARE	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Earnings Per Common Share	'
	EARNINGS PER COMMON SHARE
	The following table illustrates the computation of basic and diluted earnings per share for the years ended December 31, 2013, 2012 and 2011 (in thousands, except share and per share amounts):


		Year Ended December 31,
		2013		2012		2011
	Numerator
	Net income attributable to common stockholders	$	25,749	$	19,513	$	12,842


	Denominator
	Basic weighted average common shares and common equivalents	37,514,637		37,061,111		30,109,417

	Dilutive stock options and restricted stock units	557,289		260,406		61,808


	Diluted weighted average common shares	38,071,926		37,321,517		30,171,225


	Net income attributable to common stockholders, per:

	Basic common share	$	0.69	$	0.53	$	0.43


	Diluted common share	$	0.68	$	0.52	$	0.43

	Certain restricted stock units are considered participating securities because dividend payments are not forfeited even if the underlying award does not vest. Accordingly, the Company uses the two-class method when computing basic and diluted earnings per share. During the years ended December 31, 2013, 2012 and 2011, approximately 46,000, 27,000 and 2,400 restricted stock units, respectively, were not included because they were anti-dilutive. During the years ended December 31, 2012 and 2011, approximately 60,000 and 173,000 stock options, respectively, were not included because they were anti-dilutive. No stock options were considered anti-dilutive during the year ended December 31, 2013.

SUMMARIZED_CONDENSED_CONSOLIDA

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION	12 Months Ended
	Dec. 31, 2013
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Summarized Condensed Consolidating Information	'
	SUMMARIZED CONSOLIDATING INFORMATION
	In connection with the offerings of the Senior Notes by the Issuers in October 2010, July 2012 and May 2013, the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries.
	A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of:

	•	Any sale of the subsidiary Guarantor or of all or substantially all of its assets;

	•	A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor;

	•	A subsidiary Guarantor is declared “unrestricted” for covenant purposes under the Senior Notes Indentures;

	•	The requirements for legal defeasance or covenant defeasance or to discharge the Senior Notes Indentures have been satisfied;

	•	A liquidation or dissolution, to the extent permitted under the Senior Notes Indentures, of a subsidiary Guarantor; and

	•	The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty.
	Pursuant to Rule 3-10 of Regulation S-X, the following summarized consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra’s proportionate share of each subsidiary’s net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the consolidating statement of cash flows.
	Consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:


















	CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(in thousands, except share and per share amounts)



		Parent			Issuers			Combined			Combined Non-			Elimination				Consolidated
		Company						Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101		$	—		$	751,771		$	163,546		$	—			$	915,418

	Loans receivable and other investments, net	—			—			185,293			—			—				185,293

	Cash and cash equivalents	3,551			—			—			757			—				4,308

	Restricted cash	—			—			121			5,231			—				5,352

	Deferred tax assets	24,212			—			—			—			—				24,212

	Prepaid expenses, deferred financing costs and other assets	1,217			9,207			46,694			6,134			—				63,252

	Intercompany	333,125			270,194			—			42,637			(645,956		)		—

	Investment in subsidiaries	128,640			267,505			25,205			—			(421,350		)		—

	Total assets	$	490,846		$	546,906		$	1,009,084		$	218,305		$	(1,067,306	)		$	1,197,835

Liabilities and stockholders’ equity
Mortgage notes payable	$	—		$	—		$	—		$	141,328		$	—			$	141,328

Secured revolving credit facility	—			—			135,500			—			—				135,500

Senior unsecured notes payable	—			414,402			—			—			—				414,402

Accounts payable and accrued liabilities	6,470			3,864			11,008			887			—				22,229

Tax liability	24,212			—			—			—			—				24,212

Intercompany	—			—			645,956			—			(645,956		)		—

Total liabilities	30,682			418,266			792,464			142,215			(645,956		)		737,671

Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2013	58			—			—			—			—				58

Common stock, $.01 par value; 125,000,000 shares authorized, 38,788,745 shares issued and outstanding as of December 31, 2013	388			—			—			—			—				388

Additional paid-in capital	534,639			21,226			53,574			48,507			(123,307		)		534,639

Cumulative distributions in excess of net income	(74,921		)	107,414			163,046			27,583			(298,043		)		(74,921		)

Total stockholders’ equity	460,164			128,640			216,620			76,090			(421,350		)		460,164

Total liabilities and stockholders’ equity	$	490,846		$	546,906		$	1,009,084		$	218,305		$	(1,067,306	)		$	1,197,835


CONSOLIDATING BALANCE SHEET
December 31, 2012
(in thousands, except share and per share amounts)



	Parent			Issuers			Combined			Combined Non-			Elimination				Consolidated
	Company						Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Assets
Real estate investments, net of accumulated depreciation	$	151		$	—		$	655,881		$	171,103		$	—			$	827,135

Loan receivable, net	—			—			12,017			—			—				12,017

Cash and cash equivalents	15,075			—			—			2,026			—				17,101

Restricted cash	—			—			92			4,497			—				4,589

Deferred tax assets	24,212			—			—			—			—				24,212

Assets held for sale, net	—			—			—			2,215			—				2,215

Prepaid expenses, deferred financing costs and other assets	1,315			7,339			18,133			2,826			—				29,613

Intercompany	—			227,396			—			37,466			(264,862		)		—

Investment in subsidiaries	351,632			451,975			23,142			—			(826,749		)		—

Total assets	$	392,385		$	686,710		$	709,265		$	220,133		$	(1,091,611	)		$	916,882

Liabilities and stockholders’ equity
Mortgage notes	$	—		$	—		$	—		$	152,322		$	—			$	152,322

Secured revolving credit facility	—			—			92,500			—			—				92,500

Senior unsecured notes	—			330,666			—			—			—				330,666

Accounts payable and accrued liabilities	3,281			4,412			3,348			653			—				11,694

Tax liability	24,212			—			—			—			—				24,212

Intercompany	59,404			—			205,458			—			(264,862		)		—

Total liabilities	86,897			335,078			301,306			152,975			(264,862		)		611,394

Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2012	—			—			—			—			—				—

Common stock, $.01 par value; 125,000,000 shares authorized, 37,099,209 shares issued and outstanding as of December 31, 2012	371			—			—			—			—				371

Additional paid-in capital	353,861			292,939			321,666			53,952			(668,557		)		353,861

Retained earnings	(48,744		)	58,693			86,293			13,206			(158,192		)		(48,744		)

Total stockholders’ equity	305,488			351,632			407,959			67,158			(826,749		)		305,488

Total liabilities and stockholders’ equity	$	392,385		$	686,710		$	709,265		$	220,133		$	(1,091,611	)		$	916,882


CONSOLIDATING STATEMENT OF INCOME
For the Year Ended December 31, 2013
(in thousands, except share and per share amounts)



	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Revenues:
Rental income	$	—		$	—		$	99,711		$	29,277		$	—			$	128,988

Interest and other income	86			—			5,706			—			—				5,792

Total revenues	86			—			105,417			29,277			—				134,780

Expenses:
Depreciation and amortization	51			—			25,664			7,566			—				33,281

Interest	—			28,767			4,444			7,249			—				40,460

General and administrative	15,040			4			1,294			85			—				16,423

Total expenses	15,091			28,771			31,402			14,900			—				90,164


Other income (expense):
Loss on extinguishment of debt	—			(9,750		)	(351		)	—			—				(10,101		)

Other expense	—			—			(800		)	—			—				(800		)


Total other income (expense)	—			(9,750		)	(1,151		)	—			—				(10,901		)


Income in subsidiary	48,720			87,241			3,889			—			(139,850		)		—


Net income	33,715			48,720			76,753			14,377			(139,850		)		33,715


Preferred dividends	(7,966		)	—			—			—			—				(7,966		)


Net income attributable to common stockholders	$	25,749		$	48,720		$	76,753		$	14,377		$	(139,850	)		$	25,749


Net income attributable to common stockholders, per:
Basic common share																	$	0.69

Diluted common share																	$	0.68

Weighted-average number of common shares outstanding, basic																	37,514,637

Weighted-average number of common shares outstanding, diluted																	38,071,926

CONSOLIDATING STATEMENT OF INCOME
For the Year Ended December 31, 2012
(in thousands, except share and per share amounts)



	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Revenues:
Rental income	$	—		$	—		$	75,606		$	26,136		$	—			$	101,742

Interest and other income	18			—			1,410			—			—				1,428

Total revenues	18			—			77,016			26,136			—				103,170

Expenses:
Depreciation and amortization	49			—			22,061			8,153			—				30,263

Interest	—			22,392			2,724			9,219			—				34,335

General and administrative	14,631			3			1,392			78			—				16,104

Impairment	—						—			2,481			—				2,481

Total expenses	14,680			22,395			26,177			19,931			—				83,183


Other income (expense):
Loss on extinguishment of debt	—			—			—			(2,670		)	—				(2,670		)

Other income	—			—			—			2,196			—				2,196


Total other income (expense)	—			—			—			(474		)	—				(474		)


Income (loss) in subsidiary	34,175			56,570			(3,693		)	—			(87,052		)		—


Net income attributable to common stockholders	$	19,513		$	34,175		$	47,146		$	5,731		$	(87,052	)		$	19,513


Net income attributable to common stockholders, per:
Basic common share																	$	0.53

Diluted common share																	$	0.52

Weighted-average number of common shares outstanding, basic																	37,061,111

Weighted-average number of common shares outstanding, diluted																	37,321,517


CONSOLIDATING STATEMENT OF INCOME
For the Year Ended December 31, 2011
(in thousands, except share and per share amounts)



	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Revenues:
Rental income	$	—		$	—		$	55,447		$	25,231		$	—			$	80,678

Interest and other income	64			—			3,479			4			—				3,547

Total revenues	64			—			58,926			25,235			—				84,225

Expenses:
Depreciation and amortization	53			—			18,144			8,394			—				26,591

Interest	—			18,913			1,333			10,073			—				30,319

General and administrative	9,905			1			4,476			91			—				14,473

Total expenses	9,958			18,914			23,953			18,558			—				71,383


Income in subsidiary	22,736			41,650			493			—			(64,879		)		—


Net income attributable to common stockholders	$	12,842		$	22,736		$	35,466		$	6,677		$	(64,879	)		$	12,842


Net income attributable to common stockholders, per:
Basic common share																	$	0.43

Diluted commons share																	$	0.43

Weighted-average number of common shares outstanding, basic																	30,109,417

Weighted-average number of common shares outstanding, diluted																	30,171,225



CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2013
(in thousands)



	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Net cash provided by operating activities	$	47,810		$	—		$	—		$	14,289		$	—			$	62,099

Cash flows from investing activities:
Acquisitions of real estate	—			—			(125,955		)	—			—				(125,955		)

Origination of loans receivable	—			—			(165,960		)	—			—				(165,960		)

Preferred equity investments	—			—			(7,038		)	—			—				(7,038		)

Additions to real estate	—			—			(764		)	—			—				(764		)

Net proceeds from the sale of real estate	—			—			—			2,208			—				2,208

Distribution from Subsidiary	4,066			4,066			—			—			(8,132		)		—

Intercompany financing	(178,015		)	(258,819		)	—			—			436,834				—

Net cash (used in) provided by investing activities	(173,949		)	(254,753		)	(299,717		)	2,208			428,702				(297,509		)

Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes	—			200,000			—			—			—				200,000

Principal payments on senior unsecured notes	—			(113,750		)	—			—			—				(113,750		)

Proceeds from secured revolving credit facility	—			—			143,500			—			—				143,500

Payments on secured revolving credit facility	—			—			(100,500		)	—			—				(100,500		)

Principal payments on mortgage notes payable	—			—			—			(10,994		)	—				(10,994		)

Payments of deferred financing costs	—			(5,446		)	(3,010		)	(498		)	—				(8,954		)

Payment of contingent consideration	—			—			(1,300		)	—			—				(1,300		)

Issuance of preferred stock	138,249			—			—			—			—				138,249

Issuance of common stock	34,517			—			—			—			—				34,517

Dividends paid on common and preferred stock	(58,151		)	—			—			—			—				(58,151		)

Distribution to Parent	—			(4,066		)	—			(4,066		)	8,132				—

Intercompany financing	—			178,015			261,027			(2,208		)	(436,834		)		—

Net cash provided by (used in) financing activities	114,615			254,753			299,717			(17,766		)	(428,702		)		222,617

Net decrease in cash and cash equivalents	(11,524		)	—			—			(1,269		)	—				(12,793		)

Cash and cash equivalents, beginning of period	15,075			—			—			2,026			—				17,101

Cash and cash equivalents, end of period	$	3,551		$	—		$	—		$	757		$	—			$	4,308


CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2012
(in thousands)




	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Net cash provided by operating activities	$	53,584		$	—		$	—		$	2,668		$	—			$	56,252

Cash flows from investing activities:
Acquisitions of real estate	—			—			(205,424		)	—			—				(205,424		)

Origination of note receivable	—			—			(22,180		)	—			—				(22,180		)

Additions to real estate	(14		)	—			(1,032		)	—			—				(1,046		)

Repayment of note receivable	—			—			10,000			—			—				10,000

Investment in Subsidiary	(7,191		)	(7,191		)	—			—			14,382				—

Distribution from Subsidiary	1,751			1,751			—			—			(3,502		)		—

Intercompany financing	(25,915		)	(128,721		)	—			—			154,636				—

Net cash used in investing activities	(31,369		)	(134,161		)	(218,636		)	—			165,516				(218,650		)

Cash flows from financing activities:
Proceeds from the issuance of senior unsecured notes	—			106,000			—			—			—				106,000

Proceeds from secured revolving credit facility	—			—			135,000			—			—				135,000

Payments on secured revolving credit facility	—			—			(42,500		)	—			—				(42,500		)

Proceeds from mortgage notes	—			—			—			56,651			—				56,651

Principal payments on mortgage notes payable	—			—			—			(62,226		)	—				(62,226		)

Payments of deferred financing costs	—			(3,194		)	(2,585		)	(1,021		)	—				(6,800		)

Issuance of common stock	53			—			—			—			—				53

Dividends paid	(48,929		)	—			—			—			—				(48,929		)

Contribution from Parent	—			7,191			—			7,191			(14,382		)		—

Distribution to Parent	—			(1,751		)	—			(1,751		)	3,502				—

Intercompany financing	—			25,915			128,721			—			(154,636		)		—

Net cash (used in) provided by financing activities	(48,876		)	134,161			218,636			(1,156		)	(165,516		)		137,249

Net (decrease) increase in cash and cash equivalents	(26,661		)	—			—			1,512			—				(25,149		)

Cash and cash equivalents, beginning of period	41,736			—			—			514			—				42,250

Cash and cash equivalents, end of period	$	15,075		$	—		$	—		$	2,026		$	—			$	17,101




CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2011
(in thousands)



	Parent Company			Issuers			Combined			Combined Non-			Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Net cash provided by operating activities	$	41,298		$	—		$	—		$	3,407		$	—			$	44,705

Cash flows from investing activities:
Acquisition of real estate	—			—			(204,500		)	—			—				(204,500		)

Acquisition of note receivable	(5,348		)	—			—			—			—				(5,348		)

Additions to real estate	(86		)	—			—			—			—				(86		)

Repayment of note receivable	5,348			—			—			—			—				5,348

Investment in Subsidiary	(164,030		)	(96		)	—			—			164,126				—

Distribution from Subsidiary	3,307			3,307			—			—			(6,614		)		—

Intercompany financing	(41,196		)	(204,700		)	—			—			245,896				—

Net cash used in investing activities	(202,005		)	(201,489		)	(204,500		)	—			403,408				(204,586		)

Cash flows from financing activities:
Principal payments on mortgage notes	—			—			—			(3,027		)	—				(3,027		)

Payments of deferred financing costs	—			(430		)	(200		)	(47		)	—				(677		)

Issuance of common stock	163,242			—			—			—			—				163,242

Dividends paid	(31,640		)	—			—			—			—				(31,640		)

Contribution from Parent	—			164,030			—			96			(164,126		)		—

Distribution to Parent	—			(3,307		)	—			(3,307		)	6,614				—

Intercompany financing	—			41,196			204,700			—			(245,896		)		—

Net cash provided by (used in) financing activities	131,602			201,489			204,500			(6,285		)	(403,408		)		127,898

Net decrease in cash and cash equivalents	(29,105		)	—			—			(2,878		)	—				(31,983		)

Cash and cash equivalents, beginning of period	70,841			—			—			3,392			—				74,233

Cash and cash equivalents, end of period	$	41,736		$	—		$	—		$	514		$	—			$	42,250

PRO_FORMA_FINANCIAL_INFORMATIO

PRO FORMA FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2013
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Pro Forma Financial Information	'
	PRO FORMA FINANCIAL INFORMATION (UNAUDITED)

	The following table summarizes, on an unaudited pro forma basis, the consolidated results of operations of the Company for the years ended December 31, 2013 and 2012. The Company acquired one senior housing facility and one acute care hospital during the year ended December 31, 2013. The following unaudited pro forma information has been prepared to give effect to the acquisition of Forest Park - Frisco as if the acquisition occurred on January 1, 2012. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):


		Year Ended December 31, 2013		Year Ended December 31, 2012

	Revenues	$	145,517	$	116,486

	Depreciation and amortization	36,669		34,344

	Net income attributable to common stockholders	33,459		27,559


	Net income attributable to common stockholders, per:
	Basic common share	0.89		0.74

	Diluted common share	0.88		0.74


	Weighted-average number of common shares outstanding, basic	37,514,637		37,061,111

	Weighted-average number of common shares outstanding, diluted	38,071,926		37,321,517

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
COMMITMENTS AND CONTINGENCIES	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	COMMITMENTS AND CONTINGENCIES
	Environmental
	As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. Compliance with existing environmental laws is not expected to have a material adverse effect on the Company’s financial condition and results of operations as of December 31, 2013.

	Separation and REIT Conversion Merger
	On May 24, 2010, Old Sun announced its intention to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies, Sabra and SHG Services Inc. (which was then renamed “Sun Healthcare Group, Inc.” or “Sun”). In order to effect the restructuring, Old Sun distributed to its stockholders on a pro rata basis all of the outstanding shares of common stock of Sun (this distribution is referred to as the “Separation”), together with an additional cash distribution. Immediately following the Separation, Old Sun merged with and into Sabra, with Sabra surviving the merger and Old Sun stockholders receiving shares of Sabra common stock in exchange for their shares of Old Sun common


	stock (this merger is referred to as the “REIT Conversion Merger”). Effective November 15, 2010, the Separation and REIT Conversion Merger were completed and Sabra and Sun began operations as separate companies.
	Following the Separation, Sun, through its subsidiaries, continued the business and operations of Old Sun and its subsidiaries. Sabra did not operate prior to the Separation. Immediately following the Separation, subsidiaries of Sabra owned substantially all of Old Sun’s owned real property. The owned real property held by subsidiaries of Sabra following the Separation includes fixtures and certain personal property associated with the real property. The historical consolidated financial statements of Old Sun became the historical consolidated financial statements of Sun at the time of the Separation. At the time of the Separation, the balance sheet of Sabra included the owned real property and mortgage indebtedness to third parties on the real property as well as indebtedness incurred by Sabra prior to completion of the Separation. The statements of income and cash flows of Sabra consist solely of its operations after the Separation. The Separation was accounted for as a reverse spinoff. Accordingly, Sabra’s assets and liabilities are recorded at the historical carrying values of Old Sun.
	In connection with the Separation and REIT Conversion Merger, any liability arising from or relating to legal proceedings involving the Company’s real estate investments has been assumed by the Company and the Company will indemnify Sun (and its subsidiaries, directors, officers, employees and agents and certain other related parties) against any losses arising from or relating to such legal proceedings. In addition, pursuant to a distribution agreement entered into among Old Sun, the Company and Sun in connection with the Separation and REIT Conversion Merger, Sun has agreed to indemnify the Company (and the Company’s subsidiaries, directors, officers, employees and agents and certain other related parties) for any liability arising from or relating to legal proceedings involving Old Sun’s healthcare business prior to the Separation, and, pursuant to the lease agreements between the Company and subsidiaries of Sun, the tenants agree to indemnify the Company for any liability arising from operations at the real property leased from the Company.
	Immediately prior to the Separation, Old Sun was a party to various legal actions and administrative proceedings, including various claims arising in the ordinary course of its healthcare business, which are subject to the indemnities to be provided by Sun to the Company. While these actions and proceedings are not believed to be material, individually or in the aggregate, the ultimate outcome of these matters cannot be predicted. The resolution of any such legal proceedings, either individually or in the aggregate, could have a material adverse effect on Sun’s business, financial position or results of operations, which, in turn, could have a material adverse effect on the Company’s business, financial position or results of operations if Sun or its subsidiaries are unable to meet their indemnification obligations.
	For income tax purposes, the Company is the surviving taxpayer of the Separation. Accordingly, tax positions taken by Old Sun prior to the Separation remained the Company’s obligations after the Separation. However, under an agreement with Sun relating to tax allocation matters, Sun is responsible for and will indemnify the Company against, among other things, federal, state and local taxes (including penalties and interest) related to periods prior to the Separation to the extent the deferred tax assets allocated to the Company as part of the Separation are not sufficient and/or cannot be utilized to satisfy these taxes. After the 2010 tax year, the Company and Sun have agreed, to the extent allowable by applicable law, to allocate all net operating loss attributes generated in prior years to Sun. In addition, Sun will generally have the right to control the conduct and disposition of any tax audits or other proceedings with regard to such periods, and will be entitled to any refund or credit for such periods.
	Effective December 1, 2012, Sun was acquired by Genesis HealthCare LLC (“Genesis”). As a result of its acquisition of Sun, Genesis became successor to the obligations of Sun described above.
	Legal Matters
	From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	12 Months Ended
SUBSEQUENT EVENTS	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	The Company evaluates subsequent events up until the date the consolidated financial statements are issued.
	Dividend Declaration
	On January 23, 2014, the Company announced that its board of directors declared a quarterly cash dividend of $0.36 per share of common stock. The dividend was paid on February 28, 2014 to stockholders of record as of the close of business on February 14, 2014.
	Also on January 23, 2014, the Company announced that its board of directors declared a quarterly cash dividend of $0.4453125 per share of Series A Preferred Stock. The dividend was paid on February 28, 2014 to stockholders of record as of the close of business on February 14, 2014.
	Mortgage Debt Refinancing
	On January 21, 2014, the Company refinanced $44.8 million of existing variable rate mortgage indebtedness due August 2015 with mortgages guaranteed by the United States Department of Housing and Urban Development at a rate of 4.25% with maturities between 2039 and 2044. As a result of these refinancings, the Company reduced its weighted-average effective interest rate related to its mortgage debt to 3.97% per annum from 4.08% per annum. The refinance will result in $0.5 million of write-offs for the three months ending March 31, 2014, associated with unamortized deferred financing costs.
	Nye Portfolio
	On February 14, 2014, the Company acquired six senior housing campuses (the “Nye Portfolio”) with a total of 673 beds/units, covering the spectrum of care (292 skilled nursing beds, 213 independent living units and 168 assisted living units) for $90.0 million. All six facilities are located within approximately 100 miles of Omaha, Nebraska. Concurrently with the purchase, the Company entered into a triple-net master lease agreement with affiliates of Nye Senior Services, LLC. The lease has an initial term of 10 years with four renewal options of five years each and provides for an annual rent escalator of 3.0%, resulting in annual lease revenues, determined in accordance with GAAP, of $8.0 million.
	In addition, the Company will pay an earn-out based on incremental portfolio value created through expansion and conversion projects. The earn-out amount will be determined based on portfolio performance following the third anniversary of the master lease.

SCHEDULE_III

SCHEDULE III	12 Months Ended
	Dec. 31, 2013
SEC Schedule III, Real Estate and Accumulated Depreciation Disclosure [Abstract]	'
Schedule III	'
	SCHEDULE III
	REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
	December 31, 2013
	(dollars in thousands)



								Initial Cost to Company									Cost Capitalized Subsequent to Acquisition		Gross Amount at which Carried at Close of Period														Life on Which Depreciation in Latest Income Statement is Computed
	Description	Location	Ownership Percentage	Encum- brances				Land			Building and Improve- ments(1)			Total					Land			Building and Improve- ments(1)(7)			Total			Accumulated Depreciation and Amortization			Original Date of Construction/ Renovation	Date Acquired
	Skilled Nursing/Post-Acute Facilities
	New Martinsville	New Martinsville, WV	100%	(3)				$	475		$	10,543		$	11,018		—		$	475		$	10,480		$	10,955		$	(3,318	)	1982	11/15/10	39

	Glenville	Glenville, WV	100%	—				484			2,839			3,323			—		484			2,803			3,287			(562		)	1982	11/15/10	40

	Renaissance Terrace	Harriman, TN	100%	—				76			4,459			4,535			—		76			4,101			4,177			(1,545		)	1985/1989,	11/15/10	38
																															2008
	Greenwood	Warwick, RI	100%	—				2,066			10,178			12,244			—		2,066			9,884			11,950			(2,947		)	1964	11/15/10	24

	Pawtuxet Village	Warwick, RI	100%	—				1,275			6,602			7,877			—		1,275			6,204			7,479			(1,898		)	1968	11/15/10	24

	Forest Hills (SNF)	Broken Arrow, OK	100%	(5)				1,653			11,259			12,912			—		1,653			11,078			12,731			(2,952		)	1994	11/15/10	40

	Seminole Estates	Seminole, OK	100%	—				655			3,527			4,182			—		655			3,353			4,008			(628		)	1987	11/15/10	32

	Bryan Care	Bryan, OH	100%	—				1,278			6,477			7,755			—		1,278			6,141			7,419			(1,489		)	1976	11/15/10	30

	Sylvania	Sylvania, OH	100%	(6)				942			5,627			6,569			—		942			5,282			6,224			(1,646		)	1967/1974, 1986, 1995, 2008, 2009	11/15/10	24

	Point Place	Toledo, OH	100%	—				1,089			5,364			6,453			—		1,089			5,151			6,240			(1,036		)	1995	11/15/10	36

	Perrysburg	Perrysburg, OH	100%	—				987			5,358			6,345			—		987			5,079			6,066			(1,244		)	1984	11/15/10	32

	Forest View	Dayton, OH	100%	—				819			4,214			5,033			—		819			4,028			4,847			(1,225		)	1968	11/15/10	24

	New Lebanon	New Lebanon, OH	100%	—				784			4,243			5,027			—		784			3,875			4,659			(1,036		)	1979	11/15/10	28

	New Lexington	New Lexington, OH	100%	—				63			3,487			3,550			—		63			3,311			3,374			(1,778		)	1981	11/15/10	20

	Twin Rivers	Defiance, OH	100%	—				280			3,004			3,284			—		280			2,804			3,084			(716		)	1980	11/15/10	30

	San Juan	Farmington, NM	100%	(2)				799			4,163			4,962			—		799			4,060			4,859			(1,144		)	1963/1993	11/15/10	24

	McKinley Care	Gallup, NM	100%	(2)				409			1,865			2,274			—		409			1,852			2,261			(512		)	1968	11/15/10	24

	Bedford Hills	Bedford, NH	100%	6,811				1,911			12,245			14,156			—		1,911			11,594			13,505			(2,598		)	1992/2010	11/15/10	36

	Exeter on Hampton	Exeter, NH	100%	(3)				2,365			2,350			4,715			—		2,365			2,233			4,598			(1,334		)	1976	11/15/10	40

	Pheasant Wood	Petersborough, NH	100%	—				625			3,986			4,611			—		625			3,548			4,173			(1,041		)	1975	11/15/10	28

	Westwood	Keene, NH	100%	—				699			3,823			4,522			—		699			3,453			4,152			(1,155		)	1965/2010	11/15/10	24

	Colonial Hill	Rochester, NH	100%	(3)				412			3,960			4,372			—		412			3,766			4,178			(1,185		)	1986	11/15/10	44

	Crestwood Care	Milford, NH	100%	—				557			3,441			3,998			—		557			3,124			3,681			(964		)	1972	11/15/10	28

	Applewood	Winchester, NH	100%	—				348			3,075			3,423			—		348			2,739			3,087			(706		)	1987	11/15/10	32

	The Elms Care	Milford, NH	100%	—				312			1,679			1,991			—		312			1,538			1,850			(597		)	1890/1890	11/15/10	20

	Woodland Hill	Asheboro, NC	100%	(6		)		1,706			8,053			9,759			—		1,706			7,906			9,612			(1,767		)	1987	11/15/10	32

	Missouri River	Great Falls, MT	100%	(2)				2,023			16,967			18,990			—		2,023			16,814			18,837			(4,910		)	1960/1990, 2010	11/15/10	30

Butte Care	Butte, MT	100%	(2)				1,092			12,654			13,746			—		1,092			12,570			13,662			(3,130		)	1974	11/15/10	35

Whitefish Care	Whitefish, MT	100%	(2)				651			6,339			6,990			—		651			6,284			6,935			(1,655		)	1973	11/15/10	35

Deer Lodge	Deer Lodge, MT	100%	(2)				190			3,032			3,222			—		190			3,005			3,195			(955		)	1973	11/15/10	30



							Initial Cost to Company									Cost Capitalized Subsequent to Acquisition		Gross Amount at which Carried at Close of Period														Life on Which Depreciation in Latest Income Statement is Computed
Description	Location	Ownership Percentage	Encum- brances				Land			Building and Improve- ments(1)			Total					Land			Building and Improve- ments(1)(7)			Total			Accumulated Depreciation and Amortization			Original Date of Construction/ Renovation	Date Acquired
Twin Oaks	Danvers, MA	100%	—				885			5,100			5,985			—		885			4,466			5,351			(1,230		)	1969	11/15/10	24

Maplewood	Amesbury, MA	100%	—				771			4,550			5,321			—		771			3,870			4,641			(1,121		)	1968/1969	11/15/10	24

Saugus	Saugus, MA	100%	—				285			1,643			1,928			—		285			1,099			1,384			(379		)	1967	11/15/10	24

Kensington Manor	Elizabethtown, KY	100%	—				1,864			7,523			9,387			—		1,864			7,125			8,989			(1,504		)	2001/2010	11/15/10	37

Regency Care	Louisville, KY	100%	—				1,169			5,989			7,158			185		1,169			5,736			6,905			(1,620		)	1960	11/15/10	25

Paducah Care	Paducah, KY	100%	—				1,636			4,133			5,769			—		1,636			3,845			5,481			(1,060		)	1974/1974, 2008	11/15/10	28

Countryside Care	Bardwell, KY	100%	—				239			4,790			5,029			—		239			4,494			4,733			(943		)	1993/2010	11/15/10	35

Bradford Square	South Frankfort, KY	100%	—				774			3,848			4,622			—		774			3,550			4,324			(1,058		)	1960/1990	11/15/10	25

Hillside Villa	Madisonville, KY	100%	—				277			4,272			4,549			—		277			3,914			4,191			(1,198		)	1962/1978, 1997	11/15/10	25

Klondike Care	Louisville, KY	100%	—				764			3,576			4,340			—		764			3,264			4,028			(857		)	1974/1980, 1994, 1995, 2008	11/15/10	28

Colonial Manor	Bowling Green, KY	100%	—				792			3,050			3,842			—		792			2,848			3,640			(849		)	1963	11/15/10	25

Hopkins Care	Woodburn, KY	100%	—				592			2,277			2,869			—		592			2,038			2,630			(585		)	1960	11/15/10	25

Bridge Point	Florence, KY	100%	(6		)		—			2,278			2,278			—		—			1,815			1,815			(739		)	1969/2008, 2009, 2010	11/15/10	20

Magnolia Village	Bowling Green, KY	100%	—				14			629			643			—		14			352			366			(180		)	1991	11/15/10	29

Decatur Township	Indianapolis, IN	100%	—				673			3,730			4,403			—		673			3,546			4,219			(892		)	1985	11/15/10	32

Gooding/Bennett Hills	Gooding, ID	100%	—				—			1,731			1,731			—		—			1,729			1,729			(724		)	1968/2009	11/15/10	40

Fountain City	Columbus, GA	100%	(3)				253			2,797			3,050			—		253			2,758			3,011			(1,555		)	1970	11/15/10	40

Etowah Landing	Rome, GA	100%	—				43			842			885			—		43			788			831			(409		)	1973/1977, 1987	11/15/10	40

Oakhurst	Ocala, FL	100%	—				1,474			8,212			9,686			—		1,474			7,649			9,123			(1,842		)	1984/2010	11/15/10	32

Orchard Ridge	New Port Richey, FL	100%	—				536			5,685			6,221			—		536			5,348			5,884			(1,300		)	1983/1995	11/15/10	32

Bay Tree	Palm Harbor, FL	100%	—				786			4,870			5,656			—		786			4,448			5,234			(1,221		)	1981	11/15/10	32

West Bay	Oldsmar, FL	100%	(6		)		775			4,660			5,435			—		775			4,188			4,963			(1,064		)	1982/2010	11/15/10	32

Sunset Point	Clearwater, FL	100%	(6		)		706			4,370			5,076			—		706			3,998			4,704			(1,082		)	1983	11/15/10	32

Arden House	Hamden, CT	100%	20,432				2,250			23,816			26,066			—		2,250			22,980			25,230			(5,505		)	1973/2008, 2010	11/15/10	28

Pope John Paul	Danbury, CT	100%	(6		)		—			13,702			13,702			—		—			12,945			12,945			(3,012		)	1983/2009	11/15/10	32

St. Camillus	Stamford, CT	100%	—				—			12,528			12,528			—		—			11,681			11,681			(2,787		)	1987/2008	11/15/10	32

Madison House	Madison, CT	100%	—				4,337			8,164			12,501			—		4,337			7,849			12,186			(1,625		)	1994/2009, 2010	11/15/10	36

Willows (CT)	Woodbridge, CT	100%	—				1,838			9,961			11,799			—		1,838			9,327			11,165			(2,208		)	1989/2011	11/15/10	32

The Reservoir	West Hartford, CT	100%	—				1,204			9,457			10,661			—		1,204			9,196			10,400			(1,960		)	1995/2009, 2011	11/15/10	36

Glen Hill	Danbury, CT	100%	(6		)		918			7,017			7,935			—		918			6,627			7,545			(2,017		)	1963/2009	11/15/10	24



							Initial Cost to Company									Cost Capitalized Subsequent to Acquisition		Gross Amount at which Carried at Close of Period														Life on Which Depreciation in Latest Income Statement is Computed
Description	Location	Ownership Percentage	Encum- brances				Land			Building and Improve- ments(1)			Total					Land			Building and Improve- ments(1)(7)			Total			Accumulated Depreciation and Amortization			Original Date of Construction/ Renovation	Date Acquired
Governor's House	Simsbury, CT	100%	—				—			5,750			5,750			—		—			5,259			5,259			(1,788		)	1895/2008, 2010	11/15/10	20

Elms Haven	Thornton, CO	100%	(3)				3,717			18,473			22,190			—		3,717			18,096			21,813			(4,331		)	1987/1989, 1997, 2007, 2008	11/15/10	40

Sable	Aurora, CO	100%	(3)				1,272			5,591			6,863			—		1,272			5,511			6,783			(1,507		)	1973	11/15/10	35

Carmichael	Carmichael, CA	100%	—				—			1,741			1,741			—		—			1,621			1,621			(816		)	1960/1976, 2010	11/15/10	40

Willows (CA)	Willows, CA	100%	—				137			1,426			1,563			—		137			1,339			1,476			(556		)	1969/2010	11/15/10	40

Washington Care	San Leandro, CA	100%	(2)				—			1,331			1,331			—		—			1,262			1,262			(423		)	1969/2010	11/15/10	40

Lake Drive	Henryetta, OK	100%	—				160			549			709			—		160			466			626			(345		)	1968	11/15/10	10

Boise	Boise, ID	100%	—				—			289			289			—		—			253			253			(148		)	1991	11/15/10	40

Langdon Place of Dover	Dover, NH	100%	4,873				801			10,036			10,837			—		801			9,570			10,371			(2,428		)	1987	11/15/10	42

Clipper Harbor	Portsmouth, NH	100%	(3)				846			7,632			8,478			—		846			7,475			8,321			(2,515		)	1986	11/15/10	43

Mineral Springs	North Conway, NH	100%	(3)				417			5,352			5,769			—		417			5,146			5,563			(1,439		)	1988	11/15/10	43

Wolfeboro	Wolfeboro, NH	100%	(3)				454			4,531			4,985			—		454			4,379			4,833			(1,147		)	1984/1986, 1987, 2009	11/15/10	41

Langdon Place of Keene	Keene, NH	100%	5,304				304			3,992			4,296			—		304			3,828			4,132			(1,282		)	1995	11/15/10	46

Edmondson Care	Brownsville, KY	100%	—				446			5,087			5,533			—		446			4,619			5,065			(1,054		)	1994/2009	11/15/10	35

Heartland Villa	Lewisport, KY	100%	—				532			4,025			4,557			—		532			3,711			4,243			(815		)	1994/2009	11/15/10	35

Meridian Care	Meridian, ID	100%	(6		)		840			8,342			9,182			—		840			8,213			9,053			(2,739		)	1997	11/15/10	39

St. Joseph's	Trumbull, CT	100%	(6		)		—			21,878			21,878			—		—			21,130			21,130			(6,249		)	1959	11/15/10	24

Oak Brook Health Care	Whitehouse, TX	100%	—				1,433			9,643			11,076			—		1,433			9,643			11,076			(800		)	1998	6/30/11	40

Broadmeadow Healthcare	Middletown, DE	100%	(6		)		1,650			21,730			23,380			—		1,650			21,730			23,380			(1,496		)	2005	8/1/11	40

Capitol Healthcare	Dover, DE	100%	(6		)		4,940			15,500			20,440			—		4,940			15,500			20,440			(1,116		)	1997	8/1/11	40

Pike Creek Healthcare	Wilmington, DE	100%	(6		)		2,460			25,240			27,700			—		2,460			25,240			27,700			(1,757		)	2009	8/1/11	40

Renaissance Healthcare	Millsboro, DE	100%	(6		)		1,640			22,620			24,260			—		1,640			22,620			24,260			(1,605		)	2008	8/1/11	40

Honey Hill Care Center	Norwalk, CT	100%	—				1,736			6,069			7,805			—		1,736			6,069			7,805			(513		)	1993	9/30/11	40

Manokin Manor Nursing & Rehabilitation Center	Princess Anne, MD	100%	—				1,953			7,811			9,764			—		1,953			7,811			9,764			(631		)	1987	9/30/11	40

Wesley Woods Alzheimer's Care Center	Abilene, TX	100%	—				885			7,619			8,504			—		885			7,619			8,504			(520		)	2004	11/1/11	40

Windcrest Alzheimer's Care Center	Waco, TX	100%	—				802			4,577			5,379			—		802			4,577			5,379			(329		)	1994/1999	11/1/11	40

Clara Burke	Plymouth Meeting, PA	100%	(6		)		2,527			12,453			14,980			—		2,527			12,453			14,980			(683		)	1927/1990/2007	3/30/12	40

Warrington	Warrington, PA	100%	(6		)		2,617			11,662			14,279			—		2,617			11,662			14,279			(585		)	1958/2008	3/30/12	40

Ridgecrest	Duffield, VA	100%	—				509			5,018			5,527			579		509			5,597			6,106			(282		)	1981	5/10/12	40

Bucks Hill	Waterbury, CT	100%	—				508			2,592			3,100			—		508			2,592			3,100			(146		)	1966/1999	6/1/12	40



							Initial Cost to Company									Cost Capitalized Subsequent to Acquisition		Gross Amount at which Carried at Close of Period														Life on Which Depreciation in Latest Income Statement is Computed
Description	Location	Ownership Percentage	Encum- brances				Land			Building and Improve- ments(1)			Total					Land			Building and Improve- ments(1)(7)			Total			Accumulated Depreciation and Amortization			Original Date of Construction/ Renovation	Date Acquired
Cromwell	Cromwell, CT	100%	—				2,265			10,096			12,361			—		2,265			10,096			12,361			(472		)	1967/1998	6/1/12	40

Derry	Derry, NH	100%	—				768			3,222			3,990			—		768			3,222			3,990			(167		)	1976/1994	6/1/12	40

Camden Care Center	Minneapolis, MN	100%	—				1,235			5,777			7,012			—		1,235			5,777			7,012			(189		)	1990	11/30/12	40

Arbrook Plaza	Arlington, TX	100%	(6		)		3,783			14,219			18,002			—		3,783			14,219			18,002			(443		)	2002	11/30/12	40

Northgate Plaza	Irving, TX	100%	(6		)		4,901			10,299			15,200			—		4,901			10,299			15,200			(330		)	2003	11/30/12	40

Gulf Pointe Plaza	Rockport, TX	100%	(6		)		1,005			6,628			7,633			—		1,005			6,628			7,633			(223		)	2002	11/30/12	40



			37,419				100,423			658,813			759,236			764		100,423			636,765			737,188			(132,068		)

Senior Housing

Monroe House	Moses Lake, WA	100%	—				—			182			182			—		—			77			77			(48		)	1997	11/15/10	15

Forest Hills (ALF)	Broken Arrow, OK	100%	(5)				1,803			3,927			5,730			—		1,803			3,851			5,654			(1,225		)	2000	11/15/10	30

Langdon Place of Exeter	Exeter, NH	100%	3,923				571			7,183			7,754			—		571			6,745			7,316			(1,857		)	1987	11/15/10	43

Langdon Place of Nashua	Nashua, NH	100%	(2)				—			5,654			5,654			—		—			5,329			5,329			(1,316		)	1989	11/15/10	40

Heritage Place	Owensboro, KY	100%	—				668			5,492			6,160			—		668			5,186			5,854			(996		)	2001	11/15/10	38

The Legacy	Paducah, KY	100%	—				325			4,019			4,344			—		325			3,561			3,886			(822		)	1999	11/15/10	35

Glen Crest	Danbury, CT	100%	—				1,356			6,666			8,022			—		1,356			6,609			7,965			(1,538		)	1986	11/15/10	32

Village at Northrise	Las Cruces, NM	100%	(6		)		1,432			6,003			7,435			—		1,432			5,748			7,180			(2,188		)	1998/1999, 2010	11/15/10	29

Age-Well Senior Living	Green Bay, WI	100%	—				256			2,262			2,518			1,031		256			3,294			3,550			(364		)	2004	11/22/11	40

New Dawn Memory Care	Aurora, CO	100%	—				2,874			12,829			15,703			—		2,874			12,829			15,703			(434		)	2009	9/20/12	40

Independence Village at Frankenmuth	Frankenmuth, MI	100%	—				5,027			20,929			25,956			—		5,027			20,929			25,956			(766		)	1982	9/21/12	40

Gulf Pointe Village	Rockport, TX	100%	—				789			607			1,396			—		789			607			1,396			(32		)	1996	11/30/12	40

Aspen Ridge Retirement Village	Gaylord, MI	100%	(6		)		2,024			5,467			7,491			—		2,024			5,467			7,491			(210		)	2002	12/14/12	40

Green Acres of Cadillac	Cadillac, MI	100%	(6		)		217			3,000			3,217			—		217			3,000			3,217			(98		)	2001/2006	12/14/12	40

Green Acres of Greenville	Greenville, MI	100%	(6		)		684			5,832			6,516			—		684			5,832			6,516			(189		)	1999/2001	12/14/12	40

Green Acres of Manistee	Manistee, MI	100%	(6		)		952			2,578			3,530			—		952			2,578			3,530			(92		)	2002	12/14/12	40

Green Acres of Mason	Mason, MI	100%	(6		)		198			4,131			4,329			—		198			4,131			4,329			(140		)	2009/2012	12/14/12	40

Nottingham Place	Midland, MI	100%	(6		)		744			1,745			2,489			—		744			1,745			2,489			(56		)	1995	12/14/12	40

Royal View	Mecosta, MI	100%	(6		)		307			2,477			2,784			—		307			2,477			2,784			(92		)	2001	12/14/12	40

Tawas Village	East Tawas, MI	100%	(6		)		258			3,713			3,971			—		258			3,713			3,971			(160		)	2005	12/14/12	40

Turning Brook	Alpena, MI	100%	(6		)		546			13,139			13,685			—		546			13,139			13,685			(383		)	2006/2008/2010	12/14/12	40

Stoney River Marshfield	Marshfield, WI	100%	—				574			8,733			9,307			—		574			8,733			9,307			(251		)	2010	12/18/12	40

Greenfield of Woodstock	Greenfield, VA	100%	—				597			5,465			6,062			—		597			5,465			6,062			(80		)	1996	6/28/13	40


			3,923				22,202			132,033			154,235			1,031		22,202			131,045			153,247			(13,337		)




							Initial Cost to Company									Cost Capitalized Subsequent to Acquisition		Gross Amount at which Carried at Close of Period														Life on Which Depreciation in Latest Income Statement is Computed
Description	Location	Ownership Percentage	Encum- brances				Land			Building and Improve- ments(1)			Total					Land			Building and Improve- ments(1)(7)			Total			Accumulated Depreciation and Amortization			Original Date of Construction/ Renovation	Date Acquired




Acute Care Hospital
Texas Regional Medical Center	Sunnyvale, TX	100%	(6		)		4,020			57,620			61,640			—		4,020			57,620			61,640			(4,847		)	2009	5/3/11	40

Forest Park - Frisco	Frisco, TX	100%	—				4,966			109,201			114,167			—		4,966			109,201			114,167			(673		)	2012	10/22/13	40


			—				8,986			166,821			175,807			—		8,986			166,821			175,807			(5,520		)


Multi-property Indebtedness			99,986				—			—			—			—		—			—			—			—


			141,328				131,611			957,667			1,089,278			1,795		131,611			934,631			1,066,242			(150,925		)


Corporate Assets			—				—			136			136			118		—			254			254			(153		)



			$	141,328			$	131,611		$	957,803		$	1,089,414		$	1,913	$	131,611		$	934,885		$	1,066,496		$	(151,078	)






(1)	Building and building improvements include land improvements and furniture and equipment.

(2)	Property serves as collateral for a mortgage loan totaling $37.6 million as of December 31, 2013.

(3)	Property serves as collateral for a mortgage loan totaling $19.1 million as of December 31, 2013.

(4)	Property serves as collateral for a mortgage loan totaling $30.0 million as of December 31, 2013.

(5)	Property serves as collateral for a mortgage loan totaling $13.3 million as of December 31, 2013.

-6	Property serves as collateral for the $270.6 million secured revolving credit facility. There was $135.5 million outstanding as of December 31, 2013.

(7)	The aggregate cost of real estate for federal income tax purposes was $1.1 billion.





SABRA HEALTH CARE REIT, INC.
SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
(dollars in thousands)





	Year Ended December 31,
	2013				2012				2011
Real estate:
Balance at the beginning of the period	$	956,614			$	760,708			$	564,355

Acquisitions	120,229				202,458				202,570

Improvements	764				1,046				9

Purchase price allocation adjustment	—				(104		)		—

Write-off of fully depreciated assets	(11,111		)		(7,494		)		(6,226		)


Balance at the end of the year	$	1,066,496			$	956,614			$	760,708



Accumulated depreciation:

Balance at the beginning of the period	$	(129,479	)		$	(107,331	)		$	(87,382	)
Depreciation expense (1)	(32,710		)		(29,642		)		(26,175		)
Write-off of fully depreciated assets	11,111				7,494				6,226



Balance at the end of the year	$	(151,078	)		$	(129,479	)		$	(107,331	)


(1) Depreciation expense for each of the years ended December 31, 2012 and 2011 excludes expense of $0.3 million related the to the assets held for sale.

SCHEDULE_IV

SCHEDULE IV	12 Months Ended
	Dec. 31, 2013
Mortgage Loans on Real Estate [Abstract]	'
Schedule IV	'
	SCHEDULE IV
	MORTGAGE LOANS ON REAL ESTATE
	December 31, 2013
	(dollars in thousands)



	Description	Contractual Interest Rate		Maturity Date		Periodic Payment Terms	Prior Liens		Principal Balance		Book Value		Principal Amount of Loans Subject to Delinquent Principal or Interest

	Mortgages:
	Onion Creek	8.5	%	2017		(1)	$	—	$	11,000	$	11,040	N/A

	Weston	9		2016		(2)	—		14,531		14,608		N/A

	Sun City West	9		2018		(1)	—		13,394		13,459		N/A

	Forest Park - Dallas	8		2016		(1)	—		110,000		110,343		N/A


							—		148,925		149,450

	Construction Mortgages:
	Forest Park - Fort Worth	7.3		2016		(2) (3)	—		11,880		12,119		N/A


	Other Construction Mortgages	10		2018		Various	—		2,065		2,164		N/A


							$	—	$	162,870	$	163,733



	(1) Interest is due monthly and principal is due at the maturity date.
	(2) Interest for the first 12 months and principal is deferred and due at the maturity date. Interest after the first 12 months is due monthly.
	(3) The loan has a prepayment fee of 0.5% of the outstanding balance if prepaid before October 1, 2015.


	Changes in mortgage loans for the years ended December 31, 2013 and 2012 are summarized as follows:



		Year Ended December 31,
		2013			2012

	Balance at the beginning of the period	$	11,000		$	—

	Additions during period:
	New mortgage loans	151,173			11,000

	Interest income added to principal	697			—


	Balance at the end of the year	$	162,870		$	11,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	'
	GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
	The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis. At December 31, 2013, the Company did not have any consolidated VIEs.
	As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At December 31, 2013, none of the Company's investments in loans are accounted for as real estate joint ventures.
	As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies.
Real Estate Held for Development and Sale, Policy [Policy Text Block]	'
	Assets Held for Sale and Discontinued Operations
	The Company generally considers real estate to be “held for sale” when the following criteria are met: (i) management commits to a plan to sell the property, (ii) the property is available for sale immediately, (iii) the property is actively being marketed for sale at a price that is reasonable in relation to its current fair value, (iv) the sale of the property within one year is considered probable and (v) significant changes to the plan to sell are not expected. Real estate that is held for sale and its related assets are classified as “assets held for sale” for all periods presented in the accompanying consolidated financial statements. Mortgage notes payable and other liabilities related to real estate held for sale are classified as “liabilities related to assets held for sale” for all periods presented in the accompanying consolidated financial statements. Real estate classified as held for sale is no longer depreciated and is reported at the lower of its carrying value or its estimated fair value less estimated costs to sell. As of December 31, 2012, the Company determined that one property with an aggregate book value of $2.2 million met the held for sale criteria. The asset held for sale was sold on February 1, 2013 for $2.2 million. As of December 31, 2013, the Company did not have any assets held for sale.
	Discontinued operations is a component of an entity that has either been disposed of or is deemed to be held for sale and, (i) the operations and cash flows of the component have been or will be eliminated from ongoing operations as a result of the disposal transaction, and (ii) the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction. Under the agreement with the Company's tenant pertaining to the Company’s asset held for sale as of December 31, 2012, revenues and cash flows associated with the asset held for sale would not be eliminated as a result of the ultimate disposal of the asset. Accordingly, the operations of the asset held for sale as of December 31, 2012 were not classified as discontinued operations.
Finance, Loans and Leases Receivable, Policy [Policy Text Block]	'
	Loans Receivable
	The Company’s loans receivable are recorded at amortized cost on the accompanying consolidated balance sheets. The amortized cost of a real estate loan receivable is the outstanding unpaid principal balance, net of unamortized costs and fees directly associated with the origination of the loan.
	The Company reviews on a quarterly basis credit quality indicators such as payment status, changes affecting the underlying real estate collateral (for collateral dependent loans), changes affecting the operations of the facilities securing the loans, and national and regional economic factors. The Company’s loans receivable are evaluated for impairment at each balance sheet date. The Company considers a loan to be impaired when, based upon current information and events, it believes that it is probable that the Company will be unable to collect all amounts due under the contractual terms of the loan agreement resulting from the borrower’s failure to repay contractual amounts due, the granting of a concession by the Company or the Company’s expectation that it will receive assets with fair values less than the carrying value of the loan in satisfaction of the loan. If a loan is considered to be impaired, a reserve is established when the present value of payments expected to be received, observable market prices, the estimated fair value of the collateral (for loans that are dependent on the collateral for repayment) or amounts expected to be received in satisfaction of a loan are lower than the carrying value of that loan. As of December 31, 2013, all of the Company’s loans were performing and none were considered to be impaired.
	Interest Income
	Interest income on the Company’s loans receivable is recognized on an accrual basis over the life of the investment using the interest method. Direct loan origination costs are amortized over the term of the loan as an adjustment to interest income. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on nonaccrual status and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest.
Use of Estimates	'
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
Reclassification, Policy [Policy Text Block]	'
	Reclassifications
	Certain amounts in the Company’s consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. These reclassifications have not changed the results of operations of prior periods. As a result, certain reclassifications were made to the consolidated statements of income, consolidated statements of cash flows and footnote disclosures for all periods presented.
Revenue Recognition	'
	Rental Revenue Recognition
	The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. If the lease provides for tenant improvements, the Company determines whether the tenant improvements, for accounting purposes, are owned by the tenant or by the Company. When the Company is the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the physical use of the leased asset until the tenant improvements are substantially completed. When the tenant is the owner of the tenant improvements, any tenant improvement allowance that is funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term.
	The Company makes estimates of the collectibility of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns.
Real Estate Investments	'
	Real Estate Investments and Rental Revenue Recognition
	Real Estate Acquisition Valuation
	The Company accounts for the acquisition of income-producing real estate or real estate that will be used for the production of income as a business combination. All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition-date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2013, 2012 and 2011, the Company acquired two, 23, and 11 real estate properties, respectively, and expensed $1.5 million, $1.7 million and $3.2 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income.
	Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
	Depreciation and Amortization
	Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the lesser of the lease term, the expected useful life of the asset on a straight-line basis and the remaining lease term of any ground leases. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years.
	Impairment of Real Estate Investments
	The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments.
Real Estate Acquisition Valuation	'
	Real Estate Investments and Rental Revenue Recognition
	Real Estate Acquisition Valuation
	The Company accounts for the acquisition of income-producing real estate or real estate that will be used for the production of income as a business combination. All assets acquired and liabilities assumed in an acquisition of real estate are measured at their acquisition-date fair values. The acquisition value of land, building and improvements are included in real estate investments on the accompanying consolidated balance sheets. The acquisition value of tenant relationship and origination and absorption intangible assets are included in prepaid expenses, deferred financing costs and other assets in the accompanying consolidated balance sheets. Acquisition pursuit costs are expensed as incurred and restructuring costs that do not meet the definition of a liability at the acquisition date are expensed in periods subsequent to the acquisition date. During the years ended December 31, 2013, 2012 and 2011, the Company acquired two, 23, and 11 real estate properties, respectively, and expensed $1.5 million, $1.7 million and $3.2 million of acquisition pursuit costs, respectively, which is included in general and administrative expense on the accompanying consolidated statements of income.
	Estimates of the fair values of the tangible assets, identifiable intangibles and assumed liabilities require the Company to make significant assumptions to estimate market lease rates, property operating expenses, carrying costs during lease-up periods, discount rates, market absorption periods, and the number of years the property will be held for investment. The Company makes its best estimate based on the evaluation of the specific characteristics of each tenant's lease. The use of inappropriate assumptions would result in an incorrect valuation of the Company’s acquired tangible assets, identifiable intangibles and assumed liabilities, which would impact the amount of the Company’s net income.
	Depreciation and Amortization
	Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the lesser of the lease term, the expected useful life of the asset on a straight-line basis and the remaining lease term of any ground leases. Depreciation is discontinued when a property is identified as held for sale. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Depreciation of real estate assets and amortization of lease intangibles are included in depreciation and amortization in the accompanying consolidated statements of income. The Company anticipates the estimated useful lives of its assets by class to be generally as follows: land improvements, 3 to 40 years; buildings and building improvements, 3 to 40 years; and furniture and equipment, 1 to 20 years.
	Impairment of Real Estate Investments
	The Company continually monitors events and changes in circumstances that could indicate that the carrying amounts of its real estate investments may not be recoverable or realized. When indicators of potential impairment suggest that the carrying value of real estate investments may not be recoverable, the Company assesses the recoverability by estimating whether the Company will recover the carrying value of its real estate investments through its undiscounted future cash flows and the eventual disposition of the investment. If, based on this analysis, the Company does not believe that it will be able to recover the carrying value of its real estate investments, the Company would record an impairment loss to the extent that the carrying value exceeds the estimated fair value of its real estate investments. The Company recorded a $2.5 million impairment loss during the year ended December 31, 2012 related to the asset held for sale. The Company did not record any impairment losses on its real estate investments during the years ended December 31, 2013 or 2011.
	Rental Revenue Recognition
	The Company recognizes rental revenue from tenants, including rental abatements, lease incentives and contractual fixed increases attributable to operating leases, on a straight-line basis over the term of the related leases when collectability is reasonably assured. If the lease provides for tenant improvements, the Company determines whether the tenant improvements, for accounting purposes, are owned by the tenant or by the Company. When the Company is the owner of the tenant improvements, the tenant is not considered to have taken physical possession or have control of the physical use of the leased asset until the tenant improvements are substantially completed. When the tenant is the owner of the tenant improvements, any tenant improvement allowance that is funded is treated as a lease incentive and amortized as a reduction of revenue over the lease term.
	The Company makes estimates of the collectibility of its tenant receivables related to base rents, straight-line rent and other revenues. When the Company analyzes accounts receivable and evaluates the adequacy of the allowance for doubtful accounts, it considers such things as historical bad debts, tenant creditworthiness, current economic trends, current developments relevant to a tenant’s business specifically and to its business category generally, and changes in tenants’ payment patterns. As of December 31, 2013 and 2012, there was no allowance for doubtful accounts recorded against the Company's tenant receivables.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all short-term (with an original maturity of three months or less), highly-liquid investments utilized as part of the Company’s cash-management activities to be cash equivalents. Cash equivalents may include cash and short-term investments. Short-term investments are stated at cost, which approximates fair value.
	The Company’s cash and cash equivalents balance exceeded federally insurable limits as of December 31, 2013. To date, the Company has experienced no loss or lack of access to cash in its operating accounts. The Company has a corporate banking relationship with Bank of America, N.A. in which it deposits all funds.
Restricted Cash	'
	Restricted Cash
	Restricted cash primarily consists of amounts held by mortgage lenders to provide for future real estate tax expenditures, tenant improvements and capital expenditures. Pursuant to the terms of the Company’s leases with certain tenants, the Company has assigned its interests in certain of these restricted cash accounts to the tenants and this amount is included in accounts payable and accrued liabilities on the Company’s consolidated balance sheet.
Share-Based Compensation	'
	Stock-Based Compensation
	Stock-based compensation expense for stock-based awards granted to Sabra’s employees and its non-employee directors are recognized in the statements of income based on their estimated grant date fair value, as adjusted. Compensation expense for awards with graded vesting schedules is generally recognized ratably over the period from the grant date to the date when the award is no longer contingent on the employee providing additional services. Compensation expense for awards with performance based vesting conditions is recognized based on the Company's estimate of the ultimate value of such award after considering the Company's expectations of future performance.
Deferred Financing Costs	'
	Deferred Financing Costs
	Deferred financing costs representing fees paid to third parties to obtain financing are amortized over the terms of the respective financing agreements using the interest method. Unamortized deferred financing costs are generally expensed when the associated debt is refinanced or repaid before maturity. Costs incurred in seeking financings that do not close are expensed in the period in which it is determined that the financing will not close.
Income Taxes	'
	Income Taxes
	The Company elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. The Company believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute at least 90% of the Company’s annual REIT taxable income to stockholders (which is computed without regard to the dividends-paid deduction or net capital gains and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax on income that it distributes as dividends to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost, unless the Internal Revenue Service grants the Company relief under certain statutory provisions. Such an event could materially and adversely affect the Company’s net income and net cash available for distribution to stockholders. However, the Company believes that it is organized and operates in such a manner as to qualify for treatment as a REIT.
	The Company evaluates its tax positions using a two step approach: step one (recognition) occurs when a company concludes that a tax position, based solely on its technical merits, is more likely than not to be sustained upon examination and step two (measurement) is only addressed if step one has been satisfied (i.e., the position is more likely than not to be sustained). Under step two, the tax benefit is measured as the largest amount of benefit (determined on a cumulative probability basis) that is more likely than not to be realized upon ultimate settlement. The Company will recognize tax penalties relating to unrecognized tax benefits as additional tax expense.
Fair Value Measurements	'
	Fair Value Measurements
	Under GAAP, the Company is required to measure certain financial instruments at fair value on a recurring basis. In addition, the Company is required to measure other financial instruments and balances at fair value on a non-recurring basis (e.g., carrying value of impaired real estate loans receivable and long-lived assets). Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The GAAP fair value framework uses a three-tiered approach. Fair value measurements are classified and disclosed in one of the following three categories:

	•	Level 1: unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities;

	•	Level 2: quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

	•	Level 3: prices or valuation techniques where little or no market data is available that requires inputs that are both significant to the fair value measurement and unobservable.
	When available, the Company utilizes quoted market prices from an independent third-party source to determine fair value and classifies such items in Level 1 or Level 2. In instances where the market for a financial instrument is not active, regardless of the availability of a nonbinding quoted market price, observable inputs might not be relevant and could require the Company to make a significant adjustment to derive a fair value measurement. Additionally, in an inactive market, a market price quoted from an independent third party may rely more on models with inputs based on information available only to that independent third party. When the Company determines the market for a financial instrument owned by the Company to be illiquid or when market transactions for similar instruments do not appear orderly, the Company may use several valuation sources (including internal valuations, discounted cash flow analysis and quoted market prices) to establish a fair value. If more than one valuation source is used, the Company will assign weights to the various valuation sources. Additionally, when determining the fair value of liabilities in circumstances in which a quoted price in an active market for an identical liability is not available, the Company measures fair value using (i) a valuation technique that uses the quoted price of the identical liability when traded as an asset or quoted prices for similar liabilities or similar liabilities when traded as assets or (ii) another valuation technique that is consistent with the principles of fair value measurement, such as the income approach or the market approach.
	Changes in assumptions or estimation methodologies can have a material effect on these estimated fair values. In this regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, may not be realized in an immediate settlement of the instrument.
	The Company considers the following factors to be indicators of an inactive market: (i) there are few recent transactions, (ii) price quotations are not based on current information, (iii) price quotations vary substantially either over time or among market makers (for example, some brokered markets), (iv) indexes that previously were highly correlated with the fair values of the asset or liability are demonstrably uncorrelated with recent indications of fair value for that asset or liability, (v) there is a significant increase in implied liquidity risk premiums, yields, or performance indicators (such as delinquency rates or loss severities) for observed transactions or quoted prices when compared with the Company’s estimate of expected cash flows, considering all available market data about credit and other nonperformance risk for the asset or liability, (vi) there is a wide bid-ask spread or significant increase in the bid-ask spread, (vii) there is a significant decline or absence of a market for new issuances (that is, a primary market) for the asset or liability or similar assets or liabilities, and (viii) little information is released publicly (for example, a principal-to-principal market).
	The Company considers the following factors to be indicators of non-orderly transactions: (i) there was not adequate exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities under current market conditions, (ii) there was a usual and customary marketing period, but the seller marketed the asset or liability to a single market participant, (iii) the seller is in or near bankruptcy or receivership (that is, distressed), or the seller was required to sell to meet regulatory or legal requirements (that is, forced), and (iv) the transaction price is an outlier when compared with other recent transactions for the same or similar assets or liabilities.
Per Share Data	'
	Per Share Data
	Basic earnings per common share is computed by dividing net income applicable to common shares by the weighted average number of shares of common stock and common equivalents outstanding during the period. Diluted earnings per common share is calculated by including the effect of dilutive securities.
Industry Segments	'
	Industry Segments
	The Company has one reportable segment consisting of investments in healthcare-related real estate properties.

ACQUISITIONS_OF_REAL_ESTATE_Ta

ACQUISITIONS OF REAL ESTATE (Tables)	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Schedule of Purchase Price Allocation	'
	During the year ended December 31, 2013, the Company acquired one senior housing facility and one acute care hospital for total consideration of $122.8 million. The consideration was allocated as follows (in thousands):


					Intangibles
	Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Consideration
	$	5,563	$	114,666	$	2,196	$	349	$	122,774

REAL_ESTATE_INVESTMENTS_Tables

REAL ESTATE INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Real Estate Investments, Net [Abstract]	'
Schedule of Real Estate Properties	'
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of *December 31, 2013*


	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	737,188	$	(132,068	)	$	605,120

	Senior Housing		23		1,518			153,247		(13,337		)	139,910

	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287


			121		12,468			1,066,242		(150,925		)	915,317

	Corporate Level							254		(153		)	101

								$	1,066,496	$	(151,078	)	$	915,418

	As of *December 31, 2012*


	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	746,510	$	(116,426	)	$	630,084

	Senior Housing		22		1,486			148,210		(9,949		)	138,261

	Acute Care Hospital		1		70			61,640		(3,001		)	58,639

			119		12,382			956,360		(129,376		)	826,984

	Corporate Level							254		(103		)	151

								$	956,614	$	(129,479	)	$	827,135



		December 31, 2013			December 31, 2012
	Building and improvements	$	879,926		$	782,221

	Furniture and equipment	50,567			43,810

	Land improvements	4,392			4,535

	Land	131,611			126,048

		1,066,496			956,614

	Accumulated depreciation	(151,078		)	(129,479		)
		$	915,418		$	827,135

Schedule of Future Minimum Rental Payments Receivable for Operating Leases	'
	As of December 31, 2013, the future minimum rental income from the Company’s properties under non-cancelable operating leases was as follows (in thousands):


	2014	$	126,182

	2015	129,218

	2016	132,263

	2017	135,543

	2018	138,909

	Thereafter	894,424


		$	1,556,539

TENANT_ORIGINATION_AND_ABSORPT1

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP (Tables)	12 Months Ended
	Dec. 31, 2013
TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP [Abstract]	'
Schedule of Finite-Lived Intangible Assets	'
	As of December 31, 2013 and 2012, the Company’s tenant origination and absorption costs and tenant relationship assets were as follows (in thousands):


		Tenant Origination and Absorption Costs						Tenant Relationship
		December 31,
		2013			2012			2013			2012
	Cost	$	8,884		$	6,688		$	1,900		$	1,551

	Accumulated amortization	(837		)	(344		)	(106		)	(38		)

	Net amount	$	8,047		$	6,344		$	1,794		$	1,513

Schedule of Amortization Expense of Finite-Lived Intangible Assets	'
	ecreases in net income as a result of amortization of the Company’s tenant origination and absorption costs and tenant relationship assets for the years ended December 31, 2013 and 2012 are as follows (in thousands):


		Tenant Origination and Absorption Costs						Tenant Relationship
		For the Year Ended December 31,
		2013			2012			2013			2012

	Amortization	$	(493	)	$	(269	)	$	(68	)	$	(31	)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	The remaining unamortized balance for these outstanding intangible assets and liabilities as of December 31, 2013 will be amortized for the years ending December 31 as follows (dollars in thousands):


		Tenant Origination and Absorption Costs			Tenant Relationship


	2014	$	591		$	79

	2015	591			79

	2016	591			79

	2017	591			79

	2018	591			79

	Thereafter	5,092			1,399


		$	8,047		$	1,794


	Weighted-Average Remaining Amortization Period	14.8 years			23.3 years

REAL_ESTATE_LOANS_RECEIVABLE_T

REAL ESTATE LOANS RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2013
REAL ESTATE LOANS RECEIVABLE [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	As of December 31, 2013, the Company’s loans receivable consisted of the following (dollars in thousands):


	Loan Type	Number of Loans	Facility Type	Principal Balance as of December 31, 2013		Book Value as of December 31, 2013		Weighted Average Contractual Interest Rate		Weighted Average Annualized Effective Interest Rate		Maturity Date
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	148,925	$	149,450	8.2	%	8.1	%	10/31/16 - 1/31/18

	Construction	3	Acute Care Hospital / Memory Care	13,945		14,283		7.7	%	7.6	%	9/30/16 - 10/31/18

	Mezzanine	1	Skilled Nursing	12,350		12,410		12	%	11.5	%	12/27/14

	Pre-development	2	Senior Housing	1,338		1,366		9	%	8.4	%	8/16/15 - 9/13/16

		10		$	176,558	$	177,509	8.4	%	8.3	%

DEBT_Tables

DEBT (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Mortgage Indebtness	'
	Mortgage Indebtedness. The Company’s mortgage notes payable consist of the following (dollars in thousands):


	Interest Rate Type	Book Value as of		Book Value as of		Weighted Average		Maturity
		31-Dec-13		December 31, 2012		Interest Rate at		Date
						31-Dec-13
	Fixed Rate	$	54,688	$	94,373	2.62	%	August 2015 - June 2047

	Variable Rate(1)	86,640		57,949		5	%	Aug-15

		$	141,328	$	152,322	4.08	%


	(1) Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.0% (subject to a 1.0% floor).
Schedule of Maturities of Debt	'
	he following is a schedule of maturities for the Company’s outstanding debt as of December 31, 2013 (in thousands):


		Mortgage		Senior Notes (1)		Secured Revolving			Total
		Indebtedness				Credit Facility (2)
	2014	$	3,739	$	—	$	—		$	3,739

	2015	86,075		—		—			86,075

	2016	1,647		—		135,500			137,147

	2017	1,688		—		—			1,688

	2018	1,730		211,250		—			212,980

	Thereafter	46,449		200,000		—			246,449

		$	141,328	$	411,250	$	135,500		$	688,078


	(1) Outstanding principal balance for Senior Notes does not include premium of $3.2 million as of December 31, 2013.
	(2) Subject to a one-year extension option.

FAIR_VALUE_DISCLOSURES_Tables

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'


	Balance as of December 31, 2012	$	1,300

	New contingent liability	7,300

	Increase in contingent liability	800

	Settlement of contingent liability	(1,900		)
	Balance as of December 31, 2013	$	7,500

Fair Value, Assets Measured on Recurring Basis [Table Text Block]	'
	During the year ended December 31, 2013, the Company recorded the following amounts measured at fair value (in thousands):


					Fair Value Measurements Using
					Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs			Significant Unobservable Inputs
		Total			(Level 1)		(Level 2)			(Level 3)
	Recurring Basis:
	Contingent consideration	$	7,500		—		—			7,500

Fair Value, by Balance Sheet Grouping	'
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of December 31, 2013 and December 31, 2012 whose carrying amounts do not approximate their fair value (in thousands):



		December 31, 2013									December 31, 2012
		Face			Carrying			Fair			Face		Carrying		Fair
		Value (1)			Amount (2)			Value			Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	176,558		$	177,509		$	176,985		$	11,965	$	12,017	$	12,826

	Preferred equity investments	7,695			7,784			7,950			—		—		—

	Financial liabilities:
	Senior Notes	411,250			414,402			421,122			325,000		330,666		345,313

	Mortgage indebtedness	141,328			141,328			130,622			152,322		152,322		152,559


	(1) Face value represents amounts contractually due under the terms of the respective agreements.
	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).
Fair Value Measurements, Nonrecurring	'
	The Company determined the fair value of financial instruments as of December 31, 2013 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):


					Fair Value Measurements Using
					Quoted Prices in Active Markets for Identical Assets			Significant Other Observable Inputs			Significant Unobservable Inputs
		Total			(Level 1)			(Level 2)			(Level 3)
	Financial assets:
	Loans receivable	$	176,985		$	—		$	—		$	176,985

	Preferred equity investments	7,950			—			—			7,950

	Financial liabilities:
	Senior Notes	421,122			—			421,122			—

	Mortgage indebtedness	130,622			—			—			130,622

EQUITY_Tables

EQUITY (Tables)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Schedule of Common Stock Issued During Period	'
	The following is a summary of the Company’s other common stock issuances during the years ended December 31, 2013 and 2012:


			Year Ended December 31,
			2013		2012
	Exercise of stock options		33,935		41,640

	Vesting of common stock units		239,088		165,857

Schedule of Dividends Paid	'
	The following table lists the cash dividends on common stock paid and declared by the Company during the years ended December 31, 2013 and 2012:


	Declaration Date		Record Date	Amount Per Share			Dividend Payable Date
	29-Feb-12		15-Mar-12	$	0.33		30-Mar-12

	24-Apr-12		15-May-12	0.33			31-May-12

	1-Aug-12		15-Aug-12	0.33			31-Aug-12

	29-Oct-12		15-Nov-12	0.33			30-Nov-12

	7-Jan-13		15-Feb-13	0.34			28-Feb-13

	1-May-13		15-May-13	0.34			31-May-13

	31-Jul-13		15-Aug-13	0.34			30-Aug-13

	23-Oct-13		15-Nov-13	0.34			29-Nov-13

Schedule of Characterization of Cash Dividends	'
	Following is the characterization of the Company’s cash dividends on common stock per share during the years ended December 31, 2013, 2012 and 2011:


		Year Ended December 31,
		2013			2012			2011
	Ordinary dividends	$	0.4672		$	0.7992		$	0.7833

	Nondividend distributions	0.8928			0.5208			0.1767

		$	1.36		$	1.32		$	0.96

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2013
STOCK-BASED COMPENSATION [Abstract]	'
Schedule of Share-based Payment Award, Restricted Stock Units, Valuation Assumptions [Table Text Block]	'
	The following are the key assumptions used in this valuation:


		2013			2012			2011
	Risk Free Interest Rate	0.37% - 0.67%			0.38 % - 0.40%			1.18	%

	Expected Stock Price Volatility	33.36% - 36.11%			36.41% - 48.05%			49.2	%

	Expected Service Period	3.0 years			3.0 years			2.7 years

	Expected Dividend Yield (assuming full reinvestment)	—	%		—	%		—	%
Summary of Option Activity	'
	A summary of the option activity is presented in the following table (dollars in thousands, except per share amounts):


			Range of Per Share Exercise Price		Shares Under Options			Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
	Outstanding as of December 31, 2012		$14.37 - $21.83		362,770			$	18.97	2.7	$	1,011

	Granted		—		—			—

	Exercised		$14.37 - $21.83		(298,484	)		19.35

	Forfeited		—		—			—



	Outstanding as of December 31, 2013		$17.17 - $17.31		64,286			$	17.22	2.9	$	574



	Exercisable as of December 31, 2013		$17.17 - $17.31		42,857			$	17.24	2.7	$	381

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	'
	The following table summarizes additional information concerning restricted stock units at December 31, 2013:


			Restricted Stock Units			Weighted Average Grant Date Fair Value Per Unit
	Unvested as of December 31, 2012		690,107			$	17.54

	Granted		456,921			18.52

	Vested		(513,750	)		20.83

	Dividends reinvested		30,936			16.8


	Unvested as of December 31, 2013		664,214			$	16.48

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Unrecognized Tax Benefits Roll Forward	'
	The following is a reconciliation of the Company’s beginning and ending unrecognized tax benefits (in thousands):





	Balance at December 31, 2011	$	25,540


	Additions (reductions) based on prior years’ tax positions	(1,328		)
	Additions (reductions) based on 2012 tax positions	—


	Balance at December 31, 2012	$	24,212


	Additions (reductions) based on prior years’ tax positions	—

	Additions (reductions) based on 2013 tax positions	—


	Balance at December 31, 2013	$	24,212

EARNINGS_PER_COMMON_SHARE_Tabl

EARNINGS PER COMMON SHARE (Tables)	12 Months Ended
	Dec. 31, 2013
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following table illustrates the computation of basic and diluted earnings per share for the years ended December 31, 2013, 2012 and 2011 (in thousands, except share and per share amounts):


		Year Ended December 31,
		2013		2012		2011
	Numerator
	Net income attributable to common stockholders	$	25,749	$	19,513	$	12,842


	Denominator
	Basic weighted average common shares and common equivalents	37,514,637		37,061,111		30,109,417

	Dilutive stock options and restricted stock units	557,289		260,406		61,808


	Diluted weighted average common shares	38,071,926		37,321,517		30,171,225


	Net income attributable to common stockholders, per:

	Basic common share	$	0.69	$	0.53	$	0.43


	Diluted common share	$	0.68	$	0.52	$	0.43

SUMMARIZED_CONDENSED_CONSOLIDA1

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2013
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Schedule of Condensed Balance Sheet	'
	Consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:


















	CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(in thousands, except share and per share amounts)



		Parent				Issuers				Combined				Combined Non-				Elimination				Consolidated
		Company								Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101			$	—			$	751,771			$	163,546			$	—			$	915,418

	Loans receivable and other investments, net	—				—				185,293				—				—				185,293

	Cash and cash equivalents	3,551				—				—				757				—				4,308

	Restricted cash	—				—				121				5,231				—				5,352

	Deferred tax assets	24,212				—				—				—				—				24,212

	Prepaid expenses, deferred financing costs and other assets	1,217				9,207				46,694				6,134				—				63,252

	Intercompany	333,125				270,194				—				42,637				(645,956		)		—

	Investment in subsidiaries	128,640				267,505				25,205				—				(421,350		)		—

	Total assets	$	490,846			$	546,906			$	1,009,084			$	218,305			$	(1,067,306	)		$	1,197,835

	Liabilities and stockholders’ equity
	Mortgage notes payable	$	—			$	—			$	—			$	141,328			$	—			$	141,328

	Secured revolving credit facility	—				—				135,500				—				—				135,500

	Senior unsecured notes payable	—				414,402				—				—				—				414,402

	Accounts payable and accrued liabilities	6,470				3,864				11,008				887				—				22,229

	Tax liability	24,212				—				—				—				—				24,212

	Intercompany	—				—				645,956				—				(645,956		)		—

	Total liabilities	30,682				418,266				792,464				142,215				(645,956		)		737,671

	Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2013	58				—				—				—				—				58

Common stock, $.01 par value; 125,000,000 shares authorized, 38,788,745 shares issued and outstanding as of December 31, 2013	388				—				—				—				—				388

Additional paid-in capital	534,639				21,226				53,574				48,507				(123,307		)		534,639

Cumulative distributions in excess of net income	(74,921		)		107,414				163,046				27,583				(298,043		)		(74,921		)

Total stockholders’ equity	460,164				128,640				216,620				76,090				(421,350		)		460,164

Total liabilities and stockholders’ equity	$	490,846			$	546,906			$	1,009,084			$	218,305			$	(1,067,306	)		$	1,197,835


CONSOLIDATING BALANCE SHEET
December 31, 2012
(in thousands, except share and per share amounts)



	Parent				Issuers				Combined				Combined Non-				Elimination				Consolidated
	Company								Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Assets
Real estate investments, net of accumulated depreciation	$	151			$	—			$	655,881			$	171,103			$	—			$	827,135

Loan receivable, net	—				—				12,017				—				—				12,017

Cash and cash equivalents	15,075				—				—				2,026				—				17,101

Restricted cash	—				—				92				4,497				—				4,589

Deferred tax assets	24,212				—				—				—				—				24,212

Assets held for sale, net	—				—				—				2,215				—				2,215

Prepaid expenses, deferred financing costs and other assets	1,315				7,339				18,133				2,826				—				29,613

Intercompany	—				227,396				—				37,466				(264,862		)		—

Investment in subsidiaries	351,632				451,975				23,142				—				(826,749		)		—

Total assets	$	392,385			$	686,710			$	709,265			$	220,133			$	(1,091,611	)		$	916,882

Liabilities and stockholders’ equity
Mortgage notes	$	—			$	—			$	—			$	152,322			$	—			$	152,322

Secured revolving credit facility	—				—				92,500				—				—				92,500

Senior unsecured notes	—				330,666				—				—				—				330,666

Accounts payable and accrued liabilities	3,281				4,412				3,348				653				—				11,694

Tax liability	24,212				—				—				—				—				24,212

Intercompany	59,404				—				205,458				—				(264,862		)		—

Total liabilities	86,897				335,078				301,306				152,975				(264,862		)		611,394

Stockholders’ equity:
Preferred stock, $.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2012	—				—				—				—				—				—

Common stock, $.01 par value; 125,000,000 shares authorized, 37,099,209 shares issued and outstanding as of December 31, 2012	371				—				—				—				—				371

Additional paid-in capital	353,861				292,939				321,666				53,952				(668,557		)		353,861

Retained earnings	(48,744		)		58,693				86,293				13,206				(158,192		)		(48,744		)

Total stockholders’ equity	305,488				351,632				407,959				67,158				(826,749		)		305,488

Total liabilities and stockholders’ equity	$	392,385			$	686,710			$	709,265			$	220,133			$	(1,091,611	)		$	916,882

Schedule of Condensed Income Statement	'
	CONSOLIDATING STATEMENT OF INCOME
	For the Year Ended December 31, 2013
	(in thousands, except share and per share amounts)



		Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Revenues:
	Rental income	$	—			$	—			$	99,711			$	29,277			$	—			$	128,988

	Interest and other income	86				—				5,706				—				—				5,792

	Total revenues	86				—				105,417				29,277				—				134,780

	Expenses:
	Depreciation and amortization	51				—				25,664				7,566				—				33,281

	Interest	—				28,767				4,444				7,249				—				40,460

	General and administrative	15,040				4				1,294				85				—				16,423

	Total expenses	15,091				28,771				31,402				14,900				—				90,164


	Other income (expense):
	Loss on extinguishment of debt	—				(9,750		)		(351		)		—				—				(10,101		)

	Other expense	—				—				(800		)		—				—				(800		)


	Total other income (expense)	—				(9,750		)		(1,151		)		—				—				(10,901		)


	Income in subsidiary	48,720				87,241				3,889				—				(139,850		)		—


	Net income	33,715				48,720				76,753				14,377				(139,850		)		33,715


	Preferred dividends	(7,966		)		—				—				—				—				(7,966		)


	Net income attributable to common stockholders	$	25,749			$	48,720			$	76,753			$	14,377			$	(139,850	)		$	25,749


	Net income attributable to common stockholders, per:
	Basic common share																					$	0.69

	Diluted common share																					$	0.68

	Weighted-average number of common shares outstanding, basic																					37,514,637

	Weighted-average number of common shares outstanding, diluted																					38,071,926

	CONSOLIDATING STATEMENT OF INCOME
	For the Year Ended December 31, 2012
	(in thousands, except share and per share amounts)



		Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
Guarantor										Guarantor
Subsidiaries										Subsidiaries
Revenues:
Rental income			$	—			$	—			$	75,606			$	26,136			$	—			$	101,742

Interest and other income	18				—				1,410				—				—				1,428

Total revenues	18				—				77,016				26,136				—				103,170

Expenses:
Depreciation and amortization	49				—				22,061				8,153				—				30,263

Interest	—				22,392				2,724				9,219				—				34,335

General and administrative	14,631				3				1,392				78				—				16,104

Impairment	—								—				2,481				—				2,481

Total expenses	14,680				22,395				26,177				19,931				—				83,183


Other income (expense):
Loss on extinguishment of debt	—				—				—				(2,670		)		—				(2,670		)

Other income	—				—				—				2,196				—				2,196


Total other income (expense)	—				—				—				(474		)		—				(474		)


Income (loss) in subsidiary	34,175				56,570				(3,693		)		—				(87,052		)		—


Net income attributable to common stockholders	$	19,513			$	34,175			$	47,146			$	5,731			$	(87,052	)		$	19,513


Net income attributable to common stockholders, per:
Basic common share																					$	0.53

Diluted common share																					$	0.52

Weighted-average number of common shares outstanding, basic																					37,061,111

Weighted-average number of common shares outstanding, diluted																					37,321,517


CONSOLIDATING STATEMENT OF INCOME
For the Year Ended December 31, 2011
(in thousands, except share and per share amounts)



	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Revenues:
Rental income	$	—			$	—			$	55,447			$	25,231			$	—			$	80,678

Interest and other income	64				—				3,479				4				—				3,547

Total revenues	64				—				58,926				25,235				—				84,225

Expenses:
Depreciation and amortization	53				—				18,144				8,394				—				26,591

Interest	—				18,913				1,333				10,073				—				30,319

General and administrative	9,905				1				4,476				91				—				14,473

Total expenses	9,958				18,914				23,953				18,558				—				71,383


Income in subsidiary	22,736				41,650				493				—				(64,879		)		—


Net income attributable to common stockholders	$	12,842			$	22,736			$	35,466			$	6,677			$	(64,879	)		$	12,842


Net income attributable to common stockholders, per:
Basic common share																					$	0.43

Diluted commons share																					$	0.43

Weighted-average number of common shares outstanding, basic																					30,109,417

Weighted-average number of common shares outstanding, diluted																					30,171,225

Schedule of Condensed Cash Flow Statement	'
	CONSOLIDATING STATEMENT OF CASH FLOWS
	For the Year Ended December 31, 2013
	(in thousands)



		Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
										Guarantor				Guarantor
										Subsidiaries				Subsidiaries
	Net cash provided by operating activities	$	47,810			$	—			$	—			$	14,289			$	—			$	62,099

	Cash flows from investing activities:
	Acquisitions of real estate	—				—				(125,955		)		—				—				(125,955		)

	Origination of loans receivable	—				—				(165,960		)		—				—				(165,960		)

	Preferred equity investments	—				—				(7,038		)		—				—				(7,038		)

	Additions to real estate	—				—				(764		)		—				—				(764		)

	Net proceeds from the sale of real estate	—				—				—				2,208				—				2,208

	Distribution from Subsidiary	4,066				4,066				—				—				(8,132		)		—

	Intercompany financing	(178,015		)		(258,819		)		—				—				436,834				—

	Net cash (used in) provided by investing activities	(173,949		)		(254,753		)		(299,717		)		2,208				428,702				(297,509		)

	Cash flows from financing activities:
	Proceeds from issuance of senior unsecured notes	—				200,000				—				—				—				200,000

	Principal payments on senior unsecured notes	—				(113,750		)		—				—				—				(113,750		)

	Proceeds from secured revolving credit facility	—				—				143,500				—				—				143,500

	Payments on secured revolving credit facility	—				—				(100,500		)		—				—				(100,500		)

	Principal payments on mortgage notes payable	—				—				—				(10,994		)		—				(10,994		)

	Payments of deferred financing costs	—				(5,446		)		(3,010		)		(498		)		—				(8,954		)

	Payment of contingent consideration	—				—				(1,300		)		—				—				(1,300		)

	Issuance of preferred stock	138,249				—				—				—				—				138,249

	Issuance of common stock	34,517				—				—				—				—				34,517

	Dividends paid on common and preferred stock	(58,151		)		—				—				—				—				(58,151		)

	Distribution to Parent	—				(4,066		)		—				(4,066		)		8,132				—

	Intercompany financing	—				178,015				261,027				(2,208		)		(436,834		)		—

	Net cash provided by (used in) financing activities	114,615				254,753				299,717				(17,766		)		(428,702		)		222,617

	Net decrease in cash and cash equivalents	(11,524		)		—				—				(1,269		)		—				(12,793		)

	Cash and cash equivalents, beginning of period	15,075				—				—				2,026				—				17,101

	Cash and cash equivalents, end of period	$	3,551			$	—			$	—			$	757			$	—			$	4,308


	CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2012
(in thousands)




	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Net cash provided by operating activities	$	53,584			$	—			$	—			$	2,668			$	—			$	56,252

Cash flows from investing activities:
Acquisitions of real estate	—				—				(205,424		)		—				—				(205,424		)

Origination of note receivable	—				—				(22,180		)		—				—				(22,180		)

Additions to real estate	(14		)		—				(1,032		)		—				—				(1,046		)

Repayment of note receivable	—				—				10,000				—				—				10,000

Investment in Subsidiary	(7,191		)		(7,191		)		—				—				14,382				—

Distribution from Subsidiary	1,751				1,751				—				—				(3,502		)		—

Intercompany financing	(25,915		)		(128,721		)		—				—				154,636				—

Net cash used in investing activities	(31,369		)		(134,161		)		(218,636		)		—				165,516				(218,650		)

Cash flows from financing activities:
Proceeds from the issuance of senior unsecured notes	—				106,000				—				—				—				106,000

Proceeds from secured revolving credit facility	—				—				135,000				—				—				135,000

Payments on secured revolving credit facility	—				—				(42,500		)		—				—				(42,500		)

Proceeds from mortgage notes	—				—				—				56,651				—				56,651

Principal payments on mortgage notes payable	—				—				—				(62,226		)		—				(62,226		)

Payments of deferred financing costs	—				(3,194		)		(2,585		)		(1,021		)		—				(6,800		)

Issuance of common stock	53				—				—				—				—				53

Dividends paid	(48,929		)		—				—				—				—				(48,929		)

Contribution from Parent	—				7,191				—				7,191				(14,382		)		—

Distribution to Parent	—				(1,751		)		—				(1,751		)		3,502				—

Intercompany financing	—				25,915				128,721				—				(154,636		)		—

Net cash (used in) provided by financing activities	(48,876		)		134,161				218,636				(1,156		)		(165,516		)		137,249

Net (decrease) increase in cash and cash equivalents	(26,661		)		—				—				1,512				—				(25,149		)

Cash and cash equivalents, beginning of period	41,736				—				—				514				—				42,250

Cash and cash equivalents, end of period	$	15,075			$	—			$	—			$	2,026			$	—			$	17,101




CONSOLIDATING STATEMENT OF CASH FLOWS
For the Year Ended December 31, 2011
(in thousands)



	Parent Company				Issuers				Combined				Combined Non-				Elimination				Consolidated
									Guarantor				Guarantor
									Subsidiaries				Subsidiaries
Net cash provided by operating activities	$	41,298			$	—			$	—			$	3,407			$	—			$	44,705

Cash flows from investing activities:
Acquisition of real estate	—				—				(204,500		)		—				—				(204,500		)

Acquisition of note receivable	(5,348		)		—				—				—				—				(5,348		)

Additions to real estate	(86		)		—				—				—				—				(86		)

Repayment of note receivable	5,348				—				—				—				—				5,348

Investment in Subsidiary	(164,030		)		(96		)		—				—				164,126				—

Distribution from Subsidiary	3,307				3,307				—				—				(6,614		)		—

Intercompany financing	(41,196		)		(204,700		)		—				—				245,896				—

Net cash used in investing activities	(202,005		)		(201,489		)		(204,500		)		—				403,408				(204,586		)

Cash flows from financing activities:
Principal payments on mortgage notes	—				—				—				(3,027		)		—				(3,027		)

Payments of deferred financing costs	—				(430		)		(200		)		(47		)		—				(677		)

Issuance of common stock	163,242				—				—				—				—				163,242

Dividends paid	(31,640		)		—				—				—				—				(31,640		)

Contribution from Parent	—				164,030				—				96				(164,126		)		—

Distribution to Parent	—				(3,307		)		—				(3,307		)		6,614				—

Intercompany financing	—				41,196				204,700				—				(245,896		)		—

Net cash provided by (used in) financing activities	131,602				201,489				204,500				(6,285		)		(403,408		)		127,898

Net decrease in cash and cash equivalents	(29,105		)		—				—				(2,878		)		—				(31,983		)

Cash and cash equivalents, beginning of period	70,841				—				—				3,392				—				74,233

Cash and cash equivalents, end of period	$	41,736			$	—			$	—			$	514			$	—			$	42,250

PRO_FORMA_FINANCIAL_INFORMATIO1

PRO FORMA FINANCIAL INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2013
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Business Acquisition, Pro Forma Information	'
	This pro forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):


		Year Ended December 31, 2013		Year Ended December 31, 2012

	Revenues	$	145,517	$	116,486

	Depreciation and amortization	36,669		34,344

	Net income attributable to common stockholders	33,459		27,559


	Net income attributable to common stockholders, per:
	Basic common share	0.89		0.74

	Diluted common share	0.88		0.74


	Weighted-average number of common shares outstanding, basic	37,514,637		37,061,111

	Weighted-average number of common shares outstanding, diluted	38,071,926		37,321,517

BUSINESS_Details

BUSINESS (Details)	Dec. 31, 2013	Dec. 31, 2012
BUSINESS (Details)	Facilities	Facilities
Real Estate Properties	'	'
Loans and Leases Receivable, Number of Loans	10	'
Preferred Equity Investments, Number	2	'
Operating Segments	'	'
Real Estate Properties	'	'
Number of Real Estate Properties	121	119
Skilled Nursing/Post-Acute Facilities	'	'
Real Estate Properties	'	'
Number of Real Estate Properties	96	96
Senior Housing Facilities	'	'
Real Estate Properties	'	'
Number of Real Estate Properties	23	22
Acute Care Hospitals	'	'
Real Estate Properties	'	'
Number of Real Estate Properties	2	1
Mortgage Receivable [Member]	'	'
Real Estate Properties	'	'
Loans and Leases Receivable, Number of Loans	4	'
Pre-Development Loans [Member]	'	'
Real Estate Properties	'	'
Loans and Leases Receivable, Number of Loans	2	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Real Estate (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Companies	Companies	Companies
Real Estate	'	'	'
Number of business combinations	2	23	11
Business Combination, Acquisition Related Costs	$1,500,000	$1,700,000	$3,200,000
Impairment of Real Estate Investments	$0	$2,481,000	$0
Land improvements \| Minimum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'3 years	'	'
Land improvements \| Maximum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'40 years	'	'
Buildings and building improvements \| Minimum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'3 years	'	'
Buildings and building improvements \| Maximum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'40 years	'	'
Furniture and equipment \| Minimum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'1 year	'	'
Furniture and equipment \| Maximum	'	'	'
Real Estate	'	'	'
Property, plant and equipment, useful life	'20 years	'	'

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
	Segment	Companies	Companies
	Companies
Accounting Policies	'	'	'
Number of business combinations	2	23	11
Proceeds from sale of real estate	$2,208,000	$0	$0
Cash and Cash Equivalents	'	'	'
Restricted cash	5,352,000	4,589,000	'
Deferred Financing Costs	'	'	'
Deferred financing costs, net of amortization	15,400,000	12,400,000	'
Industry Segments	'	'	'
Number of reportable segments	1	'	'
Business Combination, Acquisition Related Costs	1,500,000	1,700,000	3,200,000
Cash obligations	'	'	'
Cash and Cash Equivalents	'	'	'
Restricted cash	3,500,000	2,300,000	'
Skilled Nursing Post Acute Facility Held-for-sale [Member]	'	'	'
Industry Segments	'	'	'
Real Estate Held-for-sale	$0	$2,200,000	'

ACQUISITIONS_OF_REAL_ESTATE_De

ACQUISITIONS OF REAL ESTATE (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Oct. 22, 2013

Dec. 31, 2013

Series of Individually Immaterial Business Acquisitions [Member]

Acquisitions during 2013 [Member]

Forest Park Medical Center - Frisco

Senior Housing Facilities

Acute Care Hospitals

Tenant Origination and Absorption Costs

Tenant Relationship

Beds

Series of Individually Immaterial Business Acquisitions [Member]

Facilities

Business Acquisition

Business Acquisition, Number of Acquired Properties

Schedule of Purchase Price Allocation

Intangibles

Land

Building and Improvements

Tenant Origination and Absorption Costs

Tenant Relationship

Total Consideration

5,563

114,666

2,196

349

122,774

Land

$5,563,000

Building and Improvements

114,666,000

Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles

2,196,000

349,000

Total Purchase Price

122,774,000

Acquired Finite-lived Intangible Assets, Weighted Average Useful Life

'18 years

'28 years

Revenues

134,780,000

103,170,000

84,225,000

2,900,000

Net Income (Loss) Available to Common Stockholders, Basic

25,749,000

19,513,000

12,842,000

1,000,000

Business Combination, Contingent Consideration, Liability

7,300,000

7,500,000

Number of Beds/Units

Business Combination, Consideration Transferred

119,800,000

Business Combination, Consideration Transferred, Other

10,500,000

Business Combination, Consideration Transferred, Other, Holding Period

'20 months

Business Combination, Consideration Transferred, Other, Annual Fee during Holding Period

500,000

Deposit Assets

10,500,000

Change in fair value of contingent consideration

$200,000

REAL_ESTATE_INVESTMENTS_Detail

REAL ESTATE INVESTMENTS (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 18, 2012

Dec. 31, 2013

Operating Segments

Skilled Nursing/Post-Acute Facilities

Senior Housing Facilities

Acute Care Hospitals

Corporate Level

Stoney River Marshfield

Facilities

Beds

Facilities

Beds

Facilities

Beds

Facilities

Real Estate Properties

Number of Properties

121

119

Number of Beds/Units

12,468

12,382

10,826

1,518

1,486

124

Buildings and improvements

$879,926,000

$782,221,000

Fixtures and equipment

50,567,000

43,810,000

Land improvements

4,392,000

4,535,000

Land

131,611,000

126,048,000

Total Real Estate at Cost

1,066,496,000

956,614,000

1,066,242,000

956,360,000

737,188,000

746,510,000

153,247,000

148,210,000

175,807,000

61,640,000

254,000

Accumulated Depreciation

-151,078,000

-129,479,000

-150,925,000

-129,376,000

-132,068,000

-116,426,000

-13,337,000

-9,949,000

-5,520,000

-3,001,000

-153,000

-103,000

Total Real Estate Investments, Net

915,418,000

827,135,000

915,317,000

826,984,000

605,120,000

630,084,000

139,910,000

138,261,000

170,287,000

58,639,000

101,000

151,000

Business Combination, Consideration Transferred

8,200,000

Business Combination, Contingent Consideration, Liability

1,300,000

Payment of contingent consideration

1,300,000

1,900,000

Change in fair value of contingent consideration

$200,000

$600,000

REAL_ESTATE_INVESTMENTS_Operat

REAL ESTATE INVESTMENTS Operating Lease (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
			Minimum	Maximum	Operating Segments	Operating Segments	Operating Segments
					Facilities	Facilities	Genesis Healthcare, Inc [Member]
							Facilities
Property Subject to or Available for Operating Lease	'	'	'	'	'	'	'
Operating Leases, Lease Expiration Period	'	'	'7 years	'21 years	'	'	'
Operating Leases, Weighted Average Lease Expiration Period	'11 years	'	'	'	'	'	'
Security Deposit Liability	$1,600,000	$1,100,000	'	'	'	'	'
Number of Real Estate Properties	'	'	'	'	121	119	81
Future Minimum Payments Receivable	'	'	'	'	'	'	'
2014	126,182,000	'	'	'	'	'	'
2015	129,218,000	'	'	'	'	'	'
2016	132,263,000	'	'	'	'	'	'
2017	135,543,000	'	'	'	'	'	'
2018	138,909,000	'	'	'	'	'	'
Thereafter	894,424,000	'	'	'	'	'	'
Total	$1,556,539,000	'	'	'	'	'	'

TENANT_ORIGINATION_AND_ABSORPT2

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP Intangible Assets, Net (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Tenant Origination and Absorption Costs	'	'
Intangible Assets, Net	'	'
Cost	$8,884	$6,688
Accumulated amortization	-837	-344
Net amount	8,047	6,344
Tenant Relationship	'	'
Intangible Assets, Net	'	'
Cost	1,900	1,551
Accumulated amortization	-106	-38
Net amount	$1,794	$1,513

TENANT_ORIGINATION_AND_ABSORPT3

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP Amortization Expense (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Tenant Origination and Absorption Costs	'	'
Finite-Lived Intangible Assets	'	'
Amortization of Intangible Assets	($493)	($269)
Tenant Relationship	'	'
Finite-Lived Intangible Assets	'	'
Amortization of Intangible Assets	($68)	($31)

TENANT_ORIGINATION_AND_ABSORPT4

TENANT ORIGINATION AND ABSORPTION COSTS AND TENANT RELATIONSHIP Future Amortization Expense (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Tenant Origination and Absorption Costs	'
Finite-Lived Intangible Assets	'
2014	591
2015	591
2016	591
2017	591
2018	591
Thereafter	5,092
Total	8,047
Tenant Origination and Absorption Costs \| Weighted Average	'
Finite-Lived Intangible Assets	'
Remaining Amortization Period	'14 years 9 months
Tenant Relationship	'
Finite-Lived Intangible Assets	'
2014	79
2015	79
2016	79
2017	79
2018	79
Thereafter	1,399
Total	1,794
Tenant Relationship \| Weighted Average	'
Finite-Lived Intangible Assets	'
Remaining Amortization Period	'23 years 4 months

REAL_ESTATE_LOANS_RECEIVABLE_D

REAL ESTATE LOANS RECEIVABLE (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Mar. 05, 2013

Dec. 31, 2013

Mar. 05, 2013

Nov. 07, 2013

Dec. 31, 2013

Oct. 31, 2013

Dec. 31, 2013

Oct. 22, 2013

Dec. 31, 2013

Sep. 30, 2013

Dec. 31, 2013

Jun. 28, 2013

Dec. 31, 2013

Sep. 30, 2013

Dec. 31, 2013

Jan. 31, 2013

Facilities

Affiliated Entity [Member]

Memory Care Facility [Member]

Skilled Nursing Facilities [Member]

Weston

New Dawn Virginia Loans

Mortgage Receivable [Member]

Construction Loans [Member]

Mezzanine Loan [Member]

Pre-Development Loans [Member]

Forest Park - Dallas

FPMC Fort Worth Realty Partners, LP [Member]

Chai Mezzanine Loan Portfolio [Member]

Sun City West Mortgage Loan [Member] [Domain]

Affiliated Entity [Member]

Beds

unit

Facilities

New Dawn Memory Care Facility - Henrico, Virginia

New Dawn Memory Care Facility - Williamsburg, Virginia

Facilities

Inpatient_Room

Operating_Room

Room

Interest Rate

10-year Treasury Rate

Wholly Owned Subsidiary [Member]

Beds

loan

unit

Beds

Renewal_Options

Beds

Accounts, Notes, Loans and Financing Receivable [Line Items]

Loans and Leases Receivable, Commitments

$14,700,000

$17,100,000

$66,800,000

Loans and Leases Receivable, Number of Units in Real Estate Property Used as Collateral

Loans and Leases Receivable, Number of Loans

Loans and Leases Receivable, Number of Facilities to be Constructed

Loans and Leases Receivable, Gross

176,558,000

14,400,000

2,100,000

2,000,000

148,925,000

13,945,000

12,350,000

1,338,000

110,000,000

11,900,000

500,000

12,400,000

12,800,000

Loans and Leases Receivable, Fixed Interest Rate

8.43%

9.00%

10.00%

8.20%

7.70%

12.00%

9.00%

8.00%

7.25%

12.00%

9.00%

Loans receivable, net

185,293,000

12,017,000

149,450,000

14,283,000

12,410,000

1,366,000

Loans And Leases Receiavble, Effective Interest Rate

8.30%

8.10%

7.60%

11.50%

8.40%

Loans and Leases Receivable, Option to Purchase

168,000,000

50,000,000

15,000,000

Loans and Leases Receivable, Option to Purchase, Earnings Before Interest, Taxes, Depreciation, Amortization and Rent, Percent Threshold

15.00%

Loans and Leases Receivable, Anticipated Lease Term Upon Exercise of Purchase Option

'15

Loans and Leases Receivable, Anticipated Number of Lease Renewal Options Upon Exercise of Purchase Option

Loans and Leases Receivable, Anticipated Lease Renewal Term Upon Exercise of Purchase Option

'5 years

Loans and Leases Receivable, Anticipated Lease Rent Increase Upon Exercise of Purchase Option

3.00%

Loans and Leases Receivable, Number of Units in Real Estate Property

Loans and Leases Receivable, Repayment Period

'3 years

'18

'5 years

Loans and Leases Receivable, Repayment Period, Option for Extension

'6 months

Loans and Leases Receivable, Prepayment Prohibited Period

'3 years

Loans and Leases Receivable, Option to Purchase, Earnings Before Interest, Taxes, Depreciation, Amortization and Rent Divided by EBITDAR Coverage Ratio

168,000,000

1.5

1.3

Loans and Leases Receivable, Option to Purchase, Implied Lease Rate

0.095

0.0825

Loans and Leases Receivable, Option to Purchase, Adjusted Implied Lease Rate

$0.09

Preferred Equity Investment, Total Commitment

'7.2

Preferred Equity Investment, Number of Units in Real Estate Property

141

Preferred Equity Investment, Amount Funded

'4.3

'6.9

Option to Purchase Facility, Occupancy Achieved for Three Consecutive Months

90.00%

Option to Purchase Facility, Number of Months After Receiving Certificate of Occupancy

'36 months

Preferred Equity Investment, Preferred Rate

'0.15

Preferred Equity Investment, Deferred Distribution Period

'30

'18

Preferred Equity Investment, Right to Redeem Investment if Purchase Option is not Exercised, Duration

'180 days

Loans and Leases Receivable, Fixed Interest Rate During Extended Term

8.00%

Loans and Leases Receivable, Option to Purchase, Period

'12 months

Loans and Leases Receivable, Option to Purchase, Denominator Calculation

8.75%

Loans and Leases Receivable, Option to Purchase, Denominator Calculation, Basis Spread on Variable Rate

5.25%

DEBT_Details

DEBT (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Sep. 20, 2012

Feb. 10, 2012

Feb. 09, 2012

Feb. 10, 2012

Jan. 23, 2014

23-May-13

Oct. 27, 2010

Dec. 31, 2013

Feb. 11, 2014

Jan. 08, 2014

Dec. 31, 2013

Jul. 26, 2012

Nov. 24, 2012

Dec. 31, 2013

Jul. 29, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 21, 2014

Dec. 31, 2013

Dec. 31, 2012

Revolving Credit Facility

Letter of Credit

Senior Unsecured Notes due 2021

Senior Unsecured Notes Due 2023 [Member]

Senior Notes due 2018

Additional Senior Notes [Member]

2013 Revolving Credit Facility [Member]

Mortgage Indebtedness

Senior Notes

Subsequent Event

Revolving Credit Facility

Prior to February 1, 2017

Prior to June 2018 [Member]

Prior to June 2016 [Member]

Subsequent Event

Prior to November 2013

Revolving Credit Facility

Subsequent Event

Fixed Rate Mortgages

Variable Rate Mortgages

Subsequent Event

Minimum

Maximum

Federal Funds Rate

London Interbank Offered Rate (LIBOR)

Base Rate

Minimum

Maximum

Minimum

Maximum

Debt Instrument

Principal Outstanding, Fixed Rate

$54,688,000

$94,373,000

Principal Outstanding, Variable Rate

86,640,000

57,949,000

Total Principal Outstanding

141,328,000

152,322,000

Weighted Average Interest Rate

4.08%

3.97%

2.62%

5.00%

Debt Instrument, Description of Variable Rate Basis

' federal funds rate

'one-month LIBOR

'90-day LIBOR

Debt Instrument, Basis Spread on Variable Rate

0.50%

1.00%

4.00%

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum

1.00%

Stated interest rate

5.50%

5.38%

8.13%

4.25%

Aggregate principal amount of debt

350,000,000

200,000,000

225,000,000

100,000,000

44,800,000

411,250,000

[1]

325,000,000

[1]

Repayment of outstanding amount under revolving credit facility

100,500,000

42,500,000

4,500,000

Debt Instrument, Unamortized Premium

3,200,000

Debt Instrument, Redemption Price, Percentage

100.00%

109.49%

109.84%

Expected Tender Offer and Redemption Related Costs and Write Offs in First Quarter of Next Fiscal Year

21,600,000

Expected Tender Offer and Redemption Related Costs and Write Offs in First Quarter of Next Fiscal Year, Payments Made to Noteholders for Early Redemption

20,800,000

Expected Tender Offer and Redemption Related Costs and Write Offs in First Quarter of Next Fiscal Year, Write-Offs Associated With Unamortized Deferred Financing and Premium Costs

800,000

Debt Instrument, Percent to Par Value

106.00%

Proceeds from Issuance of Debt

350,000,000

200,000,000

225,000,000

103,000,000

Debt Instrument, Interest Rate, Effective Percentage

6.92%

Proceeds from Debt, Net of Issuance Costs

341,400,000

194,600,000

219,900,000

Debt Instrument, Redeemable, Redemption Price of Principal Amount, Percentage

108.13%

Line of Credit Facility, Maximum Borrowing Capacity

200,000,000

100,000,000

20,000,000

375,000,000

Line of Credit Facility, Commitment Fee Amount

1,200,000

Line of Credit Facility, Accordion Feature, Additional Borrowing Capacity

150,000,000

225,000,000

Line of Credit Facility, Accordion Feature, Increased Borrowing Capacity

230,000,000

Line of Credit Facility, Optional Extension Period

'1 year

Secured revolving credit facility

135,500,000

92,500,000

Line of Credit Facility, Current Borrowing Capacity

135,100,000

Line of Credit Facility, Interest Rate During Period

2.50%

3.50%

1.50%

2.50%

Line of Credit Facility, Interest Rate at Period End

3.17%

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

0.35%

0.50%

Interest Expense

40,460,000

34,335,000

30,319,000

1,700,000

Amortization of deferred financing costs

3,280,000

2,685,000

1,998,000

Interest Payable

4,700,000

5,400,000

Loss on extinguishment of debt

-10,101,000

-2,670,000

-9,800,000

Debt Instrument, Redemption Price, Principal Amount Redeemed

113,800,000

Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed

35.00%

Debt Instrument, Redemption Price, Percentage, Using Proceeds of Specific Kinds of Equity Offerings

105.50%

105.38%

Gains (Losses) on Extinguishment of Debt, before Write off of Deferred Debt Issuance Cost

-9,300,000

Write off of Deferred Debt Issuance Cost

500,000

Long-term Debt

688,078,000

211,300,000

141,328,000

[2]

411,250,000

Extinguishment of Debt, Amount

$400,000

$210,900,000

[1]

Face value represents amounts contractually due under the terms of the respective agreements.

[2]

Outstanding principal balance for Senior Notes does not include premium ofÂ $3.2 millionÂ as ofÂ DecemberÂ 31, 2013.

DEBT_Schedule_of_Debt_Maturiti

DEBT Schedule of Debt Maturities (Details) (USD $)	Dec. 31, 2013
Debt Instrument	'
2014	$3,739,000
2015	86,075,000
2016	137,147,000
2017	1,688,000
2018	212,980,000
Thereafter	246,449,000
Total	688,078,000
Mortgage Indebtedness	'
Debt Instrument	'
2014	3,739,000	[1]
2015	86,075,000	[1]
2016	1,647,000	[1]
2017	1,688,000	[1]
2018	1,730,000	[1]
Thereafter	46,449,000	[1]
Total	141,328,000	[1]
Senior Notes	'
Debt Instrument	'
Debt Instrument, Unamortized Premium	3,200,000
2014	0
2015	0
2016	0
2017	0
2018	211,250,000
Thereafter	200,000,000
Total	411,250,000
Secured Revolving Credit Facility	'
Debt Instrument	'
2014	0
2015	0
2016	135,500,000
2017	0
2018	0
Thereafter	0
Total	$135,500,000

[1]	Outstanding principal balance for Senior Notes does not include premium ofÂ $3.2 millionÂ as ofÂ DecemberÂ 31, 2013.

FAIR_VALUE_DISCLOSURES_Details

FAIR VALUE DISCLOSURES (Details) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Oct. 22, 2013

Carrying Amount

Fair Value

Senior Notes

Mortgage indebtedness

Forest Park Medical Center - Frisco

Carrying Amount

Fair Value

Carrying Amount

Fair Value

Balance Sheet Grouping, Financial Statement Captions

Contingent Consideration, Fair Value Disclosure

$7,500,000

Business Combination, Contingent Consideration, Liability

7,500,000

7,300,000

Loan Receivable, Face Value

11,965,000

Loans Receivable

12,017,000

12,826,000

Debt Instrument, Face Amount

411,250,000

[1]

325,000,000

[1]

141,328,000

[1]

152,322,000

[1]

Financial liabilities

330,666,000

[2]

345,313,000

141,328,000

[2]

152,322,000

[2]

152,559,000

Secured revolving credit facility

$135,500,000

$92,500,000

[1]

Face value represents amounts contractually due under the terms of the respective agreements.

[2]

Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

FAIR_VALUE_DISCLOSURES_Assets_

FAIR VALUE DISCLOSURES (Assets and Liabilities Measured on a Recurring and Nonrecurring Basis) (Details) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Loans and Leases Receivable, Gross	$176,558		'
Loans receivable, net	185,293		12,017
Loan Receivable, Face Value	'		11,965
Secured revolving credit facility	135,500		92,500
Senior unsecured notes payable	414,402		330,666
Fair Value, Measurements, Recurring \| Total	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Loans Receivable	176,985		'
Fair Value, Measurements, Recurring \| Level 1	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Contingent Consideration, Fair Value Disclosure	0		'
Loans Receivable	0		'
Fair Value, Measurements, Recurring \| Level 2	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Contingent Consideration, Fair Value Disclosure	0		'
Loans Receivable	0		'
Fair Value, Measurements, Recurring \| Level 3	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Contingent Consideration, Fair Value Disclosure	7,500		'
Loans Receivable	176,985		'
Senior Notes	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Debt Instrument, Face Amount	411,250	[1]	325,000	[1]
Senior Notes \| Fair Value, Measurements, Recurring \| Total	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	421,122		'
Senior Notes \| Fair Value, Measurements, Recurring \| Level 1	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	0		'
Senior Notes \| Fair Value, Measurements, Recurring \| Level 2	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	421,122		'
Senior Notes \| Fair Value, Measurements, Recurring \| Level 3	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	0		'
Mortgage indebtedness	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Debt Instrument, Face Amount	141,328	[1]	152,322	[1]
Mortgage indebtedness \| Fair Value, Measurements, Recurring \| Total	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	130,622		'
Mortgage indebtedness \| Fair Value, Measurements, Recurring \| Level 1	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	0		'
Mortgage indebtedness \| Fair Value, Measurements, Recurring \| Level 2	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	0		'
Mortgage indebtedness \| Fair Value, Measurements, Recurring \| Level 3	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	130,622		'
Carrying Amount	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Loans receivable, net	177,509		'
Loans Receivable	'		12,017
Carrying Amount \| Senior Notes	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	'		330,666	[2]
Senior unsecured notes payable	414,402		'
Carrying Amount \| Mortgage indebtedness	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	141,328	[2]	152,322	[2]
Fair Value	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Loans Receivable	'		12,826
Fair Value \| Senior Notes	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	'		345,313
Fair Value \| Mortgage indebtedness	'		'
Assets and Liabilities Measured on Recurring and Nonrecurring Basis	'		'
Financial liabilities	'		$152,559

[1]	Face value represents amounts contractually due under the terms of the respective agreements.
[2]	Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

EQUITY_Details

EQUITY (Details) (USD $)

0 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Oct. 23, 2013

Jul. 31, 2013

1-May-13

Mar. 21, 2013

Jan. 07, 2013

Oct. 29, 2012

Aug. 01, 2012

Apr. 24, 2012

Feb. 29, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Jan. 23, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

At-the-Market Offering, Sales Agents

Ordinary Dividends

Return of Capital

Subsequent Event

Restricted Stock Units (RSUs)

Stock Options

Dividend Declared

Equity

Preferred stock, shares issued

5,800,000

5,750,000

Stock-based compensation, issued during period (in shares)

239,088

165,857

33,935

41,640

Common stock dividends, declared (in dollars per share)

$0.34

$0.33

$1.36

$1.32

$0.96

$0.36

Common dividends, paid

$1.36

$1.32

$0.96

$0.47

$0.80

$0.78

$0.89

$0.52

$0.18

Preferred Stock, Dividend Rate, Percentage

7.13%

Preferred Stock, Redemption Price Per Share

$25

Issuance of preferred stock

138,300,000

138,249,000

Convertible Preferred Stock, Terms of Conversion

'1.7864

Common Stock, At The Market Stock Offering, Max Possible Gross Proceeds

100,000,000

Common Stock, At the Market Stock Offering, Sales Commision

2.00%

Number of shares of common stock sold under ATM Program

1,400,000

Average price per share of common stock sold under ATM Program

$27.01

Gross proceeds from issuance of common stock, ATM Program

34,517,000

53,000

163,242,000

38,300,000

Stock issuance costs, commissions, ATM Program

700,000

Amount available under ATM Program

$61,700,000

STOCKBASED_COMPENSATION_Option

STOCK-BASED COMPENSATION Option Activity (Details) (USD $)	12 Months Ended
STOCK-BASED COMPENSATION Option Activity (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Range of Per Share Exercise Price	'	'	'
Outstanding, Minimum (dollars per share)	$14.37	'	'
Outstanding, Maximum (dollars per share)	$21.83	'	'
Granted, Minimum (dollars per share)	$0	'	'
Granted, Maximum (dollars per share)	$0	'	'
Exercised, Minimum (dollars per share)	$14.37	'	'
Exercised, Maximum (dollars per share)	$21.83	'	'
Forfeited, Minimum (dollars per share)	$0	'	'
Forfeited, Maximum (dollars per share)	$0	'	'
Outstanding, Minimum (dollars per share)	$17.17	$14.37	'
Outstanding, Maximum (dollars per share)	$17.31	$21.83	'
Exercisable, Minimum (dollars per share)	$17.17	'	'
Exercisable, Maximum (dollars per share)	$17.31	'	'
Shares Under Options	'	'	'
Outstanding (shares)	362,770	'	'
Granted (shares)	0	'	'
Exercised (shares)	-298,484	'	'
Forfeited (shares)	0	'	'
Outstanding (shares)	64,286	362,770	'
Exercisable, Shares Under Options	42,857	'	'
Weighted Average Exercise Price Per Share	'	'	'
Outstanding (dollars per share)	$18.97	'	'
Granted (dollars per share)	$0	'	'
Exercised (dollars per share)	$19.35	'	'
Forfeited (dollars per share)	$0	'	'
Outstanding (dollars per share)	$17.22	$18.97	'
Exercisable (dollars per share)	$17.24	'	'
Additional Disclosures	'	'	'
Outstanding, Weighted Average Remaining Contractual Term (Years)	'2 years 11 months	'2 years 8 months	'
Exercisable, Weighted Average Remaining Contractual Term (Years)	'2 years 8 months	'	'
Outstanding, Aggregate Intrinsic Value	$1,011,000	'	'
Outstanding, Aggregate Intrinsic Value	574,000	1,011,000	'
Exercisable, Aggregate Intrinsic Value	381,000	'	'
Intrinsic value of stock options exercised	1,800,000	200,000	200,000
Cash received for stock options exercised	'	500,000	500,000
Fair Value of stock options vested	$300,000	$600,000	$700,000

STOCKBASED_COMPENSATION_Restri

STOCK-BASED COMPENSATION Restricted Stock Units (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restricted Stock Units Activity	'	'	'
Unvested Units	690,107	'	'
Granted	456,921	'	'
Vested	-513,750	'	'
Reinvested	30,936	'	'
Unvested Units	664,214	690,107	'
Weighted Average Grant Date Fair Value Per Unit	'	'	'
Fair value of units vested	$10.70	$2.10	$1.30
Restricted Stock Units (RSUs)	'	'	'
Weighted Average Grant Date Fair Value Per Unit	'	'	'
Unvested	$17.54	'	'
Granted (dollars per share)	$18.52	$18.34	$16.74
Vested (dollars per share)	$20.83	'	'
Reinvested (dollar per share)	$16.80	'	'
Unvested	$16.48	$17.54	'
Weighted Average Remaining Contractual Term	'2 years 2 months	'	'
Funds From Operations Units \| Minimum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Award vesting percentage	0.00%	'	'
Funds From Operations Units \| Maximum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Award vesting percentage	250.00%	'	'
TSR Units	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	'	1.18%
TSR Units \| Minimum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.37%	0.38%	'
Award vesting percentage	0.00%	'	'
TSR Units \| Maximum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.67%	0.40%	'
Award vesting percentage	150.00%	'	'
Performance Incentive Plan of 2009 \| Restricted Stock Units (RSUs) \| Minimum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Award vesting period	'3 years	'	'
Performance Incentive Plan of 2009 \| Restricted Stock Units (RSUs) \| Maximum	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Award vesting period	'5 years	'	'

STOCKBASED_COMPENSATION_Fair_V

STOCK-BASED COMPENSATION Fair Value Assumptions (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Assumptions used in fair value valuation	'	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	7.3	'	'
Unrecognized Share Based Compensation, Weighted Average Remaining Period	'2 years 5 months	'	'
TSR Units	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award	'	'	'
Historical volatility rate period	'3 years	'	'
Assumptions used in fair value valuation	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	'	'	1.18%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	'	'	49.20%
Expected Service Period:	'3 years	'3 years	'2 years 8 months
Expected Dividend Yield (assuming full reinvestment):	0.00%	0.00%	0.00%
Minimum \| TSR Units	'	'	'
Assumptions used in fair value valuation	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.37%	0.38%	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	33.36%	36.41%	'
Maximum \| TSR Units	'	'	'
Assumptions used in fair value valuation	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	0.67%	0.40%	'
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	36.11%	48.05%	'

STOCKBASED_COMPENSATION_Employ

STOCK-BASED COMPENSATION Employee Benefit Plan (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
STOCK-BASED COMPENSATION [Abstract]	'	'	'
Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent	3.00%	'	'
Defined Contribution Plan, Employer Discretionary Contribution Amount	$44,000	$25,000	$27,000

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
INCOME TAXES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Jan. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'	'
Income tax expense	$0	$0	$0	'
Built-in-gains tax associated to properties	'	'	'	145,800,000
Corporate tax rate	40.00%	'	'	'
Reconciliation of Unrecognized Tax Benefits	'	'	'	'
Unrecognized tax benefits, beginning balance	25,540,000	'	'	'
Additions (reductions) based on prior years' tax positions	0	'	'	'
Additions (reductions) based on prior yearsâ€™ tax positions	'	-1,328,000	'	'
Additions (reductions) based on current year tax positions	0	0	'	'
Unrecognized tax benefits, ending balance	$24,212,000	$25,540,000	'	'

EARNINGS_PER_COMMON_SHARE_Deta

EARNINGS PER COMMON SHARE (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Numerator	'	'	'
Net Income (Loss) Available to Common Stockholders, Basic	$25,749	$19,513	$12,842
Denominator	'	'	'
Basic weighted average common shares (in shares)	37,514,637	37,061,111	30,109,417
Dilutive stock options and restricted stock units (in shares)	557,289	260,406	61,808
Dilutive weighted average common shares (in shares)	38,071,926	37,321,517	30,171,225
Basic earnings per common share (USD per shares)	$0.69	$0.53	$0.43
Dilutive earnings per common share (USD per shares)	$0.68	$0.52	$0.43

EARNINGS_PER_COMMON_SHARE_Anti

EARNINGS PER COMMON SHARE Anti-dulitve Securities excluded from Calculation (Details)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Restricted Stock Units (RSUs)	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share	'	'	'
Anti-dilutive shares excluded from the computation of earnings per share	46,000	27,000	2,400
Stock Options	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share	'	'	'
Anti-dilutive shares excluded from the computation of earnings per share	0	60,000	173,000

SUMMARIZED_CONDENSED_CONSOLIDA2

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION Condensed Consolidating Balance Sheet (Details) (USD $)	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 21, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	$915,418	'	$827,135	'	'
Loans receivable, net	185,293	'	12,017	'	'
Cash and cash equivalents	4,308	'	17,101	42,250	74,233
Restricted cash	5,352	'	4,589	'	'
Deferred tax assets	24,212	'	24,212	'	'
Assets held for sale, net	0	'	2,215	'	'
Prepaid expenses, deferred financing costs and other assets	63,252	'	29,613	'	'
Intercompany	0	'	0	'	'
Investments in subsidiaries	0	'	0	'	'
Total assets	1,197,835	'	916,882	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	141,328	'	152,322	'	'
Secured revolving credit facility	135,500	'	92,500	'	'
Senior unsecured notes payable	414,402	'	330,666	'	'
Accounts payable and accrued liabilities	22,229	'	11,694	'	'
Tax liability	24,212	'	24,212	'	'
Intercompany	0	'	0	'	'
Total liabilities	737,671	'	611,394	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	58	'	0	'	'
Common stock	388	'	371	'	'
Additional paid-in capital	534,639	'	353,861	'	'
Cumulative distributions in excess of net income	-74,921	'	-48,744	'	'
Total stockholders' equity	460,164	'	305,488	326,573	177,533
Total liabilities and stockholdersâ€™ equity	1,197,835	'	916,882	'	'
Parenthetical Information	'	'	'	'	'
Preferred stock, par value	$0.01	'	$0.01	'	'
Preferred stock, shares authorized	10,000,000	'	10,000,000	'	'
Preferred stock, shares issued	5,750,000	5,800,000	0	'	'
Preferred stock, shares outstanding	0	'	0	'	'
Common stock, par value	$0.01	'	$0.01	'	'
Common stock, shares authorized	125,000,000	'	125,000,000	'	'
Common stock, shares issued	38,788,745	'	37,099,202	'	'
Common stock, shares outstanding	38,788,745	'	37,099,202	'	'
Parent Company	'	'	'	'	'
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	101	'	151	'	'
Loans receivable, net	0	'	0	'	'
Cash and cash equivalents	3,551	'	15,075	41,736	70,841
Restricted cash	0	'	0	'	'
Deferred tax assets	24,212	'	24,212	'	'
Assets held for sale, net	'	'	0	'	'
Prepaid expenses, deferred financing costs and other assets	1,217	'	1,315	'	'
Intercompany	333,125	'	0	'	'
Investments in subsidiaries	128,640	'	351,632	'	'
Total assets	490,846	'	392,385	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	0	'	0	'	'
Secured revolving credit facility	0	'	0	'	'
Senior unsecured notes payable	0	'	0	'	'
Accounts payable and accrued liabilities	6,470	'	3,281	'	'
Tax liability	24,212	'	24,212	'	'
Intercompany	0	'	59,404	'	'
Total liabilities	30,682	'	86,897	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	58	'	0	'	'
Common stock	388	'	371	'	'
Additional paid-in capital	534,639	'	353,861	'	'
Cumulative distributions in excess of net income	-74,921	'	-48,744	'	'
Total stockholders' equity	460,164	'	305,488	'	'
Total liabilities and stockholdersâ€™ equity	490,846	'	392,385	'	'
Issuers	'	'	'	'	'
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	0	'	0	'	'
Loans receivable, net	0	'	0	'	'
Cash and cash equivalents	0	'	0	0	0
Restricted cash	0	'	0	'	'
Deferred tax assets	0	'	0	'	'
Assets held for sale, net	'	'	0	'	'
Prepaid expenses, deferred financing costs and other assets	9,207	'	7,339	'	'
Intercompany	270,194	'	227,396	'	'
Investments in subsidiaries	267,505	'	451,975	'	'
Total assets	546,906	'	686,710	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	0	'	0	'	'
Secured revolving credit facility	0	'	0	'	'
Senior unsecured notes payable	414,402	'	330,666	'	'
Accounts payable and accrued liabilities	3,864	'	4,412	'	'
Tax liability	0	'	0	'	'
Intercompany	0	'	0	'	'
Total liabilities	418,266	'	335,078	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	0	'	0	'	'
Common stock	0	'	0	'	'
Additional paid-in capital	21,226	'	292,939	'	'
Cumulative distributions in excess of net income	107,414	'	58,693	'	'
Total stockholders' equity	128,640	'	351,632	'	'
Total liabilities and stockholdersâ€™ equity	546,906	'	686,710	'	'
Combined Guarantor Subsidiaries	'	'	'	'	'
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	751,771	'	655,881	'	'
Loans receivable, net	185,293	'	12,017	'	'
Cash and cash equivalents	0	'	0	0	0
Restricted cash	121	'	92	'	'
Deferred tax assets	0	'	0	'	'
Assets held for sale, net	'	'	0	'	'
Prepaid expenses, deferred financing costs and other assets	46,694	'	18,133	'	'
Intercompany	0	'	0	'	'
Investments in subsidiaries	25,205	'	23,142	'	'
Total assets	1,009,084	'	709,265	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	0	'	0	'	'
Secured revolving credit facility	135,500	'	92,500	'	'
Senior unsecured notes payable	0	'	0	'	'
Accounts payable and accrued liabilities	11,008	'	3,348	'	'
Tax liability	0	'	0	'	'
Intercompany	645,956	'	205,458	'	'
Total liabilities	792,464	'	301,306	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	0	'	0	'	'
Common stock	0	'	0	'	'
Additional paid-in capital	53,574	'	321,666	'	'
Cumulative distributions in excess of net income	163,046	'	86,293	'	'
Total stockholders' equity	216,620	'	407,959	'	'
Total liabilities and stockholdersâ€™ equity	1,009,084	'	709,265	'	'
Combined Non-Guarantor Subsidiaries	'	'	'	'	'
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	163,546	'	171,103	'	'
Loans receivable, net	0	'	0	'	'
Cash and cash equivalents	757	'	2,026	514	3,392
Restricted cash	5,231	'	4,497	'	'
Deferred tax assets	0	'	0	'	'
Assets held for sale, net	'	'	2,215	'	'
Prepaid expenses, deferred financing costs and other assets	6,134	'	2,826	'	'
Intercompany	42,637	'	37,466	'	'
Investments in subsidiaries	0	'	0	'	'
Total assets	218,305	'	220,133	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	141,328	'	152,322	'	'
Secured revolving credit facility	0	'	0	'	'
Senior unsecured notes payable	0	'	0	'	'
Accounts payable and accrued liabilities	887	'	653	'	'
Tax liability	0	'	0	'	'
Intercompany	0	'	0	'	'
Total liabilities	142,215	'	152,975	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	0	'	0	'	'
Common stock	0	'	0	'	'
Additional paid-in capital	48,507	'	53,952	'	'
Cumulative distributions in excess of net income	27,583	'	13,206	'	'
Total stockholders' equity	76,090	'	67,158	'	'
Total liabilities and stockholdersâ€™ equity	218,305	'	220,133	'	'
Elimination	'	'	'	'	'
Assets	'	'	'	'	'
Real estate investments, net of accumulated depreciation	0	'	0	'	'
Loans receivable, net	0	'	0	'	'
Cash and cash equivalents	0	'	0	0	0
Restricted cash	0	'	0	'	'
Deferred tax assets	0	'	0	'	'
Assets held for sale, net	'	'	0	'	'
Prepaid expenses, deferred financing costs and other assets	0	'	0	'	'
Intercompany	-645,956	'	-264,862	'	'
Investments in subsidiaries	-421,350	'	-826,749	'	'
Total assets	-1,067,306	'	-1,091,611	'	'
Liabilities and stockholdersâ€™ equity	'	'	'	'	'
Mortgage notes payable	0	'	0	'	'
Secured revolving credit facility	0	'	0	'	'
Senior unsecured notes payable	0	'	0	'	'
Accounts payable and accrued liabilities	0	'	0	'	'
Tax liability	0	'	0	'	'
Intercompany	-645,956	'	-264,862	'	'
Total liabilities	-645,956	'	-264,862	'	'
Stockholdersâ€™ equity	'	'	'	'	'
Preferred stock	0	'	0	'	'
Common stock	0	'	0	'	'
Additional paid-in capital	-123,307	'	-668,557	'	'
Cumulative distributions in excess of net income	-298,043	'	-158,192	'	'
Total stockholders' equity	-421,350	'	-826,749	'	'
Total liabilities and stockholdersâ€™ equity	($1,067,306)	'	($1,091,611)	'	'

SUMMARIZED_CONDENSED_CONSOLIDA3

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION Condensed Consolidating Statement of Income (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenues:	'	'	'
Rental income	$128,988	$101,742	$80,678
Interest income	5,792	1,428	3,547
Total revenues	134,780	103,170	84,225
Expenses:	'	'	'
Depreciation and amortization	33,281	30,263	26,591
Interest	40,460	34,335	30,319
General and administrative	16,423	16,104	14,473
Impairment	0	2,481	0
Total expenses	90,164	83,183	71,383
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	-10,101	-2,670	0
Other expense	-800	2,196	0
Total other income (expense)	-10,901	-474	0
(Income) loss in subsidiary	0	0	0
Net income	33,715	19,513	12,842
Preferred Stock Dividends, Income Statement Impact	-7,966	0	0
Net Income (Loss) Available to Common Stockholders, Basic	25,749	19,513	12,842
Net income per common share, diluted	$0.68	$0.52	$0.43
Net income per common share, basic	$0.69	$0.53	$0.43
Weighted-average number of common shares outstanding, basic	37,514,637	37,061,111	30,109,417
Weighted-average number of common shares outstanding, diluted	38,071,926	37,321,517	30,171,225
Parent Company	'	'	'
Revenues:	'	'	'
Rental income	0	0	0
Interest income	86	18	64
Total revenues	86	18	64
Expenses:	'	'	'
Depreciation and amortization	51	49	53
Interest	0	0	0
General and administrative	15,040	14,631	9,905
Impairment	'	0	'
Total expenses	15,091	14,680	9,958
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	0	0	'
Other expense	0	0	'
Total other income (expense)	0	0	'
(Income) loss in subsidiary	48,720	34,175	22,736
Net income	33,715	19,513	12,842
Preferred Stock Dividends, Income Statement Impact	-7,966	'	'
Net Income (Loss) Available to Common Stockholders, Basic	25,749	'	'
Issuers	'	'	'
Revenues:	'	'	'
Rental income	0	0	0
Interest income	0	0	0
Total revenues	0	0	0
Expenses:	'	'	'
Depreciation and amortization	0	0	0
Interest	28,767	22,392	18,913
General and administrative	4	3	1
Total expenses	28,771	22,395	18,914
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	-9,750	0	'
Other expense	0	0	'
Total other income (expense)	-9,750	0	'
(Income) loss in subsidiary	87,241	56,570	41,650
Net income	48,720	34,175	22,736
Preferred Stock Dividends, Income Statement Impact	0	'	'
Net Income (Loss) Available to Common Stockholders, Basic	48,720	'	'
Combined Guarantor Subsidiaries	'	'	'
Revenues:	'	'	'
Rental income	99,711	75,606	55,447
Interest income	5,706	1,410	3,479
Total revenues	105,417	77,016	58,926
Expenses:	'	'	'
Depreciation and amortization	25,664	22,061	18,144
Interest	4,444	2,724	1,333
General and administrative	1,294	1,392	4,476
Impairment	'	0	'
Total expenses	31,402	26,177	23,953
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	-351	0	'
Other expense	-800	0	'
Total other income (expense)	-1,151	0	'
(Income) loss in subsidiary	3,889	-3,693	493
Net income	76,753	47,146	35,466
Preferred Stock Dividends, Income Statement Impact	0	'	'
Net Income (Loss) Available to Common Stockholders, Basic	76,753	'	'
Combined Non-Guarantor Subsidiaries	'	'	'
Revenues:	'	'	'
Rental income	29,277	26,136	25,231
Interest income	0	0	4
Total revenues	29,277	26,136	25,235
Expenses:	'	'	'
Depreciation and amortization	7,566	8,153	8,394
Interest	7,249	9,219	10,073
General and administrative	85	78	91
Impairment	'	2,481	'
Total expenses	14,900	19,931	18,558
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	0	-2,670	'
Other expense	0	2,196	'
Total other income (expense)	0	-474	'
(Income) loss in subsidiary	0	0	0
Net income	14,377	5,731	6,677
Preferred Stock Dividends, Income Statement Impact	0	'	'
Net Income (Loss) Available to Common Stockholders, Basic	14,377	'	'
Elimination	'	'	'
Revenues:	'	'	'
Rental income	0	0	0
Interest income	0	0	0
Total revenues	0	0	0
Expenses:	'	'	'
Depreciation and amortization	0	0	0
Interest	0	0	0
General and administrative	0	0	0
Impairment	'	0	'
Total expenses	0	0	0
Other Nonoperating Income (Expense) [Abstract]	'	'	'
Loss on extinguishment of debt	0	0	'
Other expense	0	0	'
Total other income (expense)	0	0	'
(Income) loss in subsidiary	-139,850	-87,052	-64,879
Net income	-139,850	-87,052	-64,879
Preferred Stock Dividends, Income Statement Impact	0	'	'
Net Income (Loss) Available to Common Stockholders, Basic	($139,850)	'	'

SUMMARIZED_CONDENSED_CONSOLIDA4

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION Condensed Consolidating Statement of Cash Flows (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	$62,099	$56,252	$44,705
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	-125,955	-205,424	-204,500
Payments to Acquire Notes Receivable	'	'	5,348
Origination of loans receivable	-165,960	-22,180	0
Preferred equity investments	-7,038	0	0
Additions to real estate	-764	-1,046	-86
Repayment of note receivable	0	10,000	5,348
Proceeds from sale of real estate	2,208	0	0
Investment in Subsidiary	'	0	0
Distribution from Subsidiary	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	-297,509	-218,650	-204,586
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	200,000	106,000	0
Proceeds from secured revolving credit facility	143,500	135,000	0
Proceeds from mortgage notes payable	0	56,651	0
Principal payments on senior unsecured notes	-113,750	0	0
Payments on secured revolving credit facility	-100,500	-42,500	0
Principal payments on mortgage notes payable	-10,994	-62,226	-3,027
Payments of deferred financing costs	-8,954	-6,800	-677
Payment of contingent consideration	-1,300	0	0
Issuance of preferred stock	138,249	0	0
Issuance of common stock	34,517	53	163,242
Dividends paid	-58,151	-48,929	-31,640
Contribution from Parent	'	0	0
Distribution to Parent	0	0	0
Intercompany financing	0	0	0
Net cash provided by financing activities	222,617	137,249	127,898
Net (decrease) increase in cash and cash equivalents	-12,793	-25,149	-31,983
Cash and cash equivalents, beginning of period	17,101	42,250	74,233
Cash and cash equivalents, end of period	4,308	17,101	42,250
Parent Company	'	'	'
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	47,810	53,584	41,298
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	0	0	0
Payments to Acquire Notes Receivable	'	'	5,348
Origination of loans receivable	0	0	'
Preferred equity investments	0	'	'
Additions to real estate	0	-14	-86
Repayment of note receivable	'	0	5,348
Proceeds from sale of real estate	0	'	'
Investment in Subsidiary	'	-7,191	-164,030
Distribution from Subsidiary	4,066	1,751	3,307
Intercompany financing	-178,015	-25,915	-41,196
Net cash (used in) provided by investing activities	-173,949	-31,369	-202,005
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	0	0	'
Proceeds from secured revolving credit facility	0	0	'
Proceeds from mortgage notes payable	'	0	'
Principal payments on senior unsecured notes	0	'	'
Payments on secured revolving credit facility	0	0	'
Principal payments on mortgage notes payable	0	0	0
Payments of deferred financing costs	0	0	0
Payment of contingent consideration	0	'	'
Issuance of preferred stock	138,249	'	'
Issuance of common stock	34,517	53	163,242
Dividends paid	-58,151	-48,929	-31,640
Contribution from Parent	'	0	0
Distribution to Parent	0	0	0
Intercompany financing	0	0	0
Net cash provided by financing activities	114,615	-48,876	131,602
Net (decrease) increase in cash and cash equivalents	-11,524	-26,661	-29,105
Cash and cash equivalents, beginning of period	15,075	41,736	70,841
Cash and cash equivalents, end of period	3,551	15,075	41,736
Issuers	'	'	'
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	0	0	0
Payments to Acquire Notes Receivable	'	'	0
Origination of loans receivable	0	0	'
Preferred equity investments	0	'	'
Additions to real estate	0	0	0
Repayment of note receivable	'	0	0
Proceeds from sale of real estate	0	'	'
Investment in Subsidiary	'	-7,191	-96
Distribution from Subsidiary	4,066	1,751	3,307
Intercompany financing	-258,819	-128,721	-204,700
Net cash (used in) provided by investing activities	-254,753	-134,161	-201,489
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	200,000	106,000	'
Proceeds from secured revolving credit facility	0	0	'
Proceeds from mortgage notes payable	'	0	'
Principal payments on senior unsecured notes	-113,750	'	'
Payments on secured revolving credit facility	0	0	'
Principal payments on mortgage notes payable	0	0	0
Payments of deferred financing costs	-5,446	-3,194	-430
Payment of contingent consideration	0	'	'
Issuance of preferred stock	0	'	'
Issuance of common stock	0	0	0
Dividends paid	0	0	0
Contribution from Parent	'	7,191	164,030
Distribution to Parent	-4,066	-1,751	-3,307
Intercompany financing	178,015	25,915	41,196
Net cash provided by financing activities	254,753	134,161	201,489
Net (decrease) increase in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Combined Guarantor Subsidiaries	'	'	'
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	-125,955	-205,424	-204,500
Payments to Acquire Notes Receivable	'	'	0
Origination of loans receivable	-165,960	-22,180	'
Preferred equity investments	-7,038	'	'
Additions to real estate	-764	-1,032	0
Repayment of note receivable	'	10,000	0
Proceeds from sale of real estate	0	'	'
Investment in Subsidiary	'	0	0
Distribution from Subsidiary	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	-299,717	-218,636	-204,500
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	0	0	'
Proceeds from secured revolving credit facility	143,500	135,000	'
Proceeds from mortgage notes payable	'	0	'
Principal payments on senior unsecured notes	0	'	'
Payments on secured revolving credit facility	-100,500	-42,500	'
Principal payments on mortgage notes payable	0	0	0
Payments of deferred financing costs	-3,010	-2,585	-200
Payment of contingent consideration	-1,300	'	'
Issuance of preferred stock	0	'	'
Issuance of common stock	0	0	0
Dividends paid	0	0	0
Contribution from Parent	'	0	0
Distribution to Parent	0	0	0
Intercompany financing	261,027	128,721	204,700
Net cash provided by financing activities	299,717	218,636	204,500
Net (decrease) increase in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	0	0	0
Combined Non-Guarantor Subsidiaries	'	'	'
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	14,289	2,668	3,407
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	0	0	0
Payments to Acquire Notes Receivable	'	'	0
Origination of loans receivable	0	0	'
Preferred equity investments	0	'	'
Additions to real estate	0	0	0
Repayment of note receivable	'	0	0
Proceeds from sale of real estate	2,208	'	'
Investment in Subsidiary	'	0	0
Distribution from Subsidiary	0	0	0
Intercompany financing	0	0	0
Net cash (used in) provided by investing activities	2,208	0	0
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	0	0	'
Proceeds from secured revolving credit facility	0	0	'
Proceeds from mortgage notes payable	'	56,651	'
Principal payments on senior unsecured notes	0	'	'
Payments on secured revolving credit facility	0	0	'
Principal payments on mortgage notes payable	-10,994	-62,226	-3,027
Payments of deferred financing costs	-498	-1,021	-47
Payment of contingent consideration	0	'	'
Issuance of preferred stock	0	'	'
Issuance of common stock	0	0	0
Dividends paid	0	0	0
Contribution from Parent	'	7,191	96
Distribution to Parent	-4,066	-1,751	-3,307
Intercompany financing	-2,208	0	0
Net cash provided by financing activities	-17,766	-1,156	-6,285
Net (decrease) increase in cash and cash equivalents	-1,269	1,512	-2,878
Cash and cash equivalents, beginning of period	2,026	514	3,392
Cash and cash equivalents, end of period	757	2,026	514
Elimination	'	'	'
Condensed Financial Statements	'	'	'
Net cash provided by operating activities	0	0	0
Cash flows from investing activities:	'	'	'
Acquisitions of real estate	0	0	0
Payments to Acquire Notes Receivable	'	'	0
Origination of loans receivable	0	0	'
Preferred equity investments	0	'	'
Additions to real estate	0	0	0
Repayment of note receivable	'	0	0
Proceeds from sale of real estate	0	'	'
Investment in Subsidiary	'	14,382	164,126
Distribution from Subsidiary	-8,132	-3,502	-6,614
Intercompany financing	436,834	154,636	245,896
Net cash (used in) provided by investing activities	428,702	165,516	403,408
Cash flows from financing activities:	'	'	'
Proceeds from issuance of senior unsecured notes	0	0	'
Proceeds from secured revolving credit facility	0	0	'
Proceeds from mortgage notes payable	'	0	'
Principal payments on senior unsecured notes	0	'	'
Payments on secured revolving credit facility	0	0	'
Principal payments on mortgage notes payable	0	0	0
Payments of deferred financing costs	0	0	0
Payment of contingent consideration	0	'	'
Issuance of preferred stock	0	'	'
Issuance of common stock	0	0	0
Dividends paid	0	0	0
Contribution from Parent	'	-14,382	-164,126
Distribution to Parent	8,132	3,502	6,614
Intercompany financing	-436,834	-154,636	-245,896
Net cash provided by financing activities	-428,702	-165,516	-403,408
Net (decrease) increase in cash and cash equivalents	0	0	0
Cash and cash equivalents, beginning of period	0	0	0
Cash and cash equivalents, end of period	$0	$0	$0

PRO_FORMA_FINANCIAL_INFORMATIO2

PRO FORMA FINANCIAL INFORMATION (Details) (Series of Individually Immaterial Business Acquisitions [Member], USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Business Acquisition, Pro Forma Information [Abstract]	'	'
Revenues	$145,517	$116,486
Depreciation and amortization	36,669	34,344
Net income	$33,459	$27,559
Net income per common share, basic (USD per share)	$0.89	$0.74
Net income per common share, diluted (USD per share)	$0.88	$0.74
Weighted-average number of common shares outstanding, basic (in shares)	37,514,637	37,061,111
Weighted-average number of common shares outstanding, diluted (in shares)	38,071,926	37,321,517
Senior Housing Facilities	'	'
Business Acquisition	'	'
Number of acquired properties	1	'
Acute Care Hospitals	'	'
Business Acquisition	'	'
Number of acquired properties	1	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

Oct. 23, 2013

Jul. 31, 2013

1-May-13

Jan. 07, 2013

Oct. 29, 2012

Aug. 01, 2012

Apr. 24, 2012

Feb. 29, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Feb. 14, 2014

Jan. 21, 2014

Jan. 23, 2014

Feb. 28, 2014

Mortgages

Subsequent Event

Nye Portfolio

Mortgages

Dividend Declared

Dividend Paid

Facilities

Renewal_Options

skilled_nursing_bed

unit

assisted_living_unit

independent_living_unit

Subsequent Event

Common stock dividends, declared (in dollars per share)

$0.34

$0.33

$1.36

$1.32

$0.96

$0.36

Common stock dividends, paid (in dollars per share)

$0.36

Preferred stock dividends, declared (in dollars per share)

$0.45

Preferred stock dividends, paid (in dollars per share)

$0.45

Face amount of debt

$44,800,000

Stated interest rate

4.25%

Weighted average interest rate

4.08%

3.97%

Expected write-offs in first quarter of next fiscal year associated with unamortized financing costs

500,000

Number of acquired properties

Number of Beds/Units

213

Payments to acquire properties

90,000,000

Location of facility acquired, approximate number of miles from Omaha, Nebraska

100

Term of lease

'10 years

Number of lease renewal options

Term of each renewal option

'5 years

Annual rent escalator

3.00%

Expected annual lease revenue

$8,000,000

SCHEDULE_III_Details

SCHEDULE III (Details) (USD $)

1 Months Ended

12 Months Ended

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Mortgage Indebtedness

Skilled Nursing/Post-Acute Facilities

New Martinsville

Glenville

Renaissance Terrace

Greenwood

Pawtuxet Village

Forest Hills, SNF

Seminole Estates

Bryan Care

Sylvania

Point Place

Perrysburg

Forest View

New Lebanon

New Lexington

Twin Rivers

San Juan

Mckinley Care

Bedford Hills

Exeter on Hampton

Pheasant Wood

Westwood

Colonial Hill

Crestwood Care

Applewood

Elms Care

Woodland Hill

Missouri River

Butte Care

Whitefish Care

Deer Lodge

Twin Oaks

Maplewood

Saugus

Kensington Manor

Regency Care

Paducah Care

Countryside Care

Bradford Square

Hillside Villa

Klondike Care

Colonial Manor

Hopkins Care

Bridge Point

Magnolia Village

Decatur Township

Gooding/Bennett Hills

Fountain City

Etowah Landing

Oakhurst

Orchard Ridge

Bay Tree

West Bay

Sunset Point

Arden House

Pope John Paul

Saint Camillus

Madison House

Willows Connecticut

Reservoir

Glen Hill

Governor's House

Elms Haven

Sable

Carmicheal

Willows California

Washington Care

Lake Drive

Boise

Langdon Place of Dover

Clipper Harbor

Mineral Springs

Wolfeboro

Langdon Place of Keene

Edmondson Care

Heartland Villa

Meridian Care

Saint Joseph's

Oak Brook Health Care Center

Broadmeadow Healthcare

Capitol Healthcare

Pike Creek Healthcare

Renaissance Healthcare

Honey Hill Care Center

Manokin Manor Nursing and Rehabilitation Center

Wesley Woods Alzheimer's Care Center

Windcrest Alzheimer's Care Center

Clara Burke [Member]

Warrington [Member]

Ridgecrest [Member]

Bucks Hill [Member]

Cromwell [Member]

Derry [Member]

Camden Care Center [Member]

Arbrook Plaza [Member]

Northgate Plaza [Member]

Gulf Pointe Plaza [Member]

Senior Housing Facilities

Monroe House [Member]

Forest Hills ALF

Langdon Place of Exeter

Langdon Place of Nashua

Heritage Place

The Legacy

Glen Crest

Village at Northrise

Creekside Senior Living

New Dawn Memory Care Center

Idenpendence Village at Frankenmuth

Gulfe Pointe Village

Aspen Ridge Retirement Village

Green Acres of Cadillac

Green Acres of Greenville

Green Acres of Manistee

Green Acres of Mason

Nottingham Place

Royal View

Tawas Village

Turning Brook

Stoney River Marshfield

Greenfield of Woodstock

Acute Care Hospitals

Texas Regional Medical Center

Forest Park Medical Center - Frisco

Multi-property Indebtedness

Real Estate Held for Sale

Operating Segments

Corporate Level

Property Group 1

Property Group 2

Property Group 3

Property Group 4

Real Estate and Accumulated Depreciation

Encumbrances

$141,328,000

$37,419,000

[1]

[2]

[3]

[4]

$6,811,000

[5]

[3]

[4]

[3]

[1]

[3]

$20,432,000

[3]

[1]

[3]

[4]

$4,873,000

[5]

$5,304,000

[3]

$3,923,000

[2]

$3,923,000

[5]

[3]

$99,986,000

$141,328,000

Initial Cost to Company

Land

131,611,000

100,423,000

475,000

[1]

484,000

76,000

2,066,000

1,275,000

1,653,000

[2]

655,000

1,278,000

942,000

[3]

1,089,000

987,000

819,000

784,000

63,000

280,000

799,000

[4]

409,000

[4]

1,911,000

2,365,000

[1]

625,000

699,000

412,000

[1]

557,000

348,000

312,000

1,706,000

[3]

2,023,000

[4]

1,092,000

[4]

651,000

[4]

190,000

[4]

885,000

771,000

285,000

1,864,000

1,169,000

1,636,000

239,000

774,000

277,000

764,000

792,000

592,000

[3]

14,000

673,000

253,000

[1]

43,000

1,474,000

[3]

536,000

[3]

786,000

775,000

[3]

706,000

[3]

2,250,000

[3]

4,337,000

1,838,000

1,204,000

918,000

[3]

3,717,000

[1]

1,272,000

[1]

[3]

137,000

[4]

160,000

[4]

801,000

[4]

846,000

[4]

417,000

[4]

454,000

[4]

304,000

[4]

446,000

[4]

532,000

[4]

840,000

[4]

1,433,000

1,650,000

4,940,000

2,460,000

1,640,000

1,736,000

1,953,000

885,000

802,000

2,527,000

2,617,000

[5]

509,000

[5]

508,000

[5]

2,265,000

[5]

768,000

[5]

1,235,000

3,783,000

4,901,000

[3]

1,005,000

[3]

22,202,000

1,803,000

[5]

571,000

[4]

668,000

325,000

1,356,000

1,432,000

[3]

256,000

2,874,000

5,027,000

789,000

2,024,000

[3]

217,000

[3]

684,000

[3]

952,000

[3]

198,000

[3]

744,000

[3]

307,000

[3]

258,000

[3]

546,000

[3]

574,000

597,000

8,986,000

4,020,000

[3]

4,966,000

131,611,000

Buildings and Improvements

957,803,000

[6]

658,813,000

[6]

10,543,000

[1],[6]

2,839,000

[6]

4,459,000

[6]

10,178,000

[6]

6,602,000

[6]

11,259,000

[2],[6]

3,527,000

[6]

6,477,000

[6]

5,627,000

[3],[6]

5,364,000

[6]

5,358,000

[6]

4,214,000

[6]

4,243,000

[6]

3,487,000

[6]

3,004,000

[6]

4,163,000

[4],[6]

1,865,000

[4],[6]

12,245,000

[6]

2,350,000

[1],[6]

3,986,000

[6]

3,823,000

[6]

3,960,000

[1],[6]

3,441,000

[6]

3,075,000

[6]

1,679,000

[6]

8,053,000

[3],[6]

16,967,000

[4],[6]

12,654,000

[4],[6]

6,339,000

[4],[6]

3,032,000

[4],[6]

5,100,000

[6]

4,550,000

[6]

1,643,000

[6]

7,523,000

[6]

5,989,000

[6]

4,133,000

[6]

4,790,000

[6]

3,848,000

[6]

4,272,000

[6]

3,576,000

[6]

3,050,000

[6]

2,277,000

[6]

2,278,000

[3],[6]

629,000

[6]

3,730,000

[6]

1,731,000

[6]

2,797,000

[1],[6]

842,000

[6]

8,212,000

[3],[6]

5,685,000

[3],[6]

4,870,000

[6]

4,660,000

[3],[6]

4,370,000

[3],[6]

23,816,000

[6]

13,702,000

[3],[6]

12,528,000

[6]

8,164,000

[6]

9,961,000

[6]

9,457,000

[6]

7,017,000

[3],[6]

5,750,000

[6]

18,473,000

[1],[6]

5,591,000

[1],[6]

1,741,000

[3],[6]

1,426,000

[6]

1,331,000

[4],[6]

549,000

[4],[6]

289,000

[4],[6]

10,036,000

[4],[6]

7,632,000

[4],[6]

5,352,000

[4],[6]

4,531,000

[4],[6]

3,992,000

[4],[6]

5,087,000

[4],[6]

4,025,000

[4],[6]

8,342,000

[4],[6]

21,878,000

[4],[6]

9,643,000

[6]

21,730,000

[6]

15,500,000

[6]

25,240,000

[6]

22,620,000

[6]

6,069,000

[6]

7,811,000

[6]

7,619,000

[6]

4,577,000

[6]

12,453,000

[6]

11,662,000

[5],[6]

5,018,000

[5],[6]

2,592,000

[5],[6]

10,096,000

[5],[6]

3,222,000

[5],[6]

5,777,000

[6]

14,219,000

[6]

10,299,000

[3],[6]

6,628,000

[3],[6]

132,033,000

[6]

182,000

[6]

3,927,000

[5],[6]

7,183,000

[6]

5,654,000

[4],[6]

5,492,000

[6]

4,019,000

[6]

6,666,000

[6]

6,003,000

[3],[6]

2,262,000

[6]

12,829,000

[6]

20,929,000

[6]

607,000

[6]

5,467,000

[3],[6]

3,000,000

[3],[6]

5,832,000

[3],[6]

2,578,000

[3],[6]

4,131,000

[3],[6]

1,745,000

[3],[6]

2,477,000

[3],[6]

3,713,000

[3],[6]

13,139,000

[3],[6]

8,733,000

[6]

5,465,000

[6]

166,821,000

[6]

57,620,000

[3],[6]

109,201,000

[6]

957,667,000

[6]

136,000

[6]

Total

1,089,414,000

759,236,000

11,018,000

[1]

3,323,000

4,535,000

12,244,000

7,877,000

12,912,000

[2]

4,182,000

7,755,000

6,569,000

[3]

6,453,000

6,345,000

5,033,000

5,027,000

3,550,000

3,284,000

4,962,000

[4]

2,274,000

[4]

14,156,000

4,715,000

[1]

4,611,000

4,522,000

4,372,000

[1]

3,998,000

3,423,000

1,991,000

9,759,000

[3]

18,990,000

[4]

13,746,000

[4]

6,990,000

[4]

3,222,000

[4]

5,985,000

5,321,000

1,928,000

9,387,000

7,158,000

5,769,000

5,029,000

4,622,000

4,549,000

4,340,000

3,842,000

2,869,000

2,278,000

[3]

643,000

4,403,000

1,731,000

3,050,000

[1]

885,000

9,686,000

[3]

6,221,000

[3]

5,656,000

5,435,000

[3]

5,076,000

[3]

26,066,000

13,702,000

[3]

12,528,000

12,501,000

11,799,000

10,661,000

7,935,000

[3]

5,750,000

22,190,000

[1]

6,863,000

[1]

1,741,000

[3]

1,563,000

1,331,000

[4]

709,000

[4]

289,000

[4]

10,837,000

[4]

8,478,000

[4]

5,769,000

[4]

4,985,000

[4]

4,296,000

[4]

5,533,000

[4]

4,557,000

[4]

9,182,000

[4]

21,878,000

[4]

11,076,000

23,380,000

20,440,000

27,700,000

24,260,000

7,805,000

9,764,000

8,504,000

5,379,000

14,980,000

14,279,000

[5]

5,527,000

[5]

3,100,000

[5]

12,361,000

[5]

3,990,000

[5]

7,012,000

18,002,000

15,200,000

[3]

7,633,000

[3]

154,235,000

182,000

5,730,000

[5]

7,754,000

5,654,000

[4]

6,160,000

4,344,000

8,022,000

7,435,000

[3]

2,518,000

15,703,000

25,956,000

1,396,000

7,491,000

[3]

3,217,000

[3]

6,516,000

[3]

3,530,000

[3]

4,329,000

[3]

2,489,000

[3]

2,784,000

[3]

3,971,000

[3]

13,685,000

[3]

9,307,000

6,062,000

175,807,000

61,640,000

[3]

114,167,000

1,089,278,000

136,000

Costs Capitalized Subsequent to Acquisition

1,913,000

764,000

[1]

[2]

[3]

[4]

[1]

[3]

[4]

185,000

[3]

[1]

[3]

[1]

[3]

[4]

[5]

579,000

[5]

[3]

1,031,000

[5]

[4]

[3]

1,031,000

[3]

1,795,000

118,000

Gross Amount at which Carried at Close of Period

Land

131,611,000

100,423,000

475,000

[1]

484,000

76,000

2,066,000

1,275,000

1,653,000

[2]

655,000

1,278,000

942,000

[3]

1,089,000

987,000

819,000

784,000

63,000

280,000

799,000

[4]

409,000

[4]

1,911,000

2,365,000

[1]

625,000

699,000

412,000

[1]

557,000

348,000

312,000

1,706,000

[3]

2,023,000

[4]

1,092,000

[4]

651,000

[4]

190,000

[4]

885,000

771,000

285,000

1,864,000

1,169,000

1,636,000

239,000

774,000

277,000

764,000

792,000

592,000

[3]

14,000

673,000

253,000

[1]

43,000

1,474,000

[3]

536,000

[3]

786,000

775,000

[3]

706,000

[3]

2,250,000

[3]

4,337,000

1,838,000

1,204,000

918,000

[3]

3,717,000

[1]

1,272,000

[1]

[3]

137,000

[4]

160,000

801,000

846,000

417,000

454,000

304,000

446,000

532,000

840,000

1,433,000

1,650,000

4,940,000

2,460,000

1,640,000

1,736,000

1,953,000

885,000

802,000

2,527,000

2,617,000

[5]

509,000

[5]

508,000

2,265,000

768,000

1,235,000

3,783,000

4,901,000

[3]

1,005,000

[3]

22,202,000

1,803,000

571,000

[4]

668,000

325,000

1,356,000

1,432,000

[3]

256,000

2,874,000

5,027,000

789,000

2,024,000

[3]

217,000

[3]

684,000

[3]

952,000

[3]

198,000

[3]

744,000

[3]

307,000

[3]

258,000

[3]

546,000

[3]

574,000

597,000

8,986,000

4,020,000

[3]

4,966,000

131,611,000

Building and Improvements

934,885,000

[6],[7]

636,765,000

[6],[7]

10,480,000

[1],[6],[7]

2,803,000

[6],[7]

4,101,000

[6],[7]

9,884,000

[6],[7]

6,204,000

[6],[7]

11,078,000

[2],[6],[7]

3,353,000

[6],[7]

6,141,000

[6],[7]

5,282,000

[3],[6],[7]

5,151,000

[6],[7]

5,079,000

[6],[7]

4,028,000

[6],[7]

3,875,000

[6],[7]

3,311,000

[6],[7]

2,804,000

[6],[7]

4,060,000

[4],[6],[7]

1,852,000

[4],[6],[7]

11,594,000

[6],[7]

2,233,000

[1],[6],[7]

3,548,000

[6],[7]

3,453,000

[6],[7]

3,766,000

[1],[6],[7]

3,124,000

[6],[7]

2,739,000

[6],[7]

1,538,000

[6],[7]

7,906,000

[3],[6],[7]

16,814,000

[4],[6],[7]

12,570,000

[4],[6],[7]

6,284,000

[4],[6],[7]

3,005,000

[4],[6],[7]

4,466,000

[6],[7]

3,870,000

[6],[7]

1,099,000

[6],[7]

7,125,000

[6],[7]

5,736,000

[6],[7]

3,845,000

[6],[7]

4,494,000

[6],[7]

3,550,000

[6],[7]

3,914,000

[6],[7]

3,264,000

[6],[7]

2,848,000

[6],[7]

2,038,000

[6],[7]

1,815,000

[3],[6],[7]

352,000

[6],[7]

3,546,000

[6],[7]

1,729,000

[6],[7]

2,758,000

[1],[6],[7]

788,000

[6],[7]

7,649,000

[6],[7]

5,348,000

[6],[7]

4,448,000

[6],[7]

4,188,000

[3],[6],[7]

3,998,000

[3],[6],[7]

22,980,000

[6],[7]

12,945,000

[3],[6],[7]

11,681,000

[6],[7]

7,849,000

[6],[7]

9,327,000

[6],[7]

9,196,000

[6],[7]

6,627,000

[3],[6],[7]

5,259,000

[6],[7]

18,096,000

[1],[6],[7]

5,511,000

[1],[6],[7]

1,621,000

[6],[7]

1,339,000

[6],[7]

1,262,000

[4],[6],[7]

466,000

[6],[7]

253,000

[6],[7]

9,570,000

[6],[7]

7,475,000

[1],[6],[7]

5,146,000

[1],[6],[7]

4,379,000

[1],[6],[7]

3,828,000

[6],[7]

4,619,000

[6],[7]

3,711,000

[6],[7]

8,213,000

[3],[6],[7]

21,130,000

[3],[6],[7]

9,643,000

[6],[7]

21,730,000

[3],[6],[7]

15,500,000

[3],[6],[7]

25,240,000

[3],[6],[7]

22,620,000

[3],[6],[7]

6,069,000

[6],[7]

7,811,000

[6],[7]

7,619,000

[6],[7]

4,577,000

[6],[7]

12,453,000

[3],[6],[7]

11,662,000

[3],[6],[7]

5,597,000

[6],[7]

2,592,000

[6],[7]

10,096,000

[6],[7]

3,222,000

[6],[7]

5,777,000

[6],[7]

14,219,000

[3],[6],[7]

10,299,000

[3],[6],[7]

6,628,000

[3],[6],[7]

131,045,000

[6],[7]

77,000

[6],[7]

3,851,000

[2],[6],[7]

6,745,000

[6],[7]

5,329,000

[4],[6],[7]

5,186,000

[6],[7]

3,561,000

[6],[7]

6,609,000

[6],[7]

5,748,000

[3],[6],[7]

3,294,000

[6],[7]

12,829,000

[6],[7]

20,929,000

[6],[7]

607,000

[6],[7]

5,467,000

[3],[6],[7]

3,000,000

[3],[6],[7]

5,832,000

[3],[6],[7]

2,578,000

[3],[6],[7]

4,131,000

[3],[6],[7]

1,745,000

[3],[6],[7]

2,477,000

[3],[6],[7]

3,713,000

[3],[6],[7]

13,139,000

[3],[6],[7]

8,733,000

[6],[7]

5,465,000

[6],[7]

166,821,000

[6],[7]

57,620,000

[6],[7]

109,201,000

[6],[7]

934,631,000

[6],[7]

254,000

[6],[7]

Total

760,708,000

1,066,496,000

956,614,000

737,188,000

10,955,000

[1]

3,287,000

4,177,000

11,950,000

7,479,000

12,731,000

[2]

4,008,000

7,419,000

6,224,000

[3]

6,240,000

6,066,000

4,847,000

4,659,000

3,374,000

3,084,000

4,859,000

[4]

2,261,000

[4]

13,505,000

4,598,000

[1]

4,173,000

4,152,000

4,178,000

[1]

3,681,000

3,087,000

1,850,000

9,612,000

[3]

18,837,000

[4]

13,662,000

[4]

6,935,000

[4]

3,195,000

[4]

5,351,000

4,641,000

1,384,000

8,989,000

6,905,000

5,481,000

4,733,000

4,324,000

4,191,000

4,028,000

3,640,000

2,630,000

1,815,000

[3]

366,000

4,219,000

1,729,000

3,011,000

[1]

831,000

9,123,000

[3]

5,884,000

[3]

5,234,000

4,963,000

[3]

4,704,000

[3]

25,230,000

12,945,000

[3]

11,681,000

12,186,000

11,165,000

10,400,000

7,545,000

[3]

5,259,000

21,813,000

[1]

6,783,000

[1]

1,621,000

[3]

1,476,000

1,262,000

[4]

626,000

[4]

253,000

[4]

10,371,000

[4]

8,321,000

[4]

5,563,000

[4]

4,833,000

[4]

4,132,000

[4]

5,065,000

[4]

4,243,000

[4]

9,053,000

[4]

21,130,000

[4]

11,076,000

23,380,000

20,440,000

27,700,000

24,260,000

7,805,000

9,764,000

8,504,000

5,379,000

14,980,000

14,279,000

[5]

6,106,000

[5]

3,100,000

[5]

12,361,000

[5]

3,990,000

[5]

7,012,000

18,002,000

15,200,000

[3]

7,633,000

[3]

153,247,000

77,000

5,654,000

[5]

7,316,000

5,329,000

[4]

5,854,000

3,886,000

7,965,000

7,180,000

[3]

3,550,000

15,703,000

25,956,000

1,396,000

7,491,000

[3]

3,217,000

[3]

6,516,000

[3]

3,530,000

[3]

4,329,000

[3]

2,489,000

[3]

2,784,000

[3]

3,971,000

[3]

13,685,000

[3]

9,307,000

6,062,000

175,807,000

61,640,000

[3]

114,167,000

1,066,242,000

254,000

Accumulated Depreciation and Amortization

-107,331,000

-151,078,000

-129,479,000

-132,068,000

-3,318,000

[1]

-562,000

-1,545,000

-2,947,000

-1,898,000

-2,952,000

[2]

-628,000

-1,489,000

-1,646,000

[3]

-1,036,000

-1,244,000

-1,225,000

-1,036,000

-1,778,000

-716,000

-1,144,000

[4]

-512,000

[4]

-2,598,000

-1,334,000

[1]

-1,041,000

-1,155,000

-1,185,000

[1]

-964,000

-706,000

-597,000

-1,767,000

[3]

-4,910,000

[4]

-3,130,000

[4]

-1,655,000

[4]

-955,000

[4]

-1,230,000

-1,121,000

-379,000

-1,504,000

-1,620,000

-1,060,000

-943,000

-1,058,000

-1,198,000

-857,000

-849,000

-585,000

-739,000

[3]

-180,000

-892,000

-724,000

-1,555,000

[1]

-409,000

-1,842,000

[3]

-1,300,000

[3]

-1,221,000

-1,064,000

[3]

-1,082,000

[3]

-5,505,000

-3,012,000

[3]

-2,787,000

-1,625,000

-2,208,000

-1,960,000

-2,017,000

[3]

-1,788,000

-4,331,000

[1]

-1,507,000

[1]

-816,000

[3]

-556,000

-423,000

[4]

-345,000

-148,000

-2,428,000

-2,515,000

-1,439,000

-1,147,000

-1,282,000

-1,054,000

-815,000

-2,739,000

-6,249,000

-800,000

-1,496,000

-1,116,000

-1,757,000

-1,605,000

-513,000

-631,000

-520,000

-329,000

-683,000

-585,000

[5]

-282,000

[5]

-146,000

-472,000

-167,000

-189,000

-443,000

-330,000

[3]

-223,000

[3]

-13,337,000

-48,000

-1,225,000

-1,857,000

-1,316,000

[4]

-996,000

-822,000

-1,538,000

-2,188,000

[3]

-364,000

-434,000

-766,000

-32,000

-210,000

[3]

-98,000

[3]

-189,000

[3]

-92,000

[3]

-140,000

[3]

-56,000

[3]

-92,000

[3]

-160,000

[3]

-383,000

[3]

-251,000

-80,000

-5,520,000

-4,847,000

[3]

-673,000

-150,925,000

-153,000

Life on Which Depreciation in Latest Income Statement is Computed

'39 years

[1]

'40 years

'38 years

'24 years

'40 years

[2]

'32 years

'30 years

'24 years

[3]

'36 years

'32 years

'24 years

'28 years

'20 years

'30 years

'24 years

[4]

'24 years

[4]

'36 years

'40 years

[5]

'28 years

'24 years

'44 years

[5]

'28 years

'32 years

'20 years

'32 years

[3]

'30 years

[4]

'35 years

[4]

'35 years

[4]

'30 years

[4]

'24 years

'37 years

'25 years

'28 years

'35 years

'25 years

'28 years

'25 years

'20 years

[3]

'29 years

'32 years

'40 years

[1]

'40 years

'32 years

[3]

'32 years

[3]

'32 years

[3]

'32 years

[3]

'28 years

'32 years

[3]

'32 years

'36 years

'32 years

'36 years

'24 years

[3]

'20 years

'40 years

[1]

'35 years

[1]

'40 years

[3]

'40 years

[4]

'10 years

'40 years

'42 years

'43 years

'41 years

'46 years

'35 years

'39 years

'24 years

'40 years

[4]

'40 years

[4]

'40 years

[4]

'40 years

[4]

'40 years

'15 years

'30 years

[2]

'43 years

'40 years

[5]

'38 years

[5]

'35 years

[5]

'32 years

'29 years

[2]

'40 years

Mortgage loan

141,328,000

152,322,000

37,600,000

19,100,000

30,000,000

13,300,000

Secured revolving credit facility

135,500,000

92,500,000

Initial cost of real estate for federal tax purposes

1,100,000,000

Real estate:

Balance at the beginning of the period

564,355,000

956,614,000

737,188,000

153,247,000

175,807,000

1,066,242,000

254,000

Acquisitions

202,570,000

120,229,000

202,458,000

Improvements

9,000

764,000

1,046,000

Purchase price allocation adjustment

-104,000

Write-offs of fully depreciated assets

-6,226,000

-11,111,000

-7,494,000

Balance at the end of the period

760,708,000

1,066,496,000

956,614,000

737,188,000

10,955,000

[1]

3,287,000

4,177,000

11,950,000

7,479,000

12,731,000

[2]

4,008,000

7,419,000

6,224,000

[3]

6,240,000

6,066,000

4,847,000

4,659,000

3,374,000

3,084,000

4,859,000

[4]

2,261,000

[4]

13,505,000

4,598,000

[1]

4,173,000

4,152,000

4,178,000

[1]

3,681,000

3,087,000

1,850,000

9,612,000

[3]

18,837,000

[4]

13,662,000

[4]

6,935,000

[4]

3,195,000

[4]

5,351,000

4,641,000

1,384,000

8,989,000

6,905,000

5,481,000

4,733,000

4,324,000

4,191,000

4,028,000

3,640,000

2,630,000

1,815,000

[3]

366,000

4,219,000

1,729,000

3,011,000

[1]

831,000

9,123,000

[3]

5,884,000

[3]

5,234,000

4,963,000

[3]

4,704,000

[3]

25,230,000

12,945,000

[3]

11,681,000

12,186,000

11,165,000

10,400,000

7,545,000

[3]

5,259,000

21,813,000

[1]

6,783,000

[1]

1,621,000

[3]

1,476,000

1,262,000

[4]

626,000

[4]

253,000

[4]

10,371,000

[4]

8,321,000

[4]

5,563,000

[4]

4,833,000

[4]

4,132,000

[4]

5,065,000

[4]

4,243,000

[4]

9,053,000

[4]

21,130,000

[4]

11,076,000

23,380,000

20,440,000

27,700,000

24,260,000

7,805,000

9,764,000

8,504,000

5,379,000

14,980,000

14,279,000

[5]

6,106,000

[5]

3,100,000

[5]

12,361,000

[5]

3,990,000

[5]

7,012,000

18,002,000

15,200,000

[3]

7,633,000

[3]

153,247,000

77,000

5,654,000

[5]

7,316,000

5,329,000

[4]

5,854,000

3,886,000

7,965,000

7,180,000

[3]

3,550,000

15,703,000

25,956,000

1,396,000

7,491,000

[3]

3,217,000

[3]

6,516,000

[3]

3,530,000

[3]

4,329,000

[3]

2,489,000

[3]

2,784,000

[3]

3,971,000

[3]

13,685,000

[3]

9,307,000

6,062,000

175,807,000

61,640,000

[3]

114,167,000

1,066,242,000

254,000

Accumulated depreciation:

Balance at the beginning of the period

-87,382,000

-129,479,000

-132,068,000

-13,337,000

-5,520,000

-150,925,000

-153,000

Depreciation expense

-26,175,000

[8]

-32,710,000

[8]

-29,642,000

[8]

Write-off of fully depreciated assets

6,226,000

11,111,000

7,494,000

Balance at the end of the period

-107,331,000

-151,078,000

-129,479,000

-132,068,000

-3,318,000

[1]

-562,000

-1,545,000

-2,947,000

-1,898,000

-2,952,000

[2]

-628,000

-1,489,000

-1,646,000

[3]

-1,036,000

-1,244,000

-1,225,000

-1,036,000

-1,778,000

-716,000

-1,144,000

[4]

-512,000

[4]

-2,598,000

-1,334,000

[1]

-1,041,000

-1,155,000

-1,185,000

[1]

-964,000

-706,000

-597,000

-1,767,000

[3]

-4,910,000

[4]

-3,130,000

[4]

-1,655,000

[4]

-955,000

[4]

-1,230,000

-1,121,000

-379,000

-1,504,000

-1,620,000

-1,060,000

-943,000

-1,058,000

-1,198,000

-857,000

-849,000

-585,000

-739,000

[3]

-180,000

-892,000

-724,000

-1,555,000

[1]

-409,000

-1,842,000

[3]

-1,300,000

[3]

-1,221,000

-1,064,000

[3]

-1,082,000

[3]

-5,505,000

-3,012,000

[3]

-2,787,000

-1,625,000

-2,208,000

-1,960,000

-2,017,000

[3]

-1,788,000

-4,331,000

[1]

-1,507,000

[1]

-816,000

[3]

-556,000

-423,000

[4]

-345,000

-148,000

-2,428,000

-2,515,000

-1,439,000

-1,147,000

-1,282,000

-1,054,000

-815,000

-2,739,000

-6,249,000

-800,000

-1,496,000

-1,116,000

-1,757,000

-1,605,000

-513,000

-631,000

-520,000

-329,000

-683,000

-585,000

[5]

-282,000

[5]

-146,000

-472,000

-167,000

-189,000

-443,000

-330,000

[3]

-223,000

[3]

-13,337,000

-48,000

-1,225,000

-1,857,000

-1,316,000

[4]

-996,000

-822,000

-1,538,000

-2,188,000

[3]

-364,000

-434,000

-766,000

-32,000

-210,000

[3]

-98,000

[3]

-189,000

[3]

-92,000

[3]

-140,000

[3]

-56,000

[3]

-92,000

[3]

-160,000

[3]

-383,000

[3]

-251,000

-80,000

-5,520,000

-4,847,000

[3]

-673,000

-150,925,000

-153,000

Depreciation expense related to assets held for sale

$300,000

[1]

Property serves as collateral for a mortgage loan totaling $19.1 million as of DecemberÂ 31, 2013.

[2]

Property serves as collateral for a mortgage loan totaling $13.3 million as of DecemberÂ 31, 2013.

[3]

Property serves as collateral for the $270.6 million secured revolving credit facility. There was $135.5 million outstanding as of DecemberÂ 31, 2013.

[4]

Property serves as collateral for a mortgage loan totaling $37.6 million as of DecemberÂ 31, 2013.

[5]

Property serves as collateral for a mortgage loan totaling $30.0 million as of DecemberÂ 31, 2013.

[6]

Building and building improvements include land improvements and furniture and equipment.

[7]

The aggregate cost of real estate for federal income tax purposes was $1.1 billion.

[8]

Depreciation expense for each of the years ended December 31, 2012 and 2011 excludes expense of $0.3 million related the to the assets held for sale.

SCHEDULE_IV_Details

SCHEDULE IV (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Mortgage Loans on Real Estate [Line Items]	'		'
Prepayment fee	0.50%		'
Movement in Mortgage Loans on Real Estate [Roll Forward]	'		'
Balance at the beginning of the period	$11,000		$0
New mortgage loans	151,173		11,000
Interest income added to principal	697		0
Balance at the end of the year	162,870		11,000
Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Prior Liens	0		'
Principal Balance	148,925		'
Book Value	149,450		'
Construction Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Prior Liens	0	[1],[2]	'
Principal Balance	162,870		'
Book Value	163,733		'
Onion Creek \| Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	8.50%	[3]	'
Prior Liens	0	[3]	'
Principal Balance	11,000	[3]	'
Book Value	11,040	[3]	'
Weston \| Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	9.00%	[1]	'
Prior Liens	0	[1]	'
Principal Balance	14,531	[1]	'
Book Value	14,608	[1]	'
Sun City West \| Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	9.00%	[3]	'
Prior Liens	0	[3]	'
Principal Balance	13,394	[3]	'
Book Value	13,459	[3]	'
Forest Park - Dallas \| Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	8.00%	[3]	'
Prior Liens	0	[3]	'
Principal Balance	110,000	[3]	'
Book Value	110,343	[3]	'
Forest Park - Fort Worth \| Construction Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	7.30%	[1],[2]	'
Principal Balance	11,880	[1],[2]	'
Book Value	12,119	[1],[2]	'
Other Construction Mortgages \| Construction Mortgages	'		'
Mortgage Loans on Real Estate [Line Items]	'		'
Contractual Interest Rate	10.00%		'
Principal Balance	2,065		'
Book Value	$2,164		'

[1]	Interest for the first 12 months and principal is deferred and due at the maturity date. Interest after the first 12 months is due monthly.
[2]	The loan has a prepayment fee of 0.5% of the outstanding balance if prepaid before October 1, 2015.
[3]	Interest is due monthly and principal is due at the maturity date.